4928 sets of interacting proteins for drugs from the curated DrugBank Drug Targets dataset.
| Gene Set |
Description |
|
2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
|
|
|
Ephedra
|
|
|
2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE
|
A naphthothiazole that has formula C14H9NO7S.
|
|
Indecainide
|
|
|
N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE
|
|
|
N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester)
|
|
|
Caffeine
|
A trimethylxanthine in which the three methyl groups are located at positions 1, 3, and 7. A purine alkaloid that occurs naturally in tea and coffee.
|
|
1-(biphenyl-4-ylmethyl)-1H-imidazole
|
|
|
3-Methylfentanyl
|
The monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of 3-methyl-N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
|
|
Dalfampridine
|
|
|
Inositol 1,3,4,5-Tetrakisphosphate
|
|
|
Atenolol
|
An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
|
|
WX-UK1
|
|
|
3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL
|
|
|
GV1001
|
|
|
Butanoic Acid
|
A four-carbon straight-chain saturated fatty acid.
|
|
2,4,6-Triaminoquinazoline
|
|
|
Gemfibrozil
|
An aromatic ether that has formula C15H22O3.
|
|
S-8184
|
|
|
Dydrogesterone
|
|
|
3-Bromo-7-Nitroindazole
|
|
|
AST-120
|
|
|
Fenoprofen
|
Propanoic acid in which one of the hydrogens at position 2 is substituted by a 3-phenoxyphenyl group. A non-steroidal anti-inflammatory drug, the dihydrate form of the calcium salt is used for the management of mild to moderate pain and for the relief of pain and inflammation associated with disorders such as arthritis. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding.
|
|
Pipotiazine
|
|
|
Se-Ethyl-Isoselenourea
|
|
|
Enflurane
|
An ether in which the oxygen atom is connected to 2-chloro-1,1,2-trifluoroethyl and difluoromethyl groups.
|
|
Decanoic Acid
|
|
|
(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one
|
|
|
2,6-dibromo-4-phenoxyphenol
|
|
|
Conivaptan
|
|
|
Omapatrilat
|
|
|
2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine
|
|
|
4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate
|
|
|
Oxymorphone
|
|
|
CRA_10991
|
|
|
Glycodiazine
|
|
|
Tacrine
|
|
|
Diphemanil Methylsulfate
|
The alkene resulting from the formal Wittig olefination of benzophenone and 1,1-dimethyl-4-bromopiperidinium methylsulfate. A quaternary ammonium anticholinergic, it binds muscarinic acetycholine receptors and thereby decreases secretory excretion of stomach acids, saliva and sweat, It is used topically in the treatment of hyperhidorsis (excessive sweating).
|
|
Methazolamide
|
|
|
Tetrabutylammonium Ion
|
|
|
(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate
|
|
|
10-CF3C(OH)2-DDACTHF
|
|
|
(2R)-1-(2,6-dimethylphenoxy)propan-2-amine
|
|
|
N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE
|
|
|
Glutathione
|
|
|
2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine
|
|
|
CRA_17693
|
|
|
Fudp
|
|
|
Butriptyline
|
|
|
L-Arginine
|
An L-alpha-amino acid that is the L-isomer of arginine.
|
|
WRR-112
|
|
|
4-Deoxy-Alpha-D-Glucose
|
|
|
Gliclazide
|
|
|
(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester
|
|
|
EP-2104R
|
|
|
(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one
|
|
|
+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE
|
|
|
Aspartate Beryllium Trifluoride
|
|
|
Sulindac
|
A monocarboxylic acid that is 1-benzylidene-1H-indene which is substituted at positions 2, 3, and 5 by methyl, carboxymethyl, and fluorine respectively, and in which the phenyl group of the benzylidene moiety is substituted at the para position by a methylsulfinyl group. It is a prodrug for the corresponding sulfide, a non-steroidal anti-inflammatory drug, used particularly in the treatment of acute and chronic inflammatory conditions.
|
|
Cholic Acid
|
A bile acid that is 5beta-cholan-24-oic acid bearing three alpha-hydroxy substituents at position 3, 7 and 12.
|
|
Masoprocol
|
|
|
(2S)-2-(1H-indol-3-yl)pentanoic acid
|
|
|
Sparfloxacin
|
|
|
Phenobarbital
|
A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
|
|
3-[({(1E)-[2-(trifluoromethyl)phenyl]methylidene}amino)oxy]propanoic acid
|
|
|
Icodextrin
|
|
|
2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL
|
|
|
Nitrofurantoin
|
An imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a (5-nitro-2-furyl)methylene]amino group. An antibiotic that damages bacterial DNA.
|
|
Ezogabine
|
|
|
Insulin, porcine
|
|
|
7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID
|
|
|
Lisinopril
|
A dipeptide that has formula C21H31N3O5.
|
|
Icosapent
|
|
|
REV131
|
|
|
NPI 32101
|
|
|
Echothiophate
|
|
|
Sulfisoxazole
|
A sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of gram-negative and gram-positive organisms.
|
|
4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE
|
|
|
(S)-Hmg-Coa
|
|
|
O-Acetylserine
|
|
|
Enoximone
|
|
|
4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose
|
|
|
PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE
|
|
|
Tiagabine
|
|
|
RU78783
|
|
|
CRA_9785
|
|
|
5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine
|
|
|
O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE
|
|
|
Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide
|
|
|
(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE
|
|
|
(2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[2-FLUORO-4-(2-OXOPYRIDIN-1(2H)-YL)PHENYL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE
|
|
|
Aldosterone
|
A pregnane-based steroidal hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney.
|
|
Phosphothiophosphoric Acid-Adenylate Ester
|
|
|
N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE
|
|
|
Pimozide
|
|
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide
|
|
|
(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE
|
|
|
tributylstannanyl
|
|
|
N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide
|
|
|
[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE
|
|
|
N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE
|
|
|
Maprotiline
|
|
|
Phosphonothreonine
|
|
|
Tamibarotene
|
A tetralin that has formula C22H25NO3.
|
|
1-Methylimidazole
|
|
|
Enalkiren
|
A peptide that has formula C35H56N6O6.
|
|
dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate
|
|
|
SU4984
|
|
|
Amphetamine
|
An amphetamine, the parent of the class of amphetamines, having the structure 1-phenylpropan-2-amine. It exists as a racemate.
|
|
6-Hydroxy-7,8-Dihydro Purine Nucleoside
|
|
|
N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE
|
An oxazolopyridine that has formula C22H23F2N7O.
|
|
5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide
|
|
|
Tinzaparin
|
|
|
D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate
|
|
|
L-Alpha-Glycerophosphorylserine
|
|
|
3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER
|
|
|
Amoxicillin
|
A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-(4-hydroxyphenyl)acetamido group.
|
|
Cyclosporine
|
|
|
Linagliptin
|
|
|
(5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one
|
|
|
4-Nitrophenyl Phosphate
|
An aryl phosphate resulting from the mono-esterification of phosphoric acid with 4-nitrophenol.
|
|
dioxothiomolybdenum(VI) ion
|
|
|
Sofalcone
|
|
|
ECGONINE METHYL ESTER
|
The O-debenzoyl analogue of cocaine.
|
|
[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid
|
|
|
Meta-Nitro-Tyrosine
|
|
|
Amperozide
|
|
|
N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA
|
|
|
ZK-805623
|
|
|
Purine Riboside-5'-Monophosphate
|
|
|
L-PROLINE, 1-[(2S)-3-MERCAPTO-2-METHYL-1-OXOPROPYL]-4-(PHENYLTHIO)-, 4S
|
|
|
Dronedarone
|
|
|
2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide
|
|
|
4,6-Dideoxy-4-Amino-Alpha-D-Glucose
|
|
|
2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE
|
|
|
Mycophenolic acid
|
|
|
Trifluoperazine
|
A member of the class of phenothiazines that is phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.
|
|
Nortriptyline
|
An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
|
|
Methylprednisolone
|
|
|
Epinephrine
|
|
|
Flucloxacillin
|
A penicillin compound having a 6beta-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido] side-chain.
|
|
N-Acetyl Serotonin
|
A member of the class of hydroxyindoles that is the N-acetyl derivative of serotonin.
|
|
Enoxacin
|
|
|
9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE
|
|
|
1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE
|
|
|
4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
|
|
|
Imatinib
|
|
|
{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE
|
A 1,3-thiazole that has formula C18H17N3O3S.
|
|
Ajmaline
|
|
|
Thioridazine
|
A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
|
|
(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE
|
|
|
N-(biphenyl-4-ylsulfonyl)-D-leucine
|
|
|
Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine
|
|
|
N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide
|
|
|
S-Octylglutathione
|
|
|
2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline
|
|
|
Diazepam
|
A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5.
|
|
4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol
|
|
|
3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE
|
A pyridinecarboxamide that has formula C14H16N4O2S.
|
|
Chlormerodrin
|
Urea in which one of the hydrogens is substituted by a 3-chloromercury-2-methoxyprop-1-yl group. It was formerly used as a diuretic, but more potent and less toxic drugs are now available. Its radiolabelled ((197)Hg, (203)Hg) forms were used in diagnostic aids in renal imaging and brain scans.
|
|
CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE
|
|
|
1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE
|
|
|
1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
|
|
|
Acetyldigitoxin
|
|
|
N7-Methyl-Guanosine-5'-Monophosphate
|
|
|
SP4160
|
|
|
Somatropin recombinant
|
|
|
Mestranol
|
|
|
N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide
|
|
|
Flupirtine
|
|
|
(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE
|
|
|
Nalbuphine
|
An organic heteropentacyclic compound that has formula C21H27NO4.
|
|
[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium
|
|
|
5-Mercapto-2-Nitro-Benzoic Acid
|
|
|
3-Phosphoglyceric Acid
|
A monophosphoglyceric acid having the phospho group at the 3-position. It is an intermediate in metabolic pathways like glycolysis and calvin cycle.
|
|
Thymidine-5'-Triphosphate
|
|
|
Guanosine-5'-Diphosphate-Rhamnose
|
|
|
N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE
|
|
|
Nilotinib
|
|
|
Mercaptopurine
|
A member of the class of purines that is 6,7-dihydro-1H-purine carrying a thione group at position 6.
|
|
2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone
|
|
|
Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]
|
|
|
Alpha-Linolenic Acid
|
A linolenic acid with cis-double bonds at positions 9, 12 and 15. Shown to have an antithrombotic effect.
|
|
Flumethasone Pivalate
|
A pivalate ester that has formula C27H36F2O6.
|
|
N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide
|
|
|
3-Deoxyguanosine
|
A 3'-deoxyribonucleoside that has formula C10H13N5O4.
|
|
5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine
|
|
|
Potassium
|
An alkali metal atom that has formula K.
|
|
Pseudoephedrine
|
A secondary amine that has formula C10H15NO.
|
|
CRA_10655
|
|
|
Troglitazone
|
|
|
1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide
|
|
|
MDX-018
|
|
|
9,10-Deepithio-9,10-Didehydroacanthifolicin
|
|
|
N-Pyridoxyl-Glycine-5-Monophosphate
|
|
|
4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide
|
|
|
Clodronate
|
|
|
AGRO100
|
|
|
(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE
|
|
|
1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE
|
|
|
Foscarnet
|
|
|
5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid
|
|
|
5-Phosphoarabinonic Acid
|
|
|
1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE
|
|
|
Bupranolol
|
|
|
(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE
|
|
|
Para-Coumaric Acid
|
|
|
Testosterone
|
An androstanoid having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5..
|
|
Licofelone
|
|
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
|
|
Phenelzine
|
|
|
(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE
|
|
|
Triamterene
|
|
|
(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine
|
|
|
Tacrolimus
|
|
|
Mesobiliverdin Iv Alpha
|
|
|
Bufuralol
|
A benzofuran that has formula C16H23NO2.
|
|
Methylethylamine
|
|
|
Moclobemide
|
|
|
[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID
|
|
|
Metaraminol
|
|
|
Reidispongiolide A
|
|
|
Pregnenolone
|
|
|
4'-Deaza-1'-Aza-2'-Deoxy-1'-(9-Methylene)-Immucillin-H, (3r,4r)-N-[9-Deazahypoxanthin-9-Yl)Methyl]-4-Hydroxymethyl-Pyrrolidin-3-Ol
|
|
|
DG031
|
|
|
Nitrazepam
|
|
|
N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE
|
A sulfonamide that has formula C17H12F9NO3S.
|
|
2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine
|
|
|
Desflurane
|
|
|
4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID
|
A pyrrolidinone that has formula C14H16N2O5.
|
|
Cefepime
|
A cephalosporin bearing (1-methylpyrrolidinium-1-yl)methyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton.
|
|
Methoxamine
|
|
|
Epothilone D
|
An epothilone that has formula C27H41NO5S.
|
|
Fludarabine
|
|
|
3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER
|
|
|
Tolcapone
|
|
|
Formoterol
|
|
|
Daclizumab
|
|
|
D-Gluconhydroximo-1,5-Lactam
|
|
|
Dnqx
|
|
|
N-Octane
|
|
|
Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone
|
|
|
(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol
|
|
|
Erlotinib
|
|
|
N-[(2R)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]-L-alanine
|
|
|
3-Methylpyridine
|
A methylpyridine that is pyridine substituted by a methyl group at position 3.
|
|
Coagulation Factor IX
|
|
|
Frovatriptan
|
|
|
3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol
|
|
|
Vasopressin
|
A family of cyclic nonapeptide hormones found in most mammals. Synthesised in the hypothalamus and stored in the post-pituitary, vasopressins play a key role in homeostasis, particularly in regulating the body's water content. Together with the similar neuropeptide oxytocin, they are believed to influence social cognition and behaviour.
|
|
AZD6140
|
|
|
Fusicoccin
|
An acetate ester that has formula C36H56O12.
|
|
Pentagastrin
|
|
|
Arginineamide
|
|
|
Aclidinium
|
|
|
Degarelix
|
|
|
Oxyphencyclimine
|
|
|
AC220
|
|
|
ND7001
|
|
|
(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM
|
|
|
N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide
|
|
|
N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE
|
|
|
CP-271485
|
|
|
RU79256
|
|
|
(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide
|
|
|
Tubocurarine
|
|
|
ARC1779
|
|
|
Oxyphenbutazone
|
|
|
N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid
|
|
|
Isothipendyl
|
|
|
Estrone
|
A 17-oxo steroid that is estra-1,3,5(10)-triene substituted by an hydroxy group at position 3 and an oxo group at position 17.
|
|
2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE
|
|
|
Deoxy-Bigchap
|
|
|
3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol
|
|
|
N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan
|
|
|
N-[O-Phosphono-Pyridoxyl]-Isoleucine
|
|
|
Monoisopropyl Ester Phosphonic Acid Group
|
|
|
Propidium
|
A phenanthridine that has formula C27H34N4.
|
|
Dalteparin
|
|
|
Tranexamic Acid
|
|
|
4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE
|
|
|
[(1e)-4-Phenylbut-1-Enyl]Benzene
|
|
|
1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea
|
|
|
(4-ETHYLPHENYL)SULFAMIC ACID
|
|
|
5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE
|
A benzothiazole that has formula C14H17NO3S.
|
|
3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate
|
|
|
4-Methoxyamphetamine
|
|
|
3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE
|
A member of the class of pyrrolidin-2-ones that is pyrrolidin-2-one in which a hydrogen at the 3 pro-S position is replaced by a 3-oxododecanamido group.
|
|
D-[(Amino)Carbonyl]Phenylalanine
|
|
|
Lomitapide
|
A member of the class of benzamides obtained by formal condensation of the carboxy group of 4'-(trifluoromethyl)biphenyl-2-carboxylic acid with the primary amino group of 9-[4-(4-aminopiperidin-1-yl)butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide. Used (as its mesylate salt) as a complement to a low-fat diet and other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia.
|
|
(2S)-2-({6-[(3-AMINO-5-CHLOROPHENYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)-3-METHYLBUTAN-1-OL
|
|
|
Caprylic acid
|
|
|
Lipoic Acid
|
A heterocyclic thia fatty acid comprising pentanoic acid with a 1,2-dithiolan-3-yl group at the 5-position.
|
|
Canaline
|
An alpha-amino acid that has formula C4H10N2O3.
|
|
TNX-901
|
|
|
Cimicoxib
|
An imidazole substituted at positions 1, 4 and 5 by 4-aminosulfonylphenyl, chloro and 3-fluoro-4-methyoxyphenyl groups respectively. A selective cyclooxygenase 2 inhibitor, it is used in veterinary medicine for the control of pain and inflammation associated with osteoarthritis in dogs.
|
|
Ergotamine
|
A peptide ergot alkaloid that is dihydroergotamine in which a double bond replaces the single bond between positions 9 and 10.
|
|
MF101
|
|
|
6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE
|
|
|
Cefotetan
|
A semi-synthetic cephalosporin antibiotic with [(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl, methoxy and {[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino groups at the 3, 7alpha, and 7beta positions, respectively, of the cephem skeleton. It is resistant to a wide range of beta-lactamases and is active against a broad spectrum of aerobic and anaerobic Gram-positive and Gram-negative microorganisms.
|
|
Bortezomib
|
|
|
Cefpiramide
|
A third-generation cephalosporin antibiotic with [(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl and (R)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It has a broad spectrum of antibacterial activity.
|
|
Argifin
|
|
|
SP-01A
|
|
|
Propylhexedrine
|
|
|
2,5-bis-o-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-d-glucitol
|
|
|
(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione
|
|
|
N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide
|
|
|
Piclamilast
|
A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 3-(cyclopentyloxy)-4-methoxybenzoic acid with the primary amino group of 3,5-dichloropyridin-4-amine.
|
|
H TYPE II TRISACCHARIDE
|
|
|
2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide
|
|
|
5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide
|
|
|
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid
|
A D-proline derivative that has formula C9H15NO3S.
|
|
Exenatide
|
|
|
4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine
|
|
|
NOX-700
|
|
|
Ciclesonide
|
|
|
(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL
|
|
|
(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
|
|
|
2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide
|
|
|
9-Deazaguanine
|
|
|
CP-4055
|
|
|
SCV-07
|
|
|
Glycopyrrolate
|
|
|
Genistein
|
7-Hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties.
|
|
Alprazolam
|
A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
|
|
Glutathione S-(2,4 Dinitrobenzene)
|
|
|
2-chloro-5-nitro-N-phenylbenzamide
|
|
|
Naproxen
|
A methoxynaphthalene that is 2-methoxynaphthalene substituted by a carboxy ethyl group at position 6. Naproxen is a non-steroidal anti-inflammatory drug commonly used for the reduction of pain, fever, inflammation and stiffness caused by conditions such as osteoarthritis, kidney stones, rheumatoid arthritis, psoriatic arthritis, gout, ankylosing spondylitis, menstrual cramps, tendinitis, bursitis, and for the treatment of primary dysmenorrhea. It works by inhibiting both the COX-1 and COX-2 enzymes.
|
|
Propylthiouracil
|
|
|
N-[4-(benzyloxy)phenyl]glycinamide
|
|
|
IMIDAZOPYRIDAZIN 1
|
|
|
(2s)-Pyrrolidin-2-Ylmethylamine
|
|
|
SO-101
|
|
|
Nabumetone
|
|
|
(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE
|
|
|
3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide
|
|
|
3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid
|
|
|
N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA
|
|
|
Coenzyme A
|
A thiol comprising a panthothenate unit in phosphoric anhydride linkage with a 3',5'-adenosine diphosphate unit; and an aminoethanethiol unit.
|
|
Remifentanil
|
A piperidinecarboxylate ester that is methyl piperidine-4-carboxylate in which the hydrogen attached to the nitrogen is substituted by a 3-methoxy-3-oxopropyl group and the hydrogen at position 4 is substituted the nitrogen of N-propanoylaniline.
|
|
Methoxy arachidonyl fluorophosphonate
|
|
|
1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine
|
|
|
5-Thio-a/B-D-Mannopyranosylamine
|
|
|
2-(N-Morpholino)-Ethanesulfonic Acid
|
A Good's buffer substance, pKa = 6.15 at 20 degreeC.
|
|
Oxamic Acid
|
The monoamide of oxalic acid.
|
|
(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
|
|
|
Carbamazepine
|
A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
|
|
Nepafenac
|
|
|
Mercury Diiodide
|
A mercury coordination entity composed of mercury and iodine with formula HgI2.
|
|
N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE
|
|
|
Lauryl Dimethylamine-N-Oxide
|
|
|
Bicine
|
A Good's buffer substance that is N,N-bis(2-hydroxyethyl)glycine or its zwitterionic/carboxylate form.
|
|
Phenylpropanolamine
|
|
|
R115777
|
|
|
Tetrodotoxin
|
A quinazoline alkaloid that is a marine toxin isolated from fish such as puffer fish. It has been shown to exhibit potential neutotoxicity due to its ability to block voltage-gated sodium channels.
|
|
Riboflavin Monophosphate
|
|
|
2'-Deoxyguanosine-5'-Diphosphate
|
|
|
[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid
|
|
|
2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL
|
|
|
SR 121463
|
|
|
4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide
|
A L-phenylalanine derivative that has formula C31H42N4O5S.
|
|
Almotriptan
|
|
|
Rhodamine 6g
|
A rhodamine 6G(1+) that has formula C28H31ClN2O3.
|
|
Tetradecane
|
A straight chain alkane consisting of 14 carbon atoms.
|
|
ADX-10061
|
|
|
Desloratadine
|
Loratadine in which the ethoxycarbonyl group attached to the piperidine ring is replaced by hydrogen. The major metabolite of loratidine, desloratadine is an antihistamine which is used for the symptomatic relief of allergic conditions including rhinitis and chronic urticaria. It does not readily enter the central nervous system, so does not cause drowsiness.
|
|
N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE
|
|
|
Vinylglycine
|
|
|
Cinalukast
|
2,2-Diethylsuccinanilic acid substituted at a meta- position by an (E)-2-(4-cyclobutyl-1,3-thiazol-2-yl)ethenyl group. It selectively antagonizes leukotriene D4 at the cysteinyl leukotriene receptor, in the human airway, preventing airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus. It is used in the treatment of asthma.
|
|
Mevastatin
|
A carboxylic ester that is pravastatin that is lacking the allylic hydroxy group and in which the lactone moiety has been hydrolysed to the corresponding delta-hydroxy-carboxylic acid. A hydroxymethylglutaryl-CoA reductase inhibitor (statin) isolated from Penicillium citrinum and from Penicillium brevicompactum, its clinical use as a lipid-regulating drug ceased following reports of toxicity in animals.
|
|
4-(4-FLUOROBENZYL)PIPERIDINE
|
A piperidine that has formula C12H16FN.
|
|
Trimetrexate
|
|
|
Beta-Alanine
|
|
|
Eplerenone
|
A steroid acid ester that has formula C24H30O6.
|
|
FG-4592
|
|
|
D-Lactic Acid
|
|
|
2-Aminoethanimidic Acid
|
|
|
N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE
|
|
|
N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea
|
|
|
3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE
|
|
|
Sulfinpyrazone
|
A pyrazolidine that has formula C23H20N2O3S.
|
|
2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE
|
|
|
N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE
|
|
|
1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
|
|
|
Zalcitabine
|
|
|
Adenosine Monotungstate
|
|
|
2,3,4,5,6-Pentafluorobenzyl Alcohol
|
An organofluorine compound that is benzyl alcohol substituted by fluoro groups at positions 2, 3, 4, 5 and 6.
|
|
1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE
|
|
|
3-(4-HYDROXY-PHENYL)PYRUVIC ACID
|
|
|
histamine dihydrochloride
|
|
|
(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid
|
|
|
Myricetin
|
A hexahydroxyflavone that is flavone substituted by hydroxy groups at positions 3, 3', 4', 5, 5' and 7. It has been isolated from the leaves of Myrica rubra and other plants.
|
|
Bevantolol
|
A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by 3-methylphenyl and one of the hydrogens attached to the nitrogen is substituted by 2-(3,4-dimethoxyphenyl)ethyl. A beta1 adrenoceptor antagonist, it has been shown to be as effective as other beta-blockers for the treatment of angina pectoris and hypertension.
|
|
DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE
|
|
|
Canfosfamide
|
|
|
Palonosetron
|
|
|
SYM001
|
|
|
Menthol
|
|
|
Iloprost
|
|
|
3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid
|
|
|
2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide
|
|
|
Pindolol
|
A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
|
|
I-5
|
|
|
Beraprost
|
|
|
3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
|
|
|
Myristoyl-Coa
|
A long-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of myristic acid.
|
|
Fluconazole
|
A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It has been shown to exhibit antifungal activity.
|
|
(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE
|
|
|
2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline
|
|
|
THIO-ATPA
|
|
|
N-Propyl Isocyanide
|
|
|
3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine
|
|
|
3',5'-Dinitro-N-Acetyl-L-Thyronine
|
|
|
(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE
|
|
|
Para-Toluene Sulfonate
|
|
|
Entacapone
|
|
|
RU78262
|
|
|
5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine
|
|
|
8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine
|
|
|
Amlexanox
|
|
|
Ganciclovir
|
An oxopurine that is guanine substituted by a [(1,3-dihydroxypropan-2-yl)oxy]methyl group at position 9. Ganciclovir is an antiviral drug used to treat or prevent AIDS-related cytomegalovirus infections.
|
|
(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide
|
|
|
(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)BENZYL)GUANIDINE
|
|
|
[3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine
|
|
|
3,5-dibromobiphenyl-4-ol
|
|
|
Quinacrine
|
|
|
1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea
|
|
|
Sitaxentan
|
|
|
Iloperidone
|
|
|
SB-559448
|
|
|
Chlorphenesin
|
|
|
1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
|
|
L-Thiocitrulline
|
|
|
Undecyl-Phosphinic Acid Butyl Ester
|
|
|
5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID
|
|
|
[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID
|
|
|
N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
|
|
|
1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione
|
|
|
Sorbitol 6-phosphate
|
|
|
6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE
|
|
|
Ethyl Isocyanide
|
|
|
[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid
|
A 1,3,4-oxadiazole that has formula C8H5N3O6S.
|
|
N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE
|
|
|
R-3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID
|
|
|
Halazepam
|
|
|
Tenofovir
|
|
|
N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide
|
|
|
3-Methylthiofentanyl
|
A piperidine compound having a (2-thienyl)ethyl substituent at the 1-position, a methyl group at the 3-position and an N-phenylpropanamido group at the 4-position.
|
|
7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID
|
|
|
Sodium Tetradecyl Sulfate
|
|
|
Norelgestromin
|
|
|
Cycloleucine
|
|
|
Fluorescein
|
|
|
Flucytosine
|
An organofluorine compound that has formula C4H4FN3O.
|
|
Fluocinolone Acetonide
|
A fluorinated steroid that is flunisolide in which the hydrogen at position 9 is replaced by fluorine. A corticosteroid with glucocorticoid activity, it is used (both as the anhydrous form and as the dihydrate) in creams, gels and ointments for the treatment of various skin disorders.
|
|
Triflusal
|
|
|
S-4-Nitrobutyryl-Coa
|
|
|
Dodecyl Sulfate
|
|
|
3'-Uridinemonophosphate
|
|
|
N-Butyl-N'-Hydroxyguanidine
|
|
|
Ethanolamine Oleate
|
|
|
L-Glutamic Acid
|
An optically active form of glutamic acid having L-configuration.
|
|
Trichlormethiazide
|
|
|
Salsalate
|
|
|
N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
|
|
|
Uridine-5'-Diphosphate
|
|
|
2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID
|
|
|
2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol
|
|
|
Ketazolam
|
|
|
(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE]
|
|
|
ROX-888
|
|
|
Beta-Hydroxyasparagine
|
|
|
5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide
|
|
|
Metronidazole
|
A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
|
|
N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide
|
A member of the class of benzamides obtained by formal condensation of the carboxy group of 3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydropyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzoic acid with the amino group of cyclopropylamine.
|
|
REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE
|
|
|
4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
|
|
|
N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE
|
|
|
MLN8237
|
|
|
6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One
|
|
|
2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine
|
|
|
N-Tridecanoic Acid
|
|
|
Hydroxyproline
|
A proline derivative that is proline substituted by at least one hydroxy group.
|
|
(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide
|
|
|
3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE
|
|
|
N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide
|
|
|
Dyphylline
|
An oxopurine that is theophylline bearing a 2,3-dihydroxypropyl group at the 7 position. It has broncho- and vasodilator properties, and is used in the treatment of asthma, cardiac dyspnea, and bronchitis. It is also an ingredient in preparations that have been promoted for coughs.
|
|
Insulin Aspart
|
|
|
Felbamate
|
|
|
Regadenoson
|
|
|
Phenserine
|
|
|
Penbutolol
|
|
|
6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER
|
|
|
(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile
|
|
|
Dimethyltryptamine
|
|
|
2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE
|
|
|
beta-L-fucose
|
A L-fucopyranose with a beta-configuration at the anomeric position.
|
|
Sitagliptin
|
A triazolopyrazine that exhibits hypoglycemic activity.
|
|
Ceftazidime
|
A cephalosporin bearing pyridinium-1-ylmethyl and {[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetamido groups at positions 3 and 7, respectively, of the cephem skeleton.
|
|
Lanosterol
|
A tetracyclic triterpenoid that is lanosta-8,24-diene substituted by a beta-hydroxy group at position 3. It is the compound from which all steroids are derived.
|
|
N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE
|
|
|
Quercetin
|
A pentahydroxyflavone having the five hydroxy groups placed at the 3-, 3'-, 4'-, 5- and 7-positions.
|
|
Gallium nitrate
|
|
|
Tofisopam
|
|
|
Pramlintide
|
|
|
Ipilimumab
|
|
|
Cidofovir
|
|
|
1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE
|
A pyridylpiperidine that has formula C23H29ClN4O2S.
|
|
2-Deoxy-2-Amino Glucitol-6-Phosphate
|
|
|
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol
|
|
|
S-(D-Carboxybutyl)-L-Homocysteine
|
|
|
Valganciclovir
|
|
|
(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol
|
|
|
5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine
|
|
|
Tafluprost
|
|
|
Dapagliflozin
|
|
|
3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide
|
|
|
(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID
|
|
|
Prednicarbate
|
|
|
Trabectedin
|
A tetrahydroisoquinoline alkaloid obtained from a Caribbean tunicate Ecteinascidia turbinata. Used for the treatment of soft tissue sarcoma and relapsed ovarian cancer.
|
|
5'-Guanosine-Diphosphate-Monothiophosphate
|
|
|
L-Aspartic Acid
|
The L-enantiomer of aspartic acid.
|
|
Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide
|
|
|
Cycrimine
|
|
|
LATRUNCULIN B
|
A macrolide consisting of a 14-membered bicyclic lactone attached to the rare 2-thiazolidinone moiety. It is obtained from the Red Sea sponge Latrunculia magnifica.
|
|
Dabrafenib
|
An organofluorine compound and antineoplastic agent, used as its mesylate salt in treatment of metastatic melanoma.
|
|
(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID
|
|
|
pimagedine HCl
|
|
|
Aminophenazone
|
A pyrazolone that is 1,2-dihydro-3H-pyrazol-3-one substituted by a dimethylamino group at position 4, methyl groups at positions 1 and 5 and a phenyl group at position 2. It exhibits analgesic, anti-inflammatory, and antipyretic properties.
|
|
5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE
|
|
|
Glycerol Phenylbutyrate
|
|
|
5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE
|
|
|
Ethopropazine
|
|
|
2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide
|
|
|
Flunarizine
|
|
|
(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine
|
|
|
Hemi-Babim
|
|
|
Vigabatrin
|
|
|
3r-Hydroxydecanoyl-Coa
|
|
|
HYDROXYFASUDIL
|
|
|
7-AMINO-4-METHYL-CHROMEN-2-ONE
|
|
|
Triamcinolone
|
A C21-steroid hormone that is 1,4-pregnadiene-3,20-dione carrying four hydroxy substituents at positions 11beta, 16alpha, 17alpha and 21 as well as a fluoro substituent at position 9. Used in the form of its 16,17-acetonide to treat various skin infections.
|
|
7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide
|
|
|
Digitoxin
|
|
|
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
|
|
|
N-Cyclohexyl-N'-(Propyl)Phenyl Urea
|
|
|
N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE
|
|
|
4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE
|
|
|
AZD3409
|
|
|
8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione
|
|
|
N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide
|
|
|
6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE
|
|
|
Milnacipran
|
|
|
Chlorthalidone
|
An isoindole that has formula C14H11ClN2O4S.
|
|
D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide
|
|
|
Isocarboxazid
|
|
|
Nimodipine
|
A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
|
|
4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide
|
A pyrrolopyrazine that has formula C22H32N6O5S.
|
|
Phosphoaminophosphonic Acid Guanylate Ester
|
|
|
(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE
|
|
|
Tryptophanyl-5'amp
|
|
|
XEN2174
|
|
|
Methylergometrine
|
|
|
Cephaloglycin
|
|
|
methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate
|
|
|
Amifostine
|
An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
|
|
1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose
|
|
|
Alpha-Difluoromethylornithine
|
|
|
Temocapril
|
|
|
Ingenol Mebutate
|
|
|
Lidocaine
|
The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
|
|
Propericiazine
|
|
|
Nafarelin
|
|
|
Ursodeoxycholic acid
|
A bile acid found in the bile of bears (Ursidae) as a conjugate with taurine. Used therapeutically, it prevents the synthesis and absorption of cholesterol and can lead to the dissolution of gallstones.
|
|
6-hydroxydopa quinone
|
|
|
ADL 10-0101
|
|
|
[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid
|
|
|
4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID
|
|
|
N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE
|
|
|
PLX4032
|
|
|
Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone
|
|
|
Pentamidine
|
A diether compound consisting of pentane-1,5-diol with both hydroxyls bearing 4-amidinophenyl groups.
|
|
N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE
|
|
|
Diisopropylphosphono Group
|
|
|
Moexipril
|
|
|
(S)-tacrine(10)-hupyridone
|
|
|
Formic Acid
|
|
|
Renzapride
|
|
|
Azithromycin
|
A macrolide antibiotic useful for the treatment of bacterial infections.
|
|
(2S)-2-HYDROXYOCTANOIC ACID
|
|
|
difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron
|
|
|
Mdl-29951
|
|
|
7-Nitroindazole
|
|
|
4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid
|
|
|
Clofedanol
|
|
|
Nesiritide
|
|
|
[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER
|
|
|
4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole
|
|
|
Monothioglycerol
|
A thiol that is glycerol in which one of the primary hydroxy groups is replaced by a thiol group.
|
|
Pertuzumab
|
|
|
N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
|
|
|
INCB9471
|
|
|
Hirulog
|
|
|
(S)-blebbistatin
|
The (S)-enantiomer of blebbistatin.
|
|
Apixaban
|
A pyrazolopyridine that is 7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide substituted at position 1 by a 4-methoxyphenyl group and at position 6 by a 4-(2-oxopiperidin-1-yl)phenyl group. It is used for the prevention and treatment of thromboembolic diseases.
|
|
N-Acetyl-Serine
|
|
|
Carbachol
|
An ammonium salt that has formula C6H15N2O2.Cl.
|
|
2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium
|
A pyrimidinium salt that has formula C14H19N4O3.
|
|
Muromonab
|
|
|
2-(Oxalyl-Amino)-Benzoic Acid
|
|
|
Zileuton
|
|
|
(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide
|
|
|
S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione
|
|
|
Propranolol
|
A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
|
|
Isotretinoin
|
A retinoic acid that is all-trans-retinoic acid in which the double bond which is alpha,beta- to the carboxy group is isomerised to Z configuration. A synthetic retinoid, it is used for the treatment of severe cases of acne and other skin diseases.
|
|
6-Chloropurine Riboside, 5'-Monophosphate
|
|
|
HGS-TR2J
|
|
|
Glutethimide
|
|
|
9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
|
|
|
L-Ornithine
|
An optically active form of ornithine having L-configuration.
|
|
Fluoro-Phosphite Ion
|
|
|
IMC-1C11
|
|
|
2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide
|
|
|
Cytidine-3'-Monophosphate
|
|
|
undecan-2-one
|
A dialkyl ketone with methyl and nonyl as the two alkyl groups.
|
|
Vemurafenib
|
|
|
Peginesatide
|
|
|
Insulin Lispro
|
|
|
CRA_23653
|
|
|
1-[4-(hydroxymethyl)phenyl]guanidine
|
|
|
6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID
|
An organic phosphonate and derivative of hexanoic acid and cognate transition state analogue of the esterase-like catalytic antibody D2.3.
|
|
Bicalutamide
|
A sulfone that is an oral non-steroidal antiandrogen used in the treatment of prostate cancer and hirsutism.
|
|
Methyl alpha-D-mannoside
|
A methyl mannoside having alpha-configuration at the anomeric centre.
|
|
Rifaximin
|
|
|
Amiloride
|
A monocarboxylic acid amide that is N-carbamimidoylpyrazine-2-carboxamide substituted by amino groups at positions 3 and 5 and a chloro group at position 6.
|
|
Phosphatidylethanolamine
|
|
|
1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE
|
|
|
1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide
|
|
|
Oxyphenonium
|
|
|
[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester
|
|
|
(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE
|
|
|
Tasosartan
|
|
|
4-(2-AMINOETHYL)BENZENESULFONAMIDE
|
|
|
(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid
|
|
|
Ethanesulfonic Acid
|
An alkanesulfonic acid in which the alkyl group directly linked to the sulfo functionality is ethyl.
|
|
Amiodarone
|
A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
|
|
Aeruginosin 98-B
|
|
|
N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide
|
|
|
N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE
|
|
|
Alpha-D-Fucose
|
A D-fucopyranose having alpha-configuration at its anomeric centre.
|
|
Guanidine
|
An aminocarboxamidine, the parent compound of the guanidines.
|
|
N-Acetylalanine
|
|
|
2-HYDROXY-3,5-DIIODOBENZOIC ACID
|
|
|
N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE
|
|
|
N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE
|
|
|
4-(2-aminoethyl)-2-ethylphenol
|
|
|
(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)
|
|
|
2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER
|
|
|
Arcitumomab
|
|
|
N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE
|
|
|
Rizatriptan
|
A tryptamine that has formula C15H19N5.
|
|
2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid
|
|
|
Tetrazolyl Histidine
|
|
|
Alpha-D-Glucose-6-Phosphate
|
A D-glucopyranose 6-phosphate where alpha-D-glucose is the sugar component.
|
|
N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide
|
|
|
LJP 1082
|
|
|
3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
|
|
|
2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE
|
|
|
Vilazodone
|
|
|
Sorbinil
|
An azaspiro compound having a monofluoro-substituted chromane skeleton spiro-linked to an imidazolidinedione ring.
|
|
Edetic Acid
|
|
|
Hesperetin
|
A trihydroxyflavanone having the three hydroxy gropus located at the 3'-, 5- and 7-positions and an additional methoxy substituent at the 4'-position.
|
|
Methdilazine
|
|
|
Adenosine-3'-5'-Diphosphate
|
|
|
3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE
|
|
|
Busulfan
|
|
|
Chlorhexidine
|
A bisbiguanide compound with a structure consisting of two (p-chlorophenyl)guanide units linked by a hexamethylene bridge.
|
|
Ergonovine
|
|
|
alpha-D-Xylopyranose
|
A D-xylopyranose that has formula C5H10O5.
|
|
2[4-BROMO-2-FLUOROPHENYL)METHYL]-6-FLUOROSPIRO[ISOQUINOLINE-4-(1H),3'-PYRROLIDINE]-1,2',3,5'(2H)-TETRONE
|
|
|
(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide
|
|
|
5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione
|
|
|
4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID
|
|
|
2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide
|
|
|
(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE
|
|
|
CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL
|
|
|
4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
|
|
|
N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
|
|
|
4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE
|
A pyridylpiperidine that has formula C23H27ClN4O3S.
|
|
Succinic acid
|
|
|
Mephentermine
|
|
|
2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide
|
|
|
4-Oxosebacic Acid
|
|
|
Diminazene
|
A triazene derivative that is triazene in which each of the terminal nitrogens is substituted by a 4-carbamimidoylphenyl group.
|
|
Guanethidine
|
|
|
N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid
|
A L-leucine derivative that has formula C21H26N3O6P.
|
|
Benzocaine
|
A benzoate ester having 4-aminobenzoic acid as the acid component and ethanol as the alcohol component. A surface anaesthetic, it is used to suppress the gag reflex, and as a lubricant and topical anaesthetic on the larynx, mouth, nasal cavity, respiratory tract, oesophagus, rectum, urinary tract, and vagina.
|
|
3-pyridin-4-yl-1H-indazole
|
|
|
Arachidonic Acid
|
A long-chain fatty acid that is a C20, polyunsaturated fatty acid having four (Z)-double bonds at positions 5, 8, 11 and 14.
|
|
S-(Methylmercury)-L-Cysteine
|
|
|
Tretinoin
|
|
|
[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID
|
|
|
Ethinyl Estradiol
|
|
|
9-Deazaadenine
|
|
|
S-Oxymethionine
|
|
|
Tiotropium
|
|
|
Tartronate
|
|
|
2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE
|
|
|
D-Proline
|
The D-enantiomer of proline.
|
|
(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid
|
|
|
5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol
|
A stilbenol that is 1,1'-ethane-1,2-diyldibenzene with hydroxy groups at positions 1, 3 and 4'.
|
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
|
|
|
Estradiol
|
A 3-hydroxy steroid that is estra-1,3,5(10)-triene substituted by hydroxy groups at positions 3 and 17.
|
|
Gonadorelin
|
|
|
4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID
|
|
|
RU78300
|
|
|
N-Omega-Hydroxy-L-Arginine
|
|
|
N-Ethylmaleimide
|
A member of the class of maleimides that is the N-ethyl derivative of maleimide.
|
|
1-(2-nitrophenyl)-2,2,2-trifluoroethyl]-arsenocholine
|
|
|
N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE
|
|
|
N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide
|
|
|
VIR201
|
|
|
2-Ethoxyethanol
|
|
|
(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine
|
|
|
Candesartan
|
A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
|
|
Rifapentine
|
|
|
Spermidine
|
A triamine that is the 1,5,10-triaza derivative of decane.
|
|
(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine
|
|
|
N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline
|
|
|
(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
|
|
|
4-Methylpiperazin-1-Yl Carbonyl Group
|
|
|
L-DOPA
|
An optically active form of dopa having L-configuration. Used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease
|
|
Erdosteine
|
|
|
Fructose-1,6-Diphosphate
|
|
|
Diphthamide
|
A quaternary ammonium ion that is the derivative of L-histidine having a 4-amino-4-oxo-3-(trimethylammonio)butyl group at the 2-position of the imidazole ring.
|
|
(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide
|
|
|
Ranolazine
|
|
|
Dihydroquinidine barbiturate
|
|
|
Naringenin
|
A trihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 6 and 4'.
|
|
Rivastigmine
|
|
|
3-Methoxybenzamide
|
|
|
ED-71
|
|
|
2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid
|
|
|
Voriconazole
|
A triazole-based antifungal agent used for the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. It is an inhibitor of cytochrome P450 2C9 (CYP2C9) and CYP3A4.
|
|
Proparacaine
|
|
|
Denileukin diftitox
|
|
|
Alitretinoin
|
|
|
Tofacitinib
|
|
|
5-Chloro-6-[(2-Iminopyrrolidin-1-Yl)Methyl]Pyrimidine-2,4(1h,3h)-Dione
|
|
|
(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium
|
|
|
Miglitol
|
|
|
Ximelagatran
|
A member of the class of azetidines that is melagatran in which the carboxylic acid group has been converted to the corresponding ethyl ester and in which the amidine group has been converted to the corresponding amidoxime. A prodrug for melagatran, ximelagatran was the first orally available direct thrombin inhibitor to be brought to market as an anticoagulant, but was withdrawn in 2006 following reports of it causing liver damage.
|
|
6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE
|
|
|
N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea
|
|
|
Flumazenil
|
A 1,4-benzodiazepine that has formula C15H14FN3O3.
|
|
Tris(Hydroxyethyl)Aminomethane
|
|
|
Furosemide
|
A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
|
|
Azelaic Acid
|
An alpha,omega-dicarboxylic acid that is heptane substituted at positions 1 and 7 by carboxy groups.
|
|
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide
|
|
|
Cisatracurium Besylate
|
The (1R,1'R,2R,2'R)-diastereoisomer of atracurium besylate. Commercial preparations of atracurium are mixtures of 10 stereoisomers, of which cisatracurium generally constitutes about 15%. Cisatracurium besylate is about 3 times more potent than the mixture of atracurium isomers as a neuromuscular blocking agent, and is used as a muscle relaxant for endotracheal intubation, to aid controlled ventilation, and in general anaesthesia.
|
|
N-Isopropyl-N'-Hydroxyguanidine
|
|
|
AC162352
|
|
|
5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide
|
|
|
Nitrilotriacetic Acid
|
A NTA that has formula C6H9NO6.
|
|
7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile
|
|
|
Thymidine-5'- Diphosphate
|
|
|
Streptokinase
|
|
|
Para-Mercury-Benzenesulfonic Acid
|
|
|
N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE
|
|
|
Dyclonine
|
N-Ethylpiperidine in which one of the hydrogens attached to the methyl group is substituted by a 4-butoxybenzoyl group.
|
|
ART-123
|
|
|
(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE
|
A pyridoindolecarboxamide that has formula C21H24N6O3S.
|
|
1-[N[(Phenylmethoxy)Carbonyl]-L-Leucyl-4-[[N/N-[(Phenylmethoxy)Carbonyl]-/Nl-Leucyl]Amino]-3-Pyrrolidinone/N
|
|
|
Mito-4509
|
|
|
5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid
|
|
|
Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine
|
|
|
5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone
|
|
|
(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL
|
|
|
Aplyronine A
|
|
|
16g
|
|
|
N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide
|
|
|
CRA_1144
|
|
|
4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE
|
A thiazoloindole that has formula C21H15N5O3S2.
|
|
N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE
|
|
|
5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL
|
|
|
3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID
|
|
|
3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline
|
|
|
2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL
|
A furopyrimidine that has formula C22H21N3O4.
|
|
6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE
|
A purine that has formula C22H20ClN5.
|
|
Monobenzone
|
|
|
4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid
|
|
|
Oxidized Glutathione Disulfide
|
|
|
Proellex
|
|
|
N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE
|
|
|
Cilostazol
|
A lactam that is 3,4-dihydroquinolin-2(1H)-one in which the hydrogen at position 6 is substiuted by a 4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy group.
|
|
Dasatinib
|
|
|
CYT997
|
|
|
3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine
|
|
|
Exemestane
|
A 17-oxo steroid that is androsta-1,4-diene-3,17-dione in which the hydrogens at position 6 are replaced by a double bond to a methylene group. A selective inhibitor of the aromatase (oestrogen synthase) system, it is used in the treatment of advanced breast cancer.
|
|
6-(4-Difluoromethoxy-3-Methoxy-Phenyl)-2h-Pyridazin-3-One
|
|
|
(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE
|
|
|
N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine
|
|
|
3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE
|
|
|
Aminocaproic Acid
|
|
|
FTY 720
|
|
|
Buclizine
|
|
|
Biopterin
|
A pterin derivative that consists of pterin bearing amino, oxo and 1,2-dihydroxypropyl substituents at positions 2, 4 and 6 respectively. The parent of the class of biopterins.
|
|
Ecabet
|
|
|
{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID
|
A naphthothiazole that has formula C16H11NO9S.
|
|
Pemetrexed
|
|
|
Acetohexamide
|
An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is replaced by a p-acetylphenylsulfonyl group, while a hydrogen attached to the other nitrogen is replaced by a cyclohexyl group.
|
|
Heptabarbital
|
A barbiturate that has formula C13H18N2O3.
|
|
Vorinostat
|
|
|
3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE
|
|
|
2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide
|
|
|
Bepridil
|
|
|
Oleic Acid
|
An octadec-9-enoic acid in which the double bond at C-9 has Z (cis) stereochemistry.
|
|
Xylometazoline
|
|
|
4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
|
|
|
Calcipotriol
|
A seco-cholestane that has formula C27H40O3.
|
|
Cetrorelix
|
|
|
1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE
|
|
|
Teriflunomide
|
|
|
Soraphen A
|
A macrolide and an agent highly effective against plant-pathogenic fungi. It was extensively researched for agricultural use until it was discovered to be a teratogen.
|
|
1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide
|
A benzothiazole that has formula C8H8N2O3S2.
|
|
Nitric Oxide
|
A nitrogen oxide which is a free radical, each molecule of which consists of one nitrogen and one oxygen atom.
|
|
Levonorgestrel
|
A 17beta-hydroxy steroid that has formula C21H28O2.
|
|
APD791
|
|
|
Indomethacin
|
|
|
Bafilomycin B1
|
|
|
Ivermectin
|
A mixture consisting of >= 90% 22,23-dihydroavermectin B1a (R = Me) and <= 10% 22,23-dihydroavermectin B1b (R = H). A semi-synthetic derivative of abamectin, it is used as a broad-spectrum antiparasite medication, particularly against worms (except tapeworms), although it is also effective against most mites and some lice.
|
|
METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER
|
|
|
Phenformin
|
|
|
3,7,3',4'-TETRAHYDROXYFLAVONE
|
|
|
(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE
|
|
|
Isopentyl Pyrophosphate
|
|
|
Butyrylthiocholine
|
|
|
3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide
|
|
|
PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE
|
|
|
Adenosine-5'-Phosphosulfate
|
|
|
2',3'-Dideoxyadenosine-5'-Triphosphate
|
|
|
Saxagliptin
|
|
|
Cyclopentolate
|
A carboxylic ester resulting from the formal condensation of (1-hydroxycyclopentyl)(phenyl)acetic acid with N,N-dimethylethanolamine. A tertiary amine antimuscarinic with actions similar to atropine, it is used as its hydrochloride salt to produce mydriasis (excessive dilation of the pupil) and cycloplegia (paralysis of the ciliary muscle of the eye) for opthalmic diagnostic procedures. It acts more quickly than atropine and has a shorter duration of action.
|
|
Vardenafil
|
The sulfonamide resulting from formal condensation of the sulfo group of 4-ethoxy-3-(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one-2-yl)benzenesulfonic acid and the secondary amino group of 4-ethylpiperazine.
|
|
3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN
|
|
|
Octanoyl-Coenzyme A
|
|
|
(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE
|
|
|
BETA-METHYLLACTOSIDE
|
|
|
Delta-Amino Valeric Acid
|
|
|
1,4-Dithio-Alpha-D-Mannose
|
|
|
Alpha-Methyl-N-Acetyl-D-Glucosamine
|
|
|
Alseroxylon
|
|
|
KB002
|
|
|
(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID
|
|
|
3,6,9,12,15-PENTAOXATRICOSAN-1-OL
|
|
|
Domperidone
|
|
|
3-(5-methoxy-1H-indol-3-yl)propanoic acid
|
|
|
8-Bromo-Adenosine-5'-Monophosphate
|
|
|
Clomipramine
|
A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
|
|
Sertaconazole
|
|
|
1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE
|
|
|
(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE
|
|
|
N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
|
|
|
Seocalcitol
|
|
|
Imino-Tryptophan
|
|
|
Liraglutide
|
|
|
(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID
|
|
|
2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole
|
|
|
Tirapazamine
|
A member of the class of benzotriazines that is 1,2,4-benzotriazine carrying an amino substituent at position 3 and two oxido substituents at positions 1 and 4.
|
|
3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid
|
|
|
Fluvastatin
|
|
|
Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester
|
|
|
Carbenoxolone
|
|
|
5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine
|
|
|
Halothane
|
A haloalkane comprising ethane having three flouro substituents at the 1-position as well as bromo- and chloro substituents at the 2-position.
|
|
AT1391
|
|
|
Tetraethylammonium
|
A quaternary ammonium ion that has formula C8H20N.
|
|
N-[4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL]-3-PYRIDIN-3-YLPROPANAMIDE
|
A N-acylpiperidine that has formula C24H31N3O2.
|
|
N-Methyl-N-Propargyl-3-(2,4-Dichlorophenoxy)Propylamine
|
|
|
Difluprednate
|
|
|
Theobromine
|
|
|
Insulin Glulisine
|
|
|
Prilocaine
|
An amide-type local anaesthetic in which N-propyl-DL-alanine and 2-methylaniline have combined to form the amide bond.
|
|
(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid
|
|
|
DECYL(DIMETHYL)PHOSPHINE OXIDE
|
|
|
Bivalirudin
|
|
|
(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One
|
A pyridazinone that has formula C24H24IN3O2.
|
|
N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid
|
|
|
5-Phenylsulfanyl-2,4-Quinazolinediamine
|
|
|
2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol
|
|
|
659032
|
|
|
4-TERT-BUTYLBENZENESULFONIC ACID
|
|
|
CTA018
|
|
|
4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine
|
|
|
Spironolactone
|
A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
|
|
5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide
|
|
|
1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid
|
|
|
CYT006-AngQb
|
|
|
Dimetindene
|
|
|
Etonogestrel
|
|
|
Loxapine
|
A dibenzoxazepine that has formula C18H18ClN3O.
|
|
Arbaclofen
|
|
|
5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE
|
A thiadiazole that has formula C8H7ClFN5O4S3.
|
|
4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid
|
|
|
N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide
|
|
|
Thenoyltrifluoroacetone
|
|
|
Benzylpenicilloyl Polylysine
|
Poly-L-lysine (n > 40) in which 50-70% of the epsilon-amino groups are substituted with benzylpenicilloyl groups. It is used as a skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy.
|
|
5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine
|
|
|
3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE
|
|
|
Propantheline
|
|
|
4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE
|
|
|
7,8-dihydroxy-4-phenyl-2H-chromen-2-one
|
|
|
D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide
|
|
|
Dibenzofuran-4,6-Dicarboxylic Acid
|
|
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
|
|
Prostaglandin G2
|
A prostaglandins G that has formula C20H32O6.
|
|
2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine
|
A pyridopyrimidine that has formula C19H24N6O3.
|
|
Aicar
|
|
|
1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL
|
|
|
9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol
|
|
|
Encainide
|
|
|
Tolazamide
|
|
|
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE
|
|
|
({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID
|
|
|
(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide
|
|
|
R411
|
|
|
2-Amino-Pentanoic Acid
|
An alpha-amino acid that is valeric acid which is substituted at position 2 by an amino group.
|
|
4,4'-cyclohexane-1,1-diyldiphenol
|
|
|
Ranibizumab
|
|
|
Aniracetam
|
|
|
Iproniazid
|
|
|
Rituximab
|
|
|
Deoxythymidine
|
|
|
N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea
|
|
|
Brimonidine
|
A quinoxaline derivative that has formula C11H10BrN5.
|
|
N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide
|
|
|
3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL
|
|
|
RWJ-51084
|
|
|
Crofelemer
|
|
|
CRA_10950
|
|
|
Hadacidin
|
A monocarboxylic acid that is N-hydroxyglycine in which the hydrogen attached to the nitrogen is replaced by a formyl group. It was originally isolated from cultures of Penicillium frequentans.
|
|
2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)
|
|
|
2-Deoxy-2fluoro-Glucose
|
|
|
Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine
|
|
|
Pyrazole
|
A monocyclic heteroarene that is a five-membered organic heterocycle containing two nitrogen atoms at positions 1 and 2.
|
|
Linezolid
|
|
|
(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE
|
|
|
Celecoxib
|
|
|
SEBACIC ACID
|
An alpha,omega-dicarboxylic acid that is the 1,8-dicarboxy derivative of octane.
|
|
6-Nitroindazole
|
|
|
Framycetin
|
|
|
N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE
|
|
|
Cryptenamine
|
|
|
Myo-Inositol
|
An inositol having myo- configuration.
|
|
ZK-800270
|
|
|
Raltitrexed
|
|
|
Deslanoside
|
|
|
Adenosine-5'-Diphosphate Monothiophosphate
|
|
|
Olcegepant
|
|
|
Tegaserod
|
|
|
Mitomycin
|
|
|
2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose
|
|
|
Amylamine
|
|
|
Butethal
|
|
|
Dexmethylphenidate
|
|
|
Adenosine
|
A ribonucleoside composed of a molecule of adenine attached to a ribofuranose moiety via a beta-N(9)-glycosidic bond.
|
|
Dabigatran etexilate
|
|
|
4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE
|
|
|
Vandetanib
|
A quinazoline that is 7-[(1-methylpiperidin-4-yl)methoxy]quinazoline bearing additional methoxy and 4-bromo-2-fluorophenylamino substituents at positions 6 and 4 respectively. Used for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
|
|
PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE
|
A hapten and transition state analogue containing phenylphosphonate and succinoylamino moieties.
|
|
NP-50301
|
|
|
Plasmin
|
|
|
Meta Vanadate
|
A vanadium oxoanion in which a central vanadium is divalently bound to two oxygens and monovalently bound to a hydroxide.
|
|
ISOTHIAZOLIDINONE ANALOG
|
|
|
Alpha-Phosphoribosylpyrophosphoric Acid
|
|
|
Allosamizoline
|
|
|
(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide
|
|
|
3-Phenylpropylamine
|
|
|
Phenylethane Boronic Acid
|
|
|
4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID
|
|
|
Astemizole
|
|
|
THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE
|
A thienopyridine that has formula C21H19N5O3S2.
|
|
Nisoldipine
|
|
|
5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE
|
|
|
6-Hydroxy-6-Methyl-Heptan-3-One
|
|
|
N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide
|
A 3-hydroxy steroid that has formula C34H55NO3.
|
|
Epirubicin
|
|
|
MP470
|
|
|
Etoricoxib
|
|
|
9-(5,5-Difluoro-5-Phosphonopentyl)Guanine
|
|
|
Beta-D-Glucopyranose Spirohydantoin
|
|
|
N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide
|
|
|
99mTc-ciprofloxacin
|
|
|
MYRISTIC ACID
|
A straight-chain, fourteen-carbon, long-chain saturated fatty acid mostly found in milk fat.
|
|
Bethanechol
|
The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.
|
|
Guanidine-3-Propanol
|
|
|
8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-
|
|
|
Adenosine monophosphate
|
|
|
Sertindole
|
|
|
(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide
|
|
|
5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID
|
|
|
2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID
|
|
|
Gamma-Carboxy-Glutamic Acid
|
|
|
1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID
|
|
|
Aceprometazine
|
|
|
Carbidopa
|
The hydrate of 3-(3,4-dihydroxyphenyl)propanoic acid in which the hydrogens alpha- to the carboxyl group are substituted by hydrazinyl and methyl groups (S-configuration). Carbidopa is a dopa decarboxylase inhibitor, so prevents conversion of levodopa to dopamine. It has no antiparkinson activity by itself, but is used in the management of Parkinson's disease to reduce peripheral adverse effects of levodopa.
|
|
IDN-6556
|
|
|
SLV319
|
|
|
DG051
|
|
|
(2S)-2-(1H-indol-3-yl)hexanoic acid
|
|
|
Ulapualide A
|
|
|
Latanoprost
|
A prostaglandin Falpha that is the isopropyl ester prodrug of latanoprost free acid. Used in the treatment of open-angle glaucoma and ocular hypertension.
|
|
(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID
|
|
|
Oxaloacetate Ion
|
|
|
Carbenicillin
|
|
|
4-Iodopyrazole
|
An organoiodine compound that has formula C3H3IN2.
|
|
Tirofiban
|
|
|
NN344
|
|
|
Threonine Derivative
|
An amino acid derivative resulting from reaction of threonine at the amino group or the carboxy group, or from the replacement of any hydrogen of threonine by a heteroatom. The definition normally excludes peptides containing threonine residues.
|
|
(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL
|
A pyrrolopyrimidine that has formula C21H20N4O.
|
|
MLN-518
|
|
|
Udp-Glucuronic Acid
|
|
|
Hyoscyamine
|
|
|
Hydroxyacetic Acid
|
A 2-hydroxy monocarboxylic acid that is acetic acid where the methyl group has been hydroxylated.
|
|
CRA_9334
|
|
|
4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide
|
|
|
Tesamorelin
|
|
|
3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium
|
|
|
Lutropin alfa
|
|
|
Dextromethorphan
|
An organic heterotetracyclic compound that is morphinan substituted by a methoxy group at position 3 and a methyl group at position 7. It is used as an antitussive drug for suppressing cough.
|
|
SP1049C
|
|
|
1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
|
|
|
(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL
|
|
|
S-P-Nitrobenzyloxycarbonylglutathione
|
|
|
BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE
|
|
|
N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine
|
|
|
(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE
|
An acetylenic compound that has formula C15H25N3O.
|
|
Phensuximide
|
|
|
Dapsone
|
A sulfone that is diphenylsulfone in which the hydrogen atom at the 4 position of each of the phenyl groups is substituted by an amino group. It is active against a wide range of bacteria, but is mainly employed for its actions against Mycobacterium leprae, being used as part of multidrug regimens in the treatment of all forms of leprosy.
|
|
Almitrine
|
|
|
2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol
|
|
|
Zuclopenthixol
|
|
|
Tolazoline
|
|
|
3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid
|
|
|
ADX-48621
|
|
|
Etorphine
|
An alcohol that has formula C25H33NO4.
|
|
1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA
|
|
|
N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine
|
|
|
AMPA
|
|
|
Mafenide
|
|
|
3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide
|
|
|
RALOXIFENE CORE
|
|
|
1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
|
|
|
5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE
|
|
|
O-Phosphoethanolamine
|
The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
|
|
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE
|
|
|
Rufinamide
|
|
|
N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE
|
|
|
N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE
|
|
|
12-Phenylheme
|
|
|
Glyceraldehyde-3-Phosphate
|
An aldotriose phosphate that is the 3-phospho derivative of glyceraldehyde. It is an important metabolic intermediate in several central metabolic pathways in all organisms.
|
|
Cephalexin
|
A semisynthetic first-generation cephalosporin antibiotic having methyl and beta-(2R)-2-amino-2-phenylacetamido groups at the 3- and 7- of the cephem skeleton, respectively. It is effective against both Gram-negative and Gram-positive organisms, and is used for treatment of infections of the skin, respiratory tract and urinary tract.
|
|
TNX-355
|
|
|
DODECANESULFONATE ION
|
|
|
(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate
|
|
|
Propiomazine
|
|
|
Bevacizumab
|
|
|
[2'-CARBOXYLETHYL]-10-METHYL-ANTHRACENE ENDOPEROXIDE
|
|
|
5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE
|
|
|
Flutamide
|
A (trifluoromethyl)benzene that has formula C11H11F3N2O3.
|
|
Alpha-ketoisovalerate
|
|
|
CRA_10656
|
|
|
N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide
|
|
|
N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE
|
|
|
4-(N,N-Dimethylamino)Cinnamoyl-Coa
|
|
|
DX-88
|
|
|
D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide
|
|
|
Delta1-dihydrotestosterone
|
An anabolic steroid that differs from testosterone by having a 1,2-double bond instead of a 4,5-double bond in its A ring. A potent androgen with anabolic properties, it was legally sold as a prohormone in the U.S.A. until 2005, when it was reclassified as a Schedule III drug.
|
|
Griseofulvin
|
Antibiotic produced by Penicillium griseofulvum.
|
|
(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE
|
|
|
1,2-Propanediol
|
|
|
Aleglitazar
|
|
|
Bosutinib
|
|
|
Cabazitaxel
|
|
|
Proflavine
|
|
|
2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid
|
|
|
9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine
|
|
|
4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide
|
|
|
CYT007-TNFQb
|
|
|
Toremifene
|
|
|
Hexafluronium
|
|
|
3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide
|
|
|
Buserelin
|
|
|
Pranlukast
|
|
|
Adenine
|
|
|
5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide
|
|
|
1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea
|
|
|
Metolazone
|
|
|
Everolimus
|
|
|
U-Pi-a-Pi
|
|
|
N-(3,5-dibromo-4-hydroxyphenyl)benzamide
|
|
|
Norfloxacin
|
A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
|
|
4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE
|
|
|
2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one
|
|
|
RPR128515
|
|
|
1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea
|
|
|
Laevulinic Acid
|
|
|
4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE
|
|
|
Medrysone
|
|
|
NM-702
|
|
|
(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE
|
|
|
LAX-101
|
|
|
IDD552
|
|
|
Risedronate
|
|
|
L-2-Amino-4-Methoxy-Cis-but-3-Enoic Acid
|
A dehydroamino acid that has formula C5H9N1O3.
|
|
S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE
|
|
|
PPI-2458
|
|
|
N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA
|
|
|
3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE
|
A maleimide that has formula C23H20N4O2.
|
|
XP13512
|
|
|
K-252a
|
A organic heterooctacyclic compound that is a potent inhibitor of protein kinase C and is isolated from Nocardiopsis sp K-252a
|
|
Thiopental
|
A barbiturate, the structure of which is that of 2-thiobarbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
|
|
Daunorubicin
|
A natural product found in Actinomadura roseola.
|
|
Chloramphenicol
|
An organochlorine compound that is dichloro-substituted acetamide containing a nitrobenzene ring, an amide bond and two alcohol functions.
|
|
Ibutilide
|
|
|
(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)
|
|
|
PRO-542
|
|
|
Digoxin
|
Digitoxin beta-hydroxylated at C-12. A cardiac glycoside extracted from the foxglove plant, Digitalis lanata, it is used to control ventricular rate in atrial fibrillation and in the management of congestive heart failure with atrial fibrillation, but the margin between toxic and therapeutic doses is small.
|
|
PARA-NITROPHENYL PHOSPHONOBUTANOYL L-ALANINE
|
|
|
RU82197
|
|
|
2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID
|
|
|
AN2728
|
|
|
1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone
|
|
|
Dezocine
|
|
|
6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE
|
|
|
Botulinum Toxin Type A
|
|
|
Ghavamiol
|
|
|
MCC
|
mutated in colorectal cancers|This gene is a candidate colorectal tumor suppressor gene that is thought to negatively regulate cell cycle progression. The orthologous gene in the mouse expresses a phosphoprotein associated with the plasma membrane and membrane organelles, and overexpression of the mouse protein inhibits entry into S phase. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
|
|
Naltrexone
|
An organic heteropentacyclic compound that is 4,5-epoxymorphinan-6-one substituted by a cyclopropylmethyl group at position 17 and hydroxy groups at positions 3 and 14. A mu-opioid receptor antagonist, it is used to treat alcohol dependence.
|
|
(N-{4-[(ETHYLANILINO)SULFONYL]-2-METHYLPHENYL}-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANAMIDE
|
|
|
(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide
|
|
|
Droperidol
|
An organofluorine compound that is haloperidol in which the hydroxy group has been eliminated with the introduction of a double bond in the piperidine ring, and the 4-chlorophenyl group has been replaced by a benzimidazol-2-on-1-yl group. It is used in the management of chemotherapy-induced nausea and vomiting, and in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon.
|
|
(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE
|
A triazolopyrazine that is a rigid cyclohexylamine analogue of sitagliptin.
|
|
P1-(Adenosine-5'-P5-(Uridine-5')Pentaphosphate
|
|
|
(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide
|
|
|
Alpha-Benzyl-Aminobenzyl-Phosphonic Acid
|
|
|
Fenfluramine
|
|
|
Pantoprazole
|
A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
|
|
Uridine-2',3'-Vanadate
|
|
|
N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine
|
|
|
N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE
|
|
|
Aminoguanidine
|
A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
|
|
Glycochenodeoxycholic Acid
|
A bile acid glycine conjugate having 3alpha,7alpha-dihydroxy-5beta-cholan-24-oyl as the bile acid component.
|
|
Flavin adenine dinucleotide
|
|
|
(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE
|
|
|
Thiabendazole
|
A member of the class of benzimidazoles carrying a 1,3-thiazol-4-yl substituent at position 2. A mainly post-harvest fungicide used to control a wide range of diseases including Aspergillus, Botrytis, Cladosporium and Fusarium.
|
|
Valrubicin
|
|
|
Huperzine A
|
A sesquiterpene alkaloid isolated from a club moss Huperzia serrata that has been shown to exhibit neuroprotective activity.
|
|
Bisoprolol
|
A secondary amine that has formula C18H31NO4.
|
|
(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE
|
|
|
Huperzine B
|
|
|
Leflunomide
|
A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
|
|
Methyl Nonanoate (Ester)
|
|
|
Dehydroepiandrosterone
|
An androstanoid that is androst-5-ene substituted by an beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
|
|
Ouabain
|
|
|
D-Leucine
|
The D-enantiomer of leucine.
|
|
Adefovir Dipivoxil
|
|
|
N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide
|
|
|
ABT-510
|
|
|
3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM
|
An organic cation that is the conjugate acid of 3,7-bis(dimethylamino)phenothiazine.
|
|
TD-5108
|
|
|
N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide
|
|
|
1-3 Sugar Ring of Pentamannosyl 6-Phosphate
|
|
|
Praziquantel
|
A pyrazinoisoquinoline that has formula C19H24N2O2.
|
|
Eritoran
|
A lipid A derivative used for the treatment of severe sepsis.
|
|
Clotrimazole
|
A member of the class of imidazoles that is 1H-imidazole in which the hydrogen attached to a nitrogen is replaced by a monochlorotrityl group.
|
|
1-(4-thiophen-2-ylphenyl)methanamine
|
|
|
Metharbital
|
|
|
Paclitaxel
|
A tetracyclic diterpenoid isolated originally from the bark of the Pacific yew tree, Taxus brevifolia. It is a mitotic inhibitor used in cancer chemotherapy. Note that the use of the former generic name 'taxol' is now limited, as Taxol is a registered trade mark.
|
|
5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE
|
|
|
Losartan
|
A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
|
|
3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid
|
|
|
(3r)-1-Acetyl-3-Methylpiperidine
|
A N-acylpiperidine that has formula C8H15NO.
|
|
5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
|
|
|
Dithioerythritol
|
The meso-diastereomer of 1,4-dimercaptobutane-2,3-diol; a sulfur-containing sugar derived from the monosaccharide erythrose; and an epimer of dithiothreitol.
|
|
Estriol
|
|
|
3-[(1s)-1-(Dimethylamino)Ethyl]Phenol
|
|
|
Swainsonine
|
An indolizidine alkaloid isolated from the plant Swainsona canescens with three hydroxy substituents at positions 1, 2 and 8.
|
|
Clonidine
|
|
|
Mdl 101,146
|
|
|
4-Methylimidazole
|
Imidazole substituted at position 4 by a methyl group.
|
|
Zimelidine
|
|
|
N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine
|
A member of the class of purines that is 9H-purine in which the hydrogens at positions 2 and 6 are replaced by a [4-(morpholin-4-yl)phenyl]nitrilo group and a cyclohexylamino group, respectively.
|
|
ABX-PTH
|
|
|
Telmisartan
|
|
|
4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine
|
|
|
17-METHYL-17-ALPHA-DIHYDROEQUILENIN
|
|
|
Insulin Glargine
|
|
|
Homatropine Methylbromide
|
An organic bromide salt that has formula C17H24NO3.Br.
|
|
TP-508
|
|
|
WRR-99
|
|
|
Zidovudine
|
A pyrimidine 2',3'-dideoxyribonucleoside compound having a 3'-azido substituent and thymine as the nucleobase.
|
|
Cevimeline
|
|
|
L-Tryptophan
|
The L-enantiomer of tryptophan.
|
|
N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE
|
|
|
Bromopride
|
|
|
MLN0415
|
|
|
4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE
|
|
|
2-Pyridinethiol
|
|
|
Cardiolipin
|
A phosphatidylglycerol composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol.
|
|
Pirbuterol
|
|
|
Oxypurinol
|
|
|
Nitrosoethane
|
A nitroso compound that has formula C2H5NO.
|
|
ATG003
|
|
|
N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester
|
|
|
Cytisine
|
An organic heterotricyclic compound that is the toxic principle in Laburnum seeds and is found in many members of the Fabaceae (legume, pea or bean) family. An acetylcholine agonist, it is widely used throughout Eastern Europe as an aid to giving up smoking.
|
|
Tranylcypromine
|
An alkylamine that has formula C9H11N.
|
|
Cytidine-5'-Monophosphate
|
|
|
Beta-Mercaptoethanol
|
|
|
G418
|
|
|
4-Sulfonamide-[1-(4-Aminobutane)]Benzamide
|
|
|
DB04577
|
|
|
FR236913
|
|
|
Oxaprozin
|
|
|
Valdecoxib
|
|
|
Monoisopropylphosphorylserine
|
|
|
(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid
|
|
|
(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
|
|
|
(Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V)
|
|
|
Paramethadione
|
|
|
Argadin
|
|
|
Butenoic Acid
|
Any C4, straight-chain fatty acid containing one double bond.
|
|
ABT-869
|
|
|
Grepafloxacin
|
|
|
CRA_1801
|
|
|
METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE
|
|
|
6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE
|
|
|
GPI-1485
|
|
|
Arformoterol
|
|
|
Vatalanib
|
|
|
Insulin Regular
|
|
|
Acetylcysteine
|
|
|
Droxidopa
|
A serine derivative that is L-serine substituted at the beta-position by a 3,4-dihydroxyphenyl group. A prodrug for noradrenalone, it is used for treatment of neurogenic orthostatic hypotension
|
|
(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid
|
|
|
Doxacurium chloride
|
The dichloride salt of doxacurium. It is a mixture of the (1R,2S,1'S,2'R), (1R,2S,1'R,2'S) and (1S,2R,1'S,2'R) stereoisomers (a meso isomer and two enantiomers, respectively) of 2,2'-[(1,4-dioxobutane-1,4-diyl)bis(oxypropane-3,1-diyl)]bis[6,7,8-trimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolinium] dichloride, all of which are in a trans configuration at the 1 and 2 positions of the tetrahydroisoquinolinium rings. A competitive neuromuscular blocker, it is used to provide muscle relaxation in general anaesthesia and to facilitate mechanical ventilation in patients in intensive care.
|
|
N-Formylpiperidine
|
|
|
2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID
|
|
|
Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex
|
|
|
Secobarbital
|
|
|
Arecoline
|
A tetrahydropyridine that is 1,2,5,6-tetrahydropyridine with a methyl group at position 1, and a methoxycarbonyl group at position 3. An alkaloid found in the areca nut, it acts as an agonist of muscarinic acetylcholine.
|
|
D-2-Amino-3-Phosphono-Propionic Acid
|
|
|
KB2115
|
|
|
4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL
|
|
|
Methylscopolamine bromide
|
|
|
2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE
|
An imidazole that has formula C14H12FN5OS2.
|
|
2-Thiomethyl-3-Phenylpropanoic Acid
|
|
|
Reidispongiolide C
|
|
|
3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide
|
|
|
PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE
|
|
|
2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid
|
|
|
N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide
|
|
|
Venlafaxine
|
A tertiary amino compound that is N,N-dimethylethanamine substituted at position 1 by a 1-hydroxycyclohexyl and 4-methoxyphenyl group.
|
|
5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE
|
|
|
Etidronic acid
|
A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
|
|
Chlordiazepoxide
|
A benzodiazepine that is 3H-1,4-benzodiazepine 4-oxide substituted by a chloro group at position 7, a phenyl group at position 5 and a methylamino group at position 2.
|
|
Barbital
|
|
|
1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL
|
|
|
2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine
|
|
|
C1-INH
|
|
|
(5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one
|
|
|
5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID)
|
|
|
Tolrestat
|
|
|
TBC-3711
|
|
|
(2R)-2-benzyl-3-nitropropanoic acid
|
|
|
Fluocinonide
|
|
|
(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one
|
|
|
Primaquine
|
A N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.
|
|
(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline
|
|
|
METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE
|
|
|
Indapamide
|
|
|
PN0621
|
|
|
Benzatropine
|
Tropane in which a hydrogen at position 3 is substituted by a diphenylmethoxy group (endo-isomer). An acetylcholine receptor antagonist, it is used (particularly as its methanesulphonate salt) in the treatment of Parkinson's disease, and to reduce parkinsonism and akathisia side effects of antipsychotic treatments.
|
|
TAK-475
|
|
|
(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide
|
A pyrrolidinecarboxamide that has formula C20H26N6O4S.
|
|
Benzonatate
|
The ester obtained by formal condensation of 4-butylaminobenzoic acid with nonaethylene glycol monomethyl ether. Structurally related to procaine and benzocaine, it has an anaesthetic effect on the stretch sensors in the lungs, and is used as a non-narcotic cough suppressant.
|
|
Ethylmorphine
|
|
|
2,6-Diamino-Hexanoic Acid Amide
|
|
|
Glutaric Acid
|
An alpha,omega-dicarboxylic acid that is a linear five-carbon dicarboxylic acid.
|
|
Agmatine
|
A primary amino compound that has formula C5H14N4.
|
|
Gentian Violet
|
|
|
Epothilone B
|
|
|
N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide
|
|
|
Cloxacillin
|
A semisynthetic penicillin antibiotic carrying a 3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido group at position 6.
|
|
SB939
|
|
|
Phenoxybenzamine
|
|
|
Ticlopidine
|
A thienopyridine that has formula C14H14ClNS.
|
|
4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE
|
|
|
7-Hydroxystaurosporine
|
|
|
Phenolphthalein
|
A phenol that has formula C20H14O4.
|
|
Rofecoxib
|
|
|
Hydroflumethiazide
|
|
|
N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine
|
|
|
(S)-Des-Me-Ampa
|
|
|
[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID
|
|
|
1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE
|
A polyether that consists of undecane in which the carbon atoms at positions 3, 6 and 9 are replaced by oxygen atoms.
|
|
CA4P
|
|
|
Benzoic Acid
|
A compound comprising a benzene ring core carrying a carboxylic acid substituent.
|
|
2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL
|
|
|
Nadroparin
|
|
|
2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE
|
|
|
SGN-30
|
|
|
AME-527
|
|
|
Zolpidem
|
An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
|
|
Ziprasidone
|
A piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms.
|
|
Isosorbide Dinitrate
|
A glucitol derivative that has formula C6H8N2O8.
|
|
Mometasone
|
A chlorinated steroid that has formula C22H28Cl2O4.
|
|
Metixene
|
A thioxanthene that has formula C20H23NS.
|
|
2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE
|
|
|
1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3
|
|
|
Solifenacin
|
|
|
Matuzumab
|
|
|
2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine
|
|
|
4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID
|
|
|
MLN-977
|
|
|
SU9516
|
|
|
Deamido-Nad+
|
A nicotinic acid dinucleotide that has formula C21H27N6O15P2.
|
|
Phosphoglycolohydroxamic Acid
|
The hydroxamate of phosphoglycolic acid.
|
|
O4-Sulfonylgalactose
|
|
|
Nicotinamide Mononucleotide
|
|
|
Rutin
|
A rutinoside that is quercetin with the hydroxy group at position C-3 substituted with glucose and rhamnose sugar groups.
|
|
Terbinafine
|
|
|
Betamethasone
|
A glucocorticoid that has formula C22H29FO5.
|
|
Pegaptanib
|
|
|
4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE
|
|
|
N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE
|
|
|
Olsalazine
|
|
|
AV608
|
|
|
Clevidipine
|
|
|
Cpad
|
|
|
(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid
|
A 9-HODE in which the 9-hydroxy group has S-stereochemistry.
|
|
Levallorphan
|
|
|
3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE
|
|
|
Ularitide
|
|
|
Fluphenazine
|
A member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position.
|
|
PSN357
|
|
|
4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine
|
|
|
Piretanide
|
|
|
BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE
|
|
|
Fructose-6-Phosphate
|
|
|
6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine
|
|
|
Glucagon recombinant
|
|
|
Irinotecan
|
|
|
3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol
|
|
|
Phenylmercury
|
An arylmercury compound that has formula C6H5Hg.
|
|
3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID
|
|
|
7-Methyl-Gpppa
|
|
|
iCo-007
|
|
|
N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide
|
|
|
2-Amino-3-Oxo-4-Sulfo-Butyric Acid
|
|
|
Methysergide
|
|
|
1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA
|
|
|
Cytidine-5'-Triphosphate
|
|
|
2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE
|
|
|
Voacamine
|
A citraconoyl group that has formula C43H52N4O5.
|
|
(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid
|
|
|
(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione
|
|
|
Brompheniramine
|
Pheniramine in which the hydrogen at position 4 of the phenyl substituent is substituted by bromine. A histamine H1 receptor antagonist, brompheniramine is used (commonly as its maleate salt) for the symptomatic relief of allergic conditions, including rhinitis and conjunctivitis.
|
|
5-hydroxyvaleric acid
|
|
|
N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide
|
|
|
Etanercept
|
|
|
4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium
|
|
|
5-AMINO-NAPHTALENE-2-MONOSULFONATE
|
|
|
MF268
|
|
|
Cyanamide
|
A nitrile that is hydrogen cyanide in which the hydrogen has been replaced by an amino group.
|
|
4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL
|
|
|
MDV3100
|
|
|
Al7089a
|
|
|
[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE
|
A pyrimidinethione that has formula C19H18N2O2S.
|
|
(R)-N-(1-Methyl-Hexyl)-Formamide
|
|
|
2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE
|
A furopyridine that has formula C25H26N4O.
|
|
1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE
|
|
|
N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
|
|
|
Iodo-Willardiine
|
|
|
7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE
|
A piperazine that has formula C18H23N6O2.
|
|
N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide
|
|
|
1-Hydroxy-2-Amino-3-Cyclohexylpropane
|
|
|
L-Asparagine
|
An optically active form of asparagine having L-configuration.
|
|
N-Acetyl-D-Allosamine
|
|
|
ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE
|
|
|
N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide
|
|
|
Olomoucine
|
|
|
5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
|
|
|
2-Chlorodideoxyadenosine
|
A purine 2',3'-dideoxyribonucleoside that has formula C10H12ClN5O2.
|
|
[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE
|
|
|
D-Serine
|
The R-enantiomer of serine.
|
|
(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid
|
|
|
Linaclotide
|
|
|
2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine
|
|
|
ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE
|
|
|
OSI-7904L
|
|
|
Heparin Disaccharide Iii-S
|
|
|
[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone
|
|
|
Glimepiride
|
A N-acylurea that has formula C24H34N4O5S.
|
|
N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine
|
|
|
Adenosine triphosphate
|
|
|
Paramethasone
|
|
|
2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE
|
|
|
ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate
|
|
|
N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE
|
|
|
RP101
|
|
|
N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE
|
|
|
Implitapide
|
|
|
Alpha-1-proteinase inhibitor
|
|
|
4-Flourobenzenesulfonamide
|
|
|
N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE
|
|
|
N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE
|
|
|
Granisetron
|
|
|
Nadolol
|
Nadolol is a diastereoisomeric mixture consisting of equimolar amounts of the four possible 2,3-cis-isomers of 5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol.
|
|
AT7519
|
|
|
Carboxymycobactin S
|
Any one of a class of alpha-amino acid ester-lactams secreted by, amongst others, Mycobacterium tuberculosis and which are both lipid- and water-soluble and act as siderophores.
|
|
Methimazole
|
A member of the class of imidazoles that it imidazole-2-thione in which a methyl group replaces the hydrogen which is attached to a nitrogen.
|
|
Cyclohexylformamide
|
|
|
(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE
|
|
|
Desvenlafaxine
|
|
|
NU1025
|
A member of the class of quinazolines that is quinazolin-4(1H)-one substituted by a hydroxy group at position 8 and a methyl group at position 2. It has been shown to exhibit inhibitory activity against poly(ADP-ribose) polymerase.
|
|
5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE
|
A furopyrimidine that has formula C24H25N5O.
|
|
Triphospate
|
|
|
4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE
|
|
|
Haloperidol
|
A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
|
|
Didanosine
|
A purine 2',3'-dideoxyribonucleoside that is inosine in which the hydroxy groups at both the 2' and the 3' positions on the sugar moiety have been replaced by hydrogen.
|
|
(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL
|
A hydroxypiperidine that is deoxynojirimycin (duvoglustat) in which the amino hydrogen is replaced by a nonyl group.
|
|
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide
|
|
|
Ginkgo biloba
|
|
|
N-ACETYLHISTAMINE
|
A member of the class of acetamides that is acetamide comprising histamine having an acetyl group attached to the side-chain amino function.
|
|
Dimethylallyl Diphosphate
|
|
|
4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid
|
|
|
Melatonin
|
A member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans.
|
|
2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
|
|
|
Tricarballylic Acid
|
A tricarboxylic acid that is glutaric acid in which one of the beta-hydrogens is substituted by a carboxy group.
|
|
(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE
|
An imidazolidinone that has formula C18H19N5O2.
|
|
Sphinxolide B
|
|
|
7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE
|
|
|
4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]-2-Pyrrolidinone
|
|
|
Alpha-Methylisocitric Acid
|
|
|
Mepyramine
|
An ethylenediamine derivative that is ethylenediamine in which one of the amino nitrogens is substituted by two methyl groups and the remaining amino nitrogen is substituted by a 4-methoxybenzyl and a pyridin-2-yl group.
|
|
(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid
|
|
|
Acetic Acid Salicyloyl-Amino-Ester
|
|
|
Repaglinide
|
|
|
(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
|
|
|
Anileridine
|
|
|
P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate
|
|
|
Para-Isopropylaniline
|
A substituted aniline carrying an isopropyl group at position 4. It is a metabolite of isoproturon.
|
|
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide
|
|
|
Alverine
|
|
|
(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE
|
|
|
Metyrapone
|
|
|
Human Serum Albumin
|
|
|
Tetrahydrobiopterin
|
|
|
FR230513
|
|
|
1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide
|
|
|
Adinazolam
|
A triazolo[4,3-a][1,4]benzodiazepine having a dimethylaminomethyl group at the 1-position, a phenyl group at the 6-position and a chloro substituent at the 8-position.
|
|
3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol
|
A pyrazolopyrimidine that has formula C5H4N4O.
|
|
MLN-02
|
|
|
Flavopiridol
|
|
|
Verapamil
|
A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
|
|
Tesmilifene
|
|
|
Para-Bromobenzyl Alcohol
|
|
|
Clenbuterol
|
|
|
Vecuronium
|
A 5alpha-androstane compound having 3alpha-acetoxy-, 17beta-acetoxy-, 2beta-piperidino- and 16beta-N-methylpiperidinium substituents.
|
|
Amlodipine
|
A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
|
|
Amonafide
|
|
|
Carvedilol
|
A member of the class of carbazoles that is an adrenergic antagonist with non-selective beta- and alpha-1 receptor blocking properties which helps in the management of congestive heart failure.
|
|
Di(N-Acetyl-D-Glucosamine)
|
|
|
Drotaverine
|
|
|
D-4-Phosphoerythronic Acid
|
|
|
1H-INDOL-3-YLACETIC ACID
|
A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens has been replaced by a 1H-indol-3-yl group.
|
|
Hexanoyl-Coenzyme A
|
|
|
2'-Monophosphoadenosine-5'-Diphosphate
|
|
|
CRx-119
|
|
|
Alcaftadine
|
|
|
Memantine
|
|
|
Pyrimethamine
|
|
|
5-Amidino-Benzimidazole
|
|
|
4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID
|
An aldoxime that has formula C15H14N4O6.
|
|
2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE)
|
|
|
Cefonicid
|
|
|
Heparin
|
A highly sulfated linear glycosaminoglycan comprising complex patterns of uronic acid-(1->4)-D-glucosamine repeating subunits. Used as an injectable anticoagulant, it has the highest negative charge density of any known biological molecule.
|
|
Scopolamine
|
A tropane alkaloid that is the (S)-tropic acid ester of 6beta,7beta-epoxy-1alphaH,5alphaH-tropan-3alpha-ol.
|
|
Dehydroascorbic Acid
|
A tetrahydrofuranone that has formula C6H6O6.
|
|
3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine
|
|
|
1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine
|
|
|
Tiaprofenic acid
|
An aromatic ketone that is thiophene substituted at C-2 by benzoyl and at C-4 by a 1-carboxyethyl group.
|
|
(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE
|
|
|
2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
|
|
|
intranasal apomorphine
|
|
|
Leucine - Reduced Carbonyl
|
|
|
8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
|
|
|
Azathioprine
|
A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
|
|
Aprotinin
|
|
|
N-Cyclohexyl-N'-(4-Iodophenyl)Urea
|
|
|
R673
|
|
|
CRA_9076
|
|
|
N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE
|
|
|
Dinoprost Tromethamine
|
An organic molecular entity that has formula C20H34O5.C4H11NO3.
|
|
Alemtuzumab
|
|
|
beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide
|
|
|
4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide
|
|
|
Nilutamide
|
|
|
3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine
|
|
|
Desogestrel
|
|
|
9-(4-Hydroxyphenyl)-2,7-Phenanthroline
|
|
|
7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE
|
A N-glycosylpyrrolopyrimidine that has formula C11H13IN4O3.
|
|
L-BENZYLSUCCINIC ACID
|
|
|
N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide
|
|
|
7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid
|
A thienopyran that has formula C18H14N2O9S2.
|
|
KAI-1455
|
|
|
3'-Phosphate-Adenosine-5'-Diphosphate
|
|
|
Varenicline
|
|
|
(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE
|
|
|
4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN
|
|
|
N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide
|
|
|
(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide
|
|
|
Lansoprazole
|
A sulfoxide that has formula C16H14F3N3O2S.
|
|
2-Deoxy-2-Aminogalactose
|
|
|
2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid
|
A N-acetylneuraminic acid that has formula C11H17NO8.
|
|
L-Homoarginine
|
An L-lysine derivative that is the L-enantiomer of homoarginine.
|
|
5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE
|
|
|
Indolylpropionic Acid
|
|
|
(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone
|
|
|
Oxibendazole
|
|
|
N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE
|
A fluoropyrrolidine that has formula C17H30FN3O2.
|
|
5-Phospho-D-Arabinohydroxamic Acid
|
|
|
TRAZEOLIDE
|
|
|
N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide
|
|
|
Disopyramide
|
A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
|
|
GIBBERELLIN A4
|
A C19-gibberellin.
|
|
N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE
|
|
|
Diphenoxylate
|
A piperidinecarboxylate ester that is the ethyl ester of difenoxin.
|
|
Terfenadine
|
|
|
N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide
|
|
|
Risperidone
|
A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
|
|
N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide
|
|
|
2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene
|
|
|
S-NONYL-CYSTEINE
|
|
|
Quazepam
|
|
|
1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID
|
|
|
C31G
|
|
|
Phosphatidylserine
|
|
|
Acepromazine
|
A member of the class of phenothiazines that is 10H-phenothiazine substituted by an acetyl group at position 2 and a 3-(dimethylamino)propyl group at position 10.
|
|
1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione
|
|
|
2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER
|
|
|
Ofloxacin
|
An oxazinoquinolone carrying carboxy, fluoro, methyl and 4-methylpiperazino substituents. A synthetic fluoroquinolone antibacterial agent, it inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
|
|
S-Methylcysteine
|
|
|
Tyloxapol
|
|
|
RU79073
|
|
|
RU79072
|
|
|
Aconitate Ion
|
|
|
Xanthophyll
|
A subclass of carotenoids consisting of the oxygenated carotenes.
|
|
'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine
|
|
|
S-2-(Boronoethyl)-L-Cysteine
|
L-cysteine substituted at sulfur by a 2-boronoethyl group.
|
|
Atomoxetine
|
A secondary amino compound having methyl and 3-(2-methylphenoxy)-3-phenylpropan-1-yl substituents.
|
|
Sulfasalazine
|
An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
|
|
Vincristine
|
A vinca alkaloid that has formula C46H56N4O10.
|
|
2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid
|
|
|
Uridine-5'-Monophosphate
|
|
|
Atovaquone
|
|
|
Anisotropine Methylbromide
|
A quaternary ammonium salt resulting from the reaction of the amino group of anisotropine with methyl bromide.
|
|
1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
|
|
Naphthalene Trisulfonate
|
|
|
L-709,587
|
|
|
4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN
|
|
|
Palmitoyl-Linoleoyl Phosphatidylcholine
|
|
|
Flupentixol
|
|
|
1-Deaza-Adenosine
|
|
|
1-Hydroxy-3-Methylbutane
|
|
|
NB1011
|
|
|
(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol
|
|
|
pradefovir mesylate
|
|
|
{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid
|
|
|
N-Hydroxy-4-Phosphono-Butanamide
|
|
|
6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone
|
|
|
Drospirenone
|
|
|
Fesoterodine
|
|
|
[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid
|
|
|
Cefmetazole
|
|
|
Gliquidone
|
|
|
Amsacrine
|
|
|
3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL
|
|
|
PDE4
|
|
|
4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol
|
|
|
Fulvestrant
|
|
|
1,3,3-trimethyl-2-[(1E,3E)-3-methylpenta-1,3-dien-1-yl]cyclohexene
|
|
|
METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE
|
|
|
Isoniazid
|
|
|
Phosphatidyl ethanol
|
Formula:C7H10O8PR2
|
|
Colchicine
|
An alkaloid that is a carbotricyclic compound comprising 5,6,7,9-tetrahydrobenzo[a]heptalene having four methoxy substituents at the 1-, 2-, 3- and 10-positions as well as an oxo group at the 9-position and an acetamido group at the 7-position. It has been isolated from the plants belonging to genus Colchicum.
|
|
1-biphenyl-2-ylmethanamine
|
|
|
2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide
|
|
|
T131
|
|
|
AT9283
|
|
|
Isometheptene
|
|
|
3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one
|
|
|
Fomepizole
|
A member of the class of pyrazoles that is 1H-pyrazole substituted by a methyl group at position 4.
|
|
4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE
|
A guanidine that has formula C20H36N6O3S.
|
|
D-Tyrosine
|
An optically active form of tyrosine having D-configuration.
|
|
(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
|
|
|
Dodecyl-Alpha-D-Maltoside
|
|
|
(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide
|
|
|
3,4-Methylenedioxymethamphetamine
|
A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
|
|
LFA703
|
|
|
Sunitinib
|
A pyrrole that has formula C22H27FN4O2.
|
|
trans-2-hydroxycinnamic acid
|
|
|
6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID
|
|
|
(3R,5S,7R,12S,13R)-13-FORMYL-12,14-DIHYDROXY-3,5,7-TRIMETHYLTETRADECANOIC ACID
|
|
|
6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE
|
|
|
Calusterone
|
|
|
BMS068645
|
|
|
Edotecarin
|
|
|
Esmolol
|
A carboxylic ester that is methyl 3-(4-hydroxyphenyl)propanoate in which the hydrogen attached to the phenoic hydroxy group is substituted by a 2-hydroxy-3-(isopropylamino)propyl group. A cardioselective and short-acting beta1 receptor blocker with rapid onset but lacking intrinsic sympathomimetic and membrane-stabilising properties, it is used as the hydrochloride salt in the management of supraventricular arrhythmias, and for the control of hypertension and tachycardia during surgery.
|
|
Clofarabine
|
|
|
Bis(5-Amidino-2-Benzimidazolyl)Methanone
|
|
|
Methylnaltrexone
|
|
|
6s-5,6,7,8-Tetrahydrobiopterin
|
|
|
4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide
|
|
|
Gamma Hydroxybutyric Acid
|
|
|
CRA_10762
|
|
|
Azilsartan medoxomil
|
A carboxylic ester obtained by formal condensation of the carboxy group of azilsartan with the hydroxy group of 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one. A prodrug for azilsartan, it is used for treatment of hypertension.
|
|
Demecarium
|
|
|
Lovastatin
|
A fatty acid ester that is mevastatin carrying an additional methyl group on the carbobicyclic skeleton. It is used in as a antilipemic drug and has been found in fungal species such as Aspergillus terreus and Pleurotus ostreatus (oyster mushroom).
|
|
XL019
|
|
|
AZD 3355
|
|
|
3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide
|
|
|
D-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID
|
|
|
Oxacillin
|
A penicillin antibiotic carrying a 5-methyl-3-phenylisoxazole-4-carboxamide group at position 6.
|
|
Minocycline
|
A tetracycline analogue having a dimethylamino group at position 7 and lacking the methyl and hydroxy groups at position 5.
|
|
Folic Acid
|
An N-acyl-amino acid that is a form of the water-soluble vitamin B9. Its biologically active forms (tetrahydrofolate and others) are essential for nucleotide biosynthesis and homocysteine remethylation.
|
|
Novobiocin
|
|
|
N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
|
|
|
N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine
|
A N-carbonylpiperazine that has formula C26H29N5O4S.
|
|
(1R)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID
|
|
|
Dextropropoxyphene
|
The (1S,2R)-(+)-diastereoisomer of propoxyphene.
|
|
Taurocholic Acid
|
A bile acid taurine conjugate of cholic acid that usually occurs as the sodium salt of bile in mammals.
|
|
Glutamine t-butyl ester
|
|
|
(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one
|
|
|
ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID
|
|
|
Alpha-L-1-Methyl-Fucose
|
|
|
(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one
|
|
|
Cyclotheonamide A
|
|
|
Lofexidine
|
|
|
4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide
|
|
|
Mecamylamine
|
|
|
Ropinirole
|
An indolone that has formula C16H24N2O.
|
|
N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine
|
|
|
L-2-amino-3-butynoic acid
|
|
|
Dimenhydrinate
|
The diphenhydramine salt of 8-chlorotheophylline. Its effects are similar to those of diphenhydramine, but it is less potent. It was thought that by combining the antiemetic effects of diphenhydramine with the mild stimulant effects of 8-chlorotheophyline, the extreme drowsiness induced by the former would be mitigated. However, the sedation caused by diphenhydramine is considerably stronger than the stimulation caused by 8-chlorotheophylline. Dimenhydrinate is used mainly as an antiemetic in the prevention and treatment of motion sickness.
|
|
Phenacemide
|
|
|
Diethylpropion
|
An aromatic ketone that is propiophenone in which one of the hydrogens alpha- to the carbonyl is substituted by a diethylamino group. A central stimulant and indirect-acting sympathomimetic, it is an appetite depressant and is used as the hydrochloride as an anoretic in the short term management of obesity.
|
|
Carboxymethylenecysteine
|
|
|
Remikiren
|
A N-acyl-amino acid that has formula C33H50N4O6S.
|
|
GEM-231
|
|
|
Cisplatin
|
A diamminedichloroplatinum compound in which the two ammine ligands and two chloro ligands are oriented in a cis planar configuration around the central platinum ion. An anticancer drug that interacts with, and forms cross-links between, DNA and proteins, it is used as a neoplasm inhibitor to treat solid tumours, primarily of the testis and ovary.
|
|
Erythose-4-Phosphate
|
|
|
Hyaluronidase
|
|
|
Urofollitropin
|
|
|
Oprelvekin
|
|
|
Heptane-1,2,3-Triol
|
A triol comprising heptane substituted with hydroxy groups at C-1, -2 and -3.
|
|
1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE
|
A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
|
|
N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE
|
|
|
MGI-114
|
|
|
AUROVERTIN B
|
|
|
C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide
|
|
|
Diflorasone
|
The 16beta-analogue of flumethasone. It is used as the 17,21-diacetate as a topical anti-inflammatory and antipruritic in the treatment of various skin disorders.
|
|
Pargyline
|
|
|
Trastuzumab
|
|
|
Guanosine-3'-Monophosphate-5'-Diphosphate
|
|
|
Ribostamycin
|
An amino cyclitol glycoside that is 4,6-diaminocyclohexane-1,2,3-triol having a 2,6-diamino-2,6-dideoxy-alpha-D-glucosyl residue attached at position 1 and a beta-D-ribosyl residue attached at position 2. It is an antibiotic produced by Streptomyces ribosidificus (formerly S. thermoflavus).
|
|
Cyproterone acetate
|
A chlorinated steroid that has formula C24H29ClO4.
|
|
(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid
|
|
|
Carboxyatractyloside
|
|
|
Quinethazone
|
|
|
Dexrazoxane
|
A razoxane that has formula C11H16N4O4.
|
|
Belatacept
|
|
|
N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine
|
|
|
Y-700
|
|
|
Galiximab
|
|
|
Tris(Hydroxymethyl)Aminomethane
|
|
|
(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide
|
|
|
Yohimbine
|
An indole alkaloid with alpha2-adrenoceptor antagonist activity. It is produced by Corynanthe johimbe and Rauwolfia serpentina.
|
|
(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide
|
|
|
(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid
|
|
|
3-Oxiran-2ylalanine
|
|
|
Mycophenolate mofetil
|
|
|
Methyltestosterone
|
A 17beta-hydroxy steroid that is testosterone bearing a methyl group at the 17alpha position.
|
|
Loteprednol
|
A steroid acid ester that has formula C21H27ClO5.
|
|
Itraconazole
|
A dioxolane that has formula C35H38Cl2N8O4.
|
|
N-Benzylformamide
|
A formamide that has formula C8H9NO.
|
|
PX-12
|
|
|
Dimethylformamide
|
|
|
Afatinib
|
A quinazoline compound having a 3-chloro-4-fluoroanilino group at the 4-position, a 4-dimethylamino-trans-but-2-enamido group at the 6-position, and an (S)-tetrahydrofuran-3-yloxy group at the 7-position. Used (as its dimaleate salt) for the first-line treatment of patients with metastatic non-small cell lung cancer.
|
|
Etodolac
|
A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
|
|
Clopidogrel
|
A thienopyridine that has formula C16H16ClNO2S.
|
|
HMPL-004
|
|
|
Cinacalcet
|
|
|
LE-SN38
|
|
|
3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione
|
|
|
Auranofin
|
|
|
corticotropin-releasing factor
|
|
|
1-Methoxy-2-(2-Methoxyethoxy)Ethane
|
A polyether that is the dimethyl ether derivative of diethylene glycol.
|
|
Desipramine
|
A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
|
|
indane-5-sulfonamide
|
|
|
Topiramate
|
A hexose derivative that is 2,3:4,5-di-O-isopropylidene-beta-D-fructopyranose in which the hydroxy group has been converted to the corresponding sulfamate ester. It blocks voltage-dependent sodium channels and is used as an antiepileptic and for the prevention of migraine.
|
|
6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine
|
A pyrazine that has formula C30H27N5.
|
|
Mitiglinide
|
|
|
Ephedrine
|
A phenethylamine alkaloid that is 2-phenylethanamine substituted by a methyl group at the amino nitrogen and a methyl and a hydroxy group at position 2 and 1 respectively.
|
|
AC-(D)PHE-PRO-BOROLYS-OH
|
|
|
4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid
|
|
|
5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE
|
|
|
[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester
|
|
|
Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester
|
|
|
Atracurium
|
A diester compound consisting of pentane-1,5-diol with both hydroxyls bearing 3-[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-3,4-dihydroisoquinolinium-2(1H)-yl]propanoyl groups.
|
|
Dansyllysine
|
|
|
Cinoxacin
|
|
|
Filaminast
|
|
|
Abacavir
|
|
|
7,8-DICHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE
|
A 1,2,3,4-tetrahydroisoquinoline hacing chloro substituents at the 7- and 8-positions.
|
|
7-[3-(4-FLUORO-PHENYL)-1-ISOPROPYL-1H-INDOL-2-YL]-3,5-DIHYDROXY-HEPTANOIC ACID
|
|
|
7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile
|
|
|
Cibacron Blue
|
|
|
6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE
|
An aminopyrimidine that has formula C12H14N4.
|
|
7-Nitroindazole-2-Carboxamidine
|
|
|
Liotrix
|
|
|
Mirtazapine
|
A tetracyclic antidepressant that has formula C17H19N3.
|
|
S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea
|
|
|
O2-Sulfo-Glucuronic Acid
|
|
|
Glatiramer Acetate
|
|
|
N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide
|
|
|
2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione
|
|
|
(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid
|
|
|
N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE
|
A member of the class of aromatic amines that is ammonia with two of the hydrogens replaced by 5-methylpyrazol-3-yl and 2-phenylquinazolin-4-yl groups.
|
|
ABT-874
|
|
|
L-Citrulline
|
The L-enantiomer of citrulline.
|
|
6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One
|
|
|
Acitretin
|
|
|
2'-Monophosphoadenosine 5'-Diphosphoribose
|
|
|
Famciclovir
|
2-Amino-9H-purine in which the hydrogen at position 9 is substituted by a 4-acetoxy-3-(acetoxymethyl)but-1-yl group. A prodrug of the antiviral penciclovir, it is used for the treatment of acute herpes zoster (shingles), for the treatment or suppression of recurrent genital herpes in immunocompetent patients and for the treatment of recurrent mucocutaneous herpes simplex infections in HIV infected patients.
|
|
Mesalazine
|
|
|
VEGF-AS
|
|
|
Naratriptan
|
A heteroarylpiperidine that has formula C17H25N3O2S.
|
|
2-deoxyglucose
|
|
|
SR 140333
|
|
|
(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide
|
|
|
2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE
|
|
|
Pyridoxine
|
A hydroxymethylpyridine with hydroxymethyl groups at positions 4 and 5, a hydroxy group at position 3 and a methyl group at position 2.
|
|
Dicyclomine
|
The ester resulting from the formal condensation of 1-cyclohexylcyclohexanecarboxylic acid with 2-(diethylamino)ethanol. An anticholinergic, it is used as the hydrochloride to treat or prevent spasm in the muscles of the gastrointestinal tract, particularly that associated with irritable bowel syndrome.
|
|
Sulfamethoxazole
|
An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
|
|
BMS184394
|
|
|
N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-
|
|
|
4-Methyl-Histidine
|
|
|
Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide
|
|
|
Benzthiazide
|
|
|
N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE
|
|
|
Cyclic Adenosine Monophosphate
|
|
|
Felodipine
|
The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
|
|
FARNESYL
|
|
|
12-Hydroxydodecanoic Acid
|
A medium-chain fatty acid that is the 12-hydroxylated derivative of lauric acid.
|
|
L-Threonine
|
An optically active form of threonine having L-configuration.
|
|
Dpb-T
|
|
|
Nor-N-Omega-Hydroxy-L-Arginine
|
|
|
2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide
|
|
|
Erythrityl Tetranitrate
|
|
|
Omalizumab
|
|
|
CTS-21166
|
|
|
5-BETA-ANDROSTANE-3,17-DIONE
|
An androstane-3,17-dione with a 5beta-configuration.
|
|
2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione
|
A heteroarylpiperidine that has formula C17H21N3O4.
|
|
(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}
|
|
|
5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine
|
|
|
Hexylcaine
|
|
|
Quetiapine
|
A dibenzothiazepine that has formula C21H25N3O2S.
|
|
Zopiclone
|
|
|
(1S)-MENTHYL HEXYL PHOSPHONATE GROUP
|
|
|
Fenretinide
|
|
|
Piperazine
|
An azacycloalkane that consists of a six-membered ring containing two nitrogen atoms at opposite positions.
|
|
Alpha-L-Methyl-Fucose
|
|
|
Ketorolac
|
|
|
Bis(Adenosine)-5'-Pentaphosphate
|
|
|
Cyclohexane
|
An alicyclic hydrocarbon comprising a ring of six carbon atoms; the cyclic form of hexane, used as a raw material in the manufacture of nylon.
|
|
inhaled insulin
|
|
|
Betahistine
|
|
|
O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE
|
|
|
Mivacurium
|
|
|
D-Myo-Inositol-2,4,5-Trisphosphate
|
|
|
Rilonacept
|
|
|
ABT-263
|
|
|
Azacitidine
|
|
|
4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
|
|
|
(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
|
|
|
Halobetasol Propionate
|
|
|
Moxifloxacin
|
A quinolone that consits of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid bearing a cyclopropyl substituent at position 1, a fluoro substitiuent at position 6, a (4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl group at position 7 and a methoxy substituent at position 8. A member of the fluoroquinolone class of antibacterial agents.
|
|
Erythromycin
|
Any of several wide-spectrum macrolide antibiotics obtained from actinomycete Saccharopolyspora erythraea (formerly known as Streptomyces erythraeus).
|
|
Platelet Activating Factor
|
A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine where the 2-O-acyl group is specified as acetyl; a potent phospholipid activator and mediator of many leukocyte functions, including platelet aggregation, inflammation, and anaphylaxis.
|
|
(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)
|
|
|
Carbimazole
|
|
|
ISS-1018
|
|
|
4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid
|
A 1,2,5-oxadiazole that has formula C3H2N2O4.
|
|
5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID
|
|
|
(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID
|
|
|
Icatibant
|
|
|
3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE
|
|
|
1-Hexadecanosulfonic Acid
|
|
|
Debrisoquin
|
|
|
Glycine
|
The simplest (and the only achiral) proteinogenic amino acid, with a hydrogen atom as its side chain.
|
|
Duramycin
|
A 19-membered heterodetic cyclic peptide that is isolated from Streptoverticillium cinnamoneus. It exhibits antiproliferative properties and induces apoptosis in tumour cells and has been used for treatment of cystic fibrosis.
|
|
Isatoribine
|
|
|
Cinitapride
|
|
|
Emedastine
|
|
|
Putrescine
|
A four-carbon alkane-alpha,omega-diamine. It is obtained by the breakdown of amino acids and is responsible for the foul odour of putrefying flesh.
|
|
4-Guanidinobenzoic Acid
|
Benzoic acid substituted at the para position by a guanidino group.
|
|
TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE
|
|
|
Epoetin Zeta
|
|
|
2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE
|
|
|
1-Hydroxyamine-2-Isobutylmalonic Acid
|
|
|
8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one
|
|
|
2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate
|
|
|
(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE
|
|
|
(2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine
|
The E-isomer of imidacloprid.
|
|
Diphenylpyraline
|
|
|
N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide
|
A piperazinecarboxylate ester that has formula C20H23N3O7S.
|
|
Phosphoramidon
|
A dipeptide isolated from the cultures of Streptomyces tanashiensis.
|
|
CRA_1802
|
|
|
(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER
|
|
|
AER001
|
|
|
Cefamandole
|
|
|
Testosterone Propionate
|
A steroid ester that has formula C22H32O3.
|
|
N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide
|
|
|
4,7-Dioxosebacic Acid
|
|
|
Aprindine
|
|
|
Citric Acid
|
A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
|
|
9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid
|
|
|
2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide
|
|
|
1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE
|
|
|
Tocainide
|
|
|
1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine
|
|
|
Bezafibrate
|
|
|
[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate
|
|
|
Marimastat
|
A tricarboxylic acid triamide that has formula C15H29N3O5.
|
|
[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE
|
A pyridinium salt that has formula C22H36N5O4S.
|
|
5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide
|
|
|
Physostigmine
|
An indole alkaloid that has formula C15H21N3O2.
|
|
Metoclopramide
|
A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
|
|
Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside
|
|
|
Methacholine
|
|
|
Motuporin
|
|
|
2-[3,5-DICHLORO-4-(2-{2-[2(2-MERCAPTOETHOXY)ETHOXY]ETHOXY}ETHOXY)PHENYLAMINO]BENZOIC ACID
|
|
|
Oxtriphylline
|
|
|
6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine
|
|
|
KC706
|
|
|
2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate
|
|
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE
|
|
|
Biotin
|
An organic heterobicyclic compound that consists of 2-oxohexahydro-1H-thieno[3,4-d]imidazole having a valeric acid substituent attached to the tetrahydrothiophene ring. The parent of the class of biotins.
|
|
2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL
|
|
|
Ceftriaxone
|
A cephalosporin compound having 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetylamino and [(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl side-groups.
|
|
4-(1H-IMIDAZOL-1-YL)PHENOL
|
|
|
Zanamivir
|
|
|
Nitromethyldethia Coenzyme A
|
|
|
Ceftibuten
|
|
|
Ketoprofen
|
An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.
|
|
(3R)-3-HYDROXYDODECANOIC ACID
|
The (R)-enantiomer of 3-hydroxylauric acid. An intermediate in fatty acid biosynthesis.
|
|
3-Hydroxyhippuric acid
|
|
|
LY2140023
|
|
|
Farnesol
|
|
|
Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate
|
|
|
1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine
|
|
|
Di-Stearoyl-3-Sn-Phosphatidylcholine
|
|
|
1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine
|
|
|
Gluconolactone
|
|
|
NCX 950
|
|
|
Maltose
|
|
|
6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID
|
|
|
Rivaroxaban
|
|
|
Binodenoson
|
|
|
Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate
|
|
|
ABT-089
|
|
|
KD3010
|
|
|
4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid
|
|
|
Betazole
|
Pyrazole in which a hydrogen adjacent to one of the nitrogen atoms is substituted by a 2-aminoethyl group. It is a histamine H2-receptor agonist used clinically to test gastric secretory function.
|
|
(R)-Rolipram
|
|
|
FLUORESCIN
|
A xanthene that has formula C20H14O5.
|
|
AM103
|
|
|
(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID
|
|
|
Terbutaline
|
A member of the class of phenylethanolamines that is catechol substuted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
|
|
Dutasteride
|
Finasteride in which the tert-butyl group is replaced by a 2,5-bis(trifluoromethyl)phenyl group. A synthetic 4-azasteroid, dutasteride is a selective inhibitor of both the type 1 and type 2 isoforms of steroid 5alpha-reductase, an intracellular enzyme that converts testosterone to 5alpha-dihydrotestosterone. Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
|
|
(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID
|
|
|
Dopamine
|
Catechol in which the hydrogen at position 4 is substituted by a 2-aminoethyl group.
|
|
PUROMYCIN
|
An aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome.
|
|
5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide
|
|
|
IDD594
|
|
|
2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID
|
|
|
Voglibose
|
|
|
2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid
|
|
|
Tmr
|
|
|
CRA_10972
|
|
|
Compound 4-D
|
|
|
Trans-O-Hydroxy-Alpha-Methyl Cinnamate
|
|
|
SR 31747
|
|
|
RU83876
|
|
|
9-N-Phenylmethylamino-Tacrine
|
|
|
Imiquimod
|
An imidazoquinoline that has formula C14H16N4.
|
|
Selegiline
|
|
|
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine
|
|
|
Sulfadiazine
|
A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
|
|
(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide
|
|
|
MGCD-0103
|
|
|
(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one
|
|
|
Oseltamivir
|
|
|
6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE
|
|
|
3-Indolebutyric Acid
|
|
|
MK-8931
|
|
|
3-(Benzyloxy)Pyridin-2-Amine
|
|
|
1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One
|
A member of the class of xanthones that is xanthen-9-one substituted at position 4 by a nitro group and at positions 1 and 8 by hydroxy groups.
|
|
Metocurine Iodide
|
|
|
Clemastine
|
2-[(2R)-1-Methylpyrrolidin-2-yl]ethanol in which the hydrogen of the hydroxy group is substituted by a 1-(4-chlorophenyl)-1-phenylethyl group (R configuration). An antihistamine with antimuscarinic and moderate sedative properties, it is used as its fumarate salt for the symptomatic relief of allergic conditions such as rhinitis, urticaria, conjunctivitis and in pruritic (severe itching) skin conditions.
|
|
Acetoacetic Acid
|
A 3-oxo monocarboxylic acid that is butyric acid bearing a 3-oxo substituent.
|
|
Fluorouracil
|
|
|
RU78299
|
|
|
WAY-151693
|
|
|
4-Methylthio-Alpha-D-Mannose
|
|
|
Mibefradil
|
|
|
Pyrazinamide
|
|
|
N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE
|
|
|
Ixabepilone
|
|
|
Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester
|
|
|
Hydrocodone
|
An organic heteropentacyclic compound that has formula C18H21NO3.
|
|
6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid
|
A tetralin that has formula C24H29NO2.
|
|
ZEN-012
|
|
|
2-Aminothiazoline
|
|
|
FX06
|
|
|
Coenzyme a Persulfide
|
|
|
PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE
|
|
|
XL647
|
|
|
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid
|
|
|
ORG-34517
|
|
|
Rifampicin
|
A rifamycin that is a a semisynthetic antibiotic derived from Amycolatopsis rifamycinica (previously known as Amycolatopsis mediterranei and Streptomyces mediterranei)
|
|
N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide
|
|
|
Telithromycin
|
|
|
N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE
|
|
|
Probucol
|
|
|
(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE
|
|
|
Fexaramine
|
A biphenyl that has formula C32H36N2O3.
|
|
S-Isopropyl-Isothiourea
|
|
|
Fenofibrate
|
A chlorobenzophenone that is (4-chlorophenyl)(phenyl)methanone substituted by a [2-methyl-1-oxo-1-(propan-2-yloxy)propan-2-yl]oxy group at position 1 on the phenyl ring.
|
|
TD-2749
|
|
|
Cis-tetracosenoyl sulfatide
|
|
|
(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE
|
A morpholine that has formula C18H21F2N3O7S.
|
|
(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine
|
|
|
HY10275
|
|
|
1-Methyloxy-4-Sulfone-Benzene
|
|
|
5-Nitroindazole
|
|
|
omega interferon
|
|
|
4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid
|
|
|
(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid
|
|
|
Methylphosphonic Acid Ester Group
|
|
|
Gabapentin
|
|
|
Carbazole Butanoic Acid
|
|
|
Lesopitron
|
|
|
N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE
|
|
|
Cetirizine
|
A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
|
|
Salicylate-sodium
|
|
|
4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine
|
|
|
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE
|
|
|
Tamoxifen
|
A stilbenoid that has formula C26H29NO.
|
|
[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID
|
|
|
1-Ethyl-Pyrrolidine-2,5-Dione
|
A pyrrolidinone that has formula C6H9NO2.
|
|
Troxacitabine
|
|
|
Phenylephrine
|
A member of the class of the class of phenylethanolamines that is 2-(methylamino)ethanol substituted by a 3-hydroxyphenyl group at position 1.
|
|
3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide
|
A member of the class of benzamides obtained by formal condensation of the carboxy group of 3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1-yl}-4-methylbenzoic acid with the amino group of methylamine.
|
|
1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea
|
|
|
N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane
|
|
|
AGI-1067
|
|
|
3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol
|
|
|
1-(2,2'-bithiophen-5-yl)methanamine
|
|
|
S-(4-BROMOBENZYL)CYSTEINE
|
|
|
2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE
|
|
|
Protoporphyrin Ix
|
|
|
2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine
|
|
|
1,5-Dideoxy-1,5-Imino-D-Mannitol
|
|
|
(4s)-5-Fluoro-L-Leucine
|
|
|
Ospemifene
|
An organochlorine compound that is a selective estrogen receptor modulator; used for treatment of dyspareunia.
|
|
methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate
|
|
|
(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol
|
|
|
Norgestimate
|
|
|
Halofuginone
|
|
|
Alpha-Aminoisobutyric Acid
|
|
|
4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid
|
|
|
deoxycytidylyl-3',5'-guanosine
|
|
|
Forskolin
|
A labdane diterpenoid isolated from the Indian Coleus plant.
|
|
(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE
|
|
|
Dipivefrin
|
The dipivalate ester of (+-)-epinephrine (racepinephrine). A pro-drug of epinephrine, the hydrochloride is used topically as eye drops to reduce intra-ocular pressure in the treatment of open-angle glaucoma or ocular hypertension.
|
|
1-Hydroxy-1-Thio-Glycerol
|
|
|
Adenosine Phosphonoacetic Acid
|
|
|
2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline
|
|
|
Dimethyl sulfoxide
|
A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
|
|
Clonazepam
|
1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
|
|
Trihexyphenidyl
|
|
|
4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol
|
|
|
Cholecalciferol
|
|
|
Alpha-Aminobutyric Acid
|
An alpha-amino acid that is butyric acid bearing a single amino substituent located at position 2.
|
|
Nelfinavir
|
|
|
1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE
|
|
|
5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID
|
|
|
4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid
|
|
|
OCTANE-1,3,5,7-TETRACARBOXYLIC ACID
|
|
|
Glycerol
|
A triol with a structure of propane substituted at positions 1, 2 and 3 by hydroxy groups.
|
|
2,6-dibromo-4-[(E)-2-phenylethenyl]phenol
|
|
|
(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid
|
|
|
Guanadrel
|
|
|
1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline
|
|
|
4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid
|
|
|
[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID
|
|
|
Tamsulosin
|
A sulfonamide that has formula C20H28N2O5S.
|
|
N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE
|
|
|
1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One
|
|
|
N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine
|
An epoxy monocarboxylic acid that has formula C15H27N5O5.
|
|
Barbituric acid derivative
|
|
|
6-Deoxyglucose
|
|
|
Enalapril
|
A dicarboxylic acid monoester that is ethyl 4-phenylbutanoate in which a hydrogen alpha to the carboxy group is substituted by the amino group of L-alanyl-L-proline (S-configuration).
|
|
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide
|
|
|
Nateglinide
|
|
|
Immucillin-G
|
A dihydroxypyrrolidine that has formula C11H15N5O4.
|
|
Dexmedetomidine
|
|
|
Alpha-Ketomalonic Acid
|
|
|
(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE
|
|
|
6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE
|
|
|
Pazopanib
|
|
|
L-Serine
|
The L-enantiomer of serine.
|
|
3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID
|
|
|
Cysteinesulfonic Acid
|
|
|
Mesoridazine
|
|
|
Thiodigalactoside
|
|
|
3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE
|
|
|
Acetylcholine
|
|
|
(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID
|
|
|
(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid
|
|
|
Alfimeprase
|
|
|
Amoxapine
|
A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
|
|
Sertraline
|
A member of the class of tetralins that is tetralin which is substituted at positions 1 and 4 by a methylamino and a 3,4-dichlorophenyl group, respectively (the S,S diastereoisomer). A selective serotonin-reuptake inhibitor (SSRI), it is administered orally as the hydrochloride salt as an antidepressant for the treatment of depression, obsessive-compulsive disorder, panic disorder and post-traumatic stress disorder.
|
|
Alendronate
|
|
|
(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE
|
|
|
4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID
|
|
|
Treprostinil
|
|
|
Perhexiline
|
|
|
N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE
|
|
|
4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID
|
A dicarboxylic acid monoamide resulting from the formal condensation of one of the carboxyl groups of glutaric acid with the amino group of 4-aminostilbene.
|
|
Deoxycholic Acid
|
A dihydroxy-5beta-cholanic acid that has formula C24H40O4.
|
|
AL5300
|
|
|
Malathion
|
A diester that is butanedioate substituted by a (dimethoxyphosphorothioyl)sulfanediyl group at position 2.
|
|
4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE
|
A pyrrolopyrazole that has formula C23H24N6O2S.
|
|
(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester
|
|
|
XL784
|
|
|
N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide
|
|
|
AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH
|
|
|
N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE
|
|
|
MPI-674
|
|
|
7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester
|
|
|
Ecgonine
|
A tropane alkaloid that consists of tropane bearing carboxy and hydroxy substituents at positions 2 and 3 respectively and having (1R,2R,3S,5S)-configuration. It is both a metabolite of and a precursor to cocaine.
|
|
N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE
|
A benzothiazine that has formula C20H26N6O2S.
|
|
6-CHLORO-1-(2-{[(5-CHLORO-1-BENZOTHIEN-3-YL)METHYL]AMINO}ETHYL)-3-[(2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL
|
An aminoalkylpyridine that has formula C22H31Cl2N5OS.
|
|
Eprosartan
|
|
|
6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE
|
|
|
Dihydrotachysterol
|
|
|
2-[(2-Oxo-2-Piperidin-1-Ylethyl)Thio]-6-(Trifluoromethyl)Pyrimidin-4(1h)-One
|
|
|
Practolol
|
|
|
N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide
|
|
|
Zonisamide
|
A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
|
|
Methyl Isocyanide
|
|
|
(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile
|
|
|
FR239087
|
|
|
3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE
|
|
|
6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE
|
|
|
(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol
|
|
|
CI-1033
|
|
|
Methamphetamine
|
A member of the class of amphetamines in which the amino group of (S)-amphetamine carries a methyl substituent.
|
|
Chlorpromazine
|
A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
|
|
ADL5859
|
|
|
N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE
|
|
|
Tolbutamide
|
An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
|
|
5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine
|
|
|
1,2,5,8-tetrahydroxyanthracene-9,10-dione
|
A tetrahydroxyanthraquinone having the four hydroxy groups at the 1-, 2-, 5- and 8-positions.
|
|
(2S,5R,8S,11R,12S,15S,18S,19S,E)-8-ISOBUTYL-18-((5S,6S)-6-METHOXY-3,5-DIMETHYL-7-PHENYLHEPTYL)-1,2,5,12,15,19-HEXAMETHYL-3,6,9,13,16,20,25-HEPTAOXO-1,4,7,10,14,17,21-HEPTAAZACYCLOPENTACOS-21-ENE-11,22-DICARBOXYLIC ACID
|
|
|
Aprobarbital
|
|
|
Ethanol
|
A primary alcohol that is ethane in which one of the hydrogens is substituted by a hydroxy group.
|
|
4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide
|
|
|
N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA
|
|
|
Thieno[2,3-B]Pyridine-2-Carboxamidine
|
|
|
(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol
|
|
|
Butabarbital
|
A barbiturate that has formula C10H16N2O3.
|
|
5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID
|
|
|
3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide
|
|
|
Fluticasone furoate
|
A trifluorinated corticosteroid that consists of 6alpha,9-difluoro-11beta,17alpha-dihydroxy-17beta-{[(fluoromethyl)sulfanyl]carbonyl}-16-methyl-3-oxoandrosta-1,4-diene bearing a 2-furoyl substituent at position 17. Used in combination with vilanterol trifenate for treatment of bronchospasm associated with chronic obstructive pulmonary disease.
|
|
Ibudilast
|
|
|
N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE
|
|
|
N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide
|
|
|
AP1903
|
|
|
{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol
|
|
|
3h-Indole-5,6-Diol
|
|
|
1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine
|
|
|
N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE
|
|
|
Clidinium
|
The ester resulting from formal condensation of benzilic acid and 3-hydroxy-1-methyl-1-azoniabicyclo[2.2.2]octane. It is used, generally as the bromide, for the symptomatic treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome.
|
|
7-METHOXY-1-METHYL-9H-BETA-CARBOLINE
|
|
|
ACCLAIM
|
|
|
Isoflurophate
|
|
|
2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One
|
|
|
Triglu-5-Formyl-Tetrahydrofolate
|
|
|
5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE
|
|
|
N-(phosphonacetyl)-L-aspartic acid
|
|
|
4-Hydroxy-2-Butanone
|
|
|
Sargramostim
|
|
|
{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid
|
A benzotriazole that has formula C31H25F2N4O3PS.
|
|
Sulfamerazine
|
|
|
1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine
|
|
|
3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide
|
|
|
Nitroarginine
|
|
|
2-(Sec-Butyl)Thiazole
|
|
|
N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium
|
|
|
Pyrithiamine Pyrophosphate
|
A pyridinium ion that is the O-pyrophosphoryl derivative of pyrithiamine.
|
|
Zafirlukast
|
A carbamate ester that has formula C31H33N3O6S.
|
|
Megestrol acetate
|
A steroid ester that has formula C24H32O4.
|
|
(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE
|
|
|
Iobenguane
|
|
|
Nitroglycerin
|
A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
|
|
2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID
|
|
|
Maraviroc
|
|
|
3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL
|
|
|
Diflunisal
|
An organofluorine compound comprising salicylic acid having a 2,4-difluorophenyl group at the 5-position.
|
|
Suprofen
|
|
|
6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine
|
|
|
Rabeprazole
|
A sulfoxide that has formula C18H21N3O3S.
|
|
Cefotaxime
|
A cephalosporin compound having acetoxymethyl and [2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino side groups.
|
|
Pegvisomant
|
|
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
|
|
Ethosuximide
|
A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
|
|
Phosphocholine
|
The phosphate of choline; and the parent compound of the phosphocholine family.
|
|
5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole
|
|
|
S-(N-Hydroxy-N-Bromophenylcarbamoyl)Glutathione
|
|
|
R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid
|
|
|
3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE
|
|
|
4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1-&gt;4)HEXOPYRANOSYL-(1-&gt;4)HEXOPYRANOSE
|
|
|
N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide
|
|
|
N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE
|
|
|
7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline
|
|
|
N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE
|
An aminopyrimidine that has formula C21H18F3N5O.
|
|
Alosetron
|
|
|
5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE
|
|
|
12-Bromododecanoic Acid
|
A bromo fatty acid consisting of lauric acid having a single bromo-substituent at the 12-position.
|
|
Fidarestat
|
|
|
Amylotriose
|
|
|
Brinzolamide
|
|
|
6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE
|
A pyrrolidinoquinazoline that has formula C22H21N5O3.
|
|
Nicergoline
|
|
|
Nonoxynol-9
|
|
|
Tolvaptan
|
|
|
(1'r,2's)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-Yl)Adenine
|
|
|
Interferon beta-1a
|
|
|
Efalizumab
|
|
|
FR233623
|
|
|
Moricizine
|
|
|
Pheniramine
|
|
|
17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE
|
|
|
1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
|
|
|
Mirabegron
|
|
|
4-[4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL]-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE
|
|
|
Calcitriol
|
A hydroxycalciol that is calcidiol in which the pro-S hydrogen of calcidiol is replaced by a hydroxy group. It is the active form of vitamin D3, produced fom calciol via hydoxylation in the liver to form calcidiol, which is subsequently oxidised in the kidney to give calcitriol.
|
|
Lobeline
|
|
|
METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID
|
|
|
liposomal prostaglandin E1
|
|
|
CRx-139
|
|
|
(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
|
EHNA of absolute configuration 2S,3R.
|
|
N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE
|
|
|
Geranyl Diphosphate
|
The diphosphate of the polyprenol compound geraniol.
|
|
FARNESYL DIPHOSPHATE
|
A farnesyl phosphate that has formula C15H28O7P2.
|
|
4-Aminophenylarsonic Acid
|
An organoarsonic acid that has formula C6H8AsNO3.
|
|
Ceftizoxime
|
|
|
2,3-diphenyl-1H-indole-7-carboxylic acid
|
|
|
(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE
|
|
|
Dihydromorphine
|
A morphinane alkaloid that has formula C17H21NO3.
|
|
2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE
|
An aminopiperidine that has formula C20H23N7O2.
|
|
N-Trimethyllysine
|
|
|
RU82129
|
|
|
CR002
|
|
|
Pyridostigmine
|
|
|
2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID
|
|
|
CHF-1512
|
|
|
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE
|
|
|
octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside
|
|
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
|
|
|
2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID
|
|
|
CNS-5161
|
|
|
(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE
|
A thiomorpholine that has formula C14H19FN2O2S2.
|
|
Gpi-1046
|
|
|
Loracarbef
|
|
|
L-Myo-Inositol-1-Phosphate
|
|
|
6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE
|
|
|
LY2275796
|
|
|
5-methyltetrahydrofolate
|
A group of heterocyclic compounds based on the 5-methyl-5,6,7,8-tetrahydropteroic acid skeleton conjugated with one or more L-glutamic acid or L-glutamate units.
|
|
Phosphonoserine
|
|
|
6,7-Dicarboxyl-1,2,3,4,5,8-Hexamethylhemin
|
|
|
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one
|
|
|
N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE
|
|
|
CB1954
|
|
|
Uridylyl-2'-5'-Phospho-Adenosine
|
|
|
Captopril
|
A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug.
|
|
Aprepitant
|
|
|
Uric Acid
|
An oxopurine that is the final oxidation product of purine metabolism.
|
|
KW-3902
|
|
|
N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
|
|
|
Ketamine
|
A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
|
|
3,6,9,12,15,18-HEXAOXAICOSANE
|
A polyether that has formula C14H30O6.
|
|
5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid
|
|
|
Mazindol
|
|
|
Balanol Analog 8
|
|
|
Trandolapril
|
|
|
Tenecteplase
|
|
|
Balanol Analog 2
|
|
|
Balanol Analog 1
|
|
|
(1,10 Phenanthroline)-(Tri-Carbon Monoxide) Rhenium (I)
|
|
|
N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE
|
|
|
Boldenone
|
An 3-oxo-Delta(1),Delta(4)-steroid substituted by an oxo group at position 3 and a beta-hydroxy group at position 17. It is an anabolic androgenic steroid that has been developed for veterinary use.
|
|
Choline
|
A choline that is the parent compound of the cholines class, consisting of ethanolamine having three methyl substituents attached to the amino function.
|
|
1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide
|
|
|
(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE
|
|
|
3,4-Dihydro-2h-Pyrrolium-5-Carboxylate
|
A zwitterion resulting from the transfer of a proton from the carboxy group to the nitrogen of 1-pyrroline-2-carboxylic acid; major species at pH 7.3.
|
|
(1R,2R)-N-(2-AMINOETHYL)-2-{[(4-METHOXYPHENYL)SULFONYL]METHYL}CYCLOHEXANECARBOXAMIDE
|
|
|
4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE
|
|
|
ISA247
|
|
|
Pirfenidone
|
|
|
7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE
|
|
|
Ribavirin Monophosphate
|
|
|
Pefloxacin
|
|
|
Methsuximide
|
|
|
TACRINE(8)-4-AMINOQUINOLINE
|
|
|
Quinonoid 7,8-Tetrahydrobiopterin
|
|
|
8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine
|
|
|
Roxithromycin
|
|
|
Sotalol
|
A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is sustituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
|
|
Hydroxyzine
|
A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively.
|
|
Succinylcholine
|
A quaternary ammonium ion that is the bis-choline ester of succinic acid.
|
|
Dazoxiben
|
|
|
(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione
|
|
|
4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine
|
A piperidinylimidazole that has formula C28H29F3N6.
|
|
6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID
|
|
|
Phenylalanine-N-Sulfonamide
|
|
|
(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID
|
|
|
(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one
|
|
|
1-Deoxy-1-Thio-Heptaethylene Glycol
|
|
|
Dexamethasone
|
A fluorinated steroid that is 9-fluoropregna-1,4-diene substituted by hydroxy groups at positions 11, 17 and 21, a methyl group at position 16 and oxo groups at positions 3 and 20. It is a synthetic member of the class of glucocorticoids.
|
|
1-Anilino-8-Naphthalene Sulfonate
|
|
|
(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
|
An isoquinoline that has formula C20H22FN3O2.
|
|
Estropipate
|
|
|
2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1R)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE
|
|
|
(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE
|
|
|
Kifunensine
|
|
|
Selenazole-4-Carboxyamide-Adenine Dinucleotide
|
A dinucleotide analogue that has formula C19H25N7O14P2Se.
|
|
L-Proline
|
Pyrrolidine in which the pro-S hydrogen at position 2 is substituted by a carboxylic acid group. L-Proline is the only one of the twenty DNA-encoded amino acids which has a secondary amino group alpha to the carboxyl group. It is an essential component of collagen and is important for proper functioning of joints and tendons. It also helps maintain and strengthen heart muscles.
|
|
Permethrin
|
A cyclopropanecarboxylate ester in which the esterifying alcohol is 3-phenoxybenzyl alcohol and the cyclopropane ring is substituted with a 2,2-dichlorovinyl group and with gem-dimethyl groups.
|
|
4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
|
|
|
Allopurinol
|
A bicyclic structure comprising a pyrazole ring fused to a hydroxy-substituted pyrimidine ring.
|
|
(S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid
|
|
|
(Hydroxyethyloxy)Tri(Ethyloxy)Octane
|
|
|
METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE
|
|
|
Gamma-Glutamylcysteine
|
|
|
humanized SMART Anti-IL-12 Antibody
|
|
|
WF10
|
|
|
3,5-Diiodotyrosine
|
|
|
Ciclopirox
|
1-Hydroxypyridin-2(1H)-one in which the hydrogens at positions 4 and 6 are substituted by methyl and cyclohexyl groups, repectively. A broad spectrum antigfungal agent, it also exhibits antibacterial activity against many Gram-positive and Gram-negative bacteria, and has anti-inflammatory properties. It is used a a topical treatment of fungal skin and nail infections.
|
|
Metamizole
|
A pyrazole that is antiipyrine substituted at C-4 by a methyl(sulfomethyl)amino group, the sodium salt of which, metamizole sodium, was widely used as a powerful analgesic and antipyretic, but withdrawn from many markets from the 1970s due to a risk of causing risk of causing agranulocytosis.
|
|
PARA-NITROPHENYL PHOSPHONOBUTANOYL D-ALANINE
|
|
|
Homoharringtonine
|
|
|
2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE
|
|
|
Ampicillin
|
A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group.
|
|
1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE
|
|
|
(2S) N-ACETYL-L-ALANYL-ALPHAL-PHENYLALANYL-CHLOROETHYLKETONE
|
|
|
(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
|
|
|
Atl146e
|
|
|
Hydrocortisone
|
|
|
Oxazepam
|
A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a hydroxy group at position 3 and phenyl group at position 5.
|
|
7,9-Dihydro-1h-Purine-2,6,8(3h)-Trione
|
An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
|
|
5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
|
|
|
Chloropyramine
|
|
|
Argatroban
|
An alpha-N-substituted L-arginine that has formula C23H36N6O5S.
|
|
Hyperforin
|
A sesquarterpenoid that has formula C35H52O4.
|
|
3-(INDOL-3-YL) LACTATE
|
A 2-hydroxy carboxylate that is the conjugate base of 3-(indol-3-yl)lactic acid.
|
|
1,6-DI-O-PHOSPHONO-D-MANNITOL
|
|
|
Perphenazine
|
A member of the class of phenothiazines that is phenothiazine having a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position.
|
|
Warfarin
|
A hydroxycoumarin that is 4-hydroxycoumarin which is substituted at position 3 by a 1-phenyl-3-oxo-1-butyl group.
|
|
Guanine
|
A 2-aminopurine carrying a 6-oxo substituent.
|
|
Leuprolide
|
An oligopeptide comprising pyroglutamyl, histidyl, tryptophyl, seryl, tyrosyl, D-leucyl, leucyl, arginyl, and N-ethylprolinamide residues joined in sequence. It is a synthetic nonapeptide analogue of gonadotropin-releasing hormone, and is used as a subcutaneous hydrogel implant (particularly as the acetate salt) for the treatment of prostate cancer and for the suppression of gonadal sex hormone production in children with central precocious puberty.
|
|
1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE
|
|
|
1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE
|
|
|
Finasteride
|
An aza-steroid that is a synthetic drug for the treatment of benign prostatic hyperplasia.
|
|
Bepotastine
|
|
|
Omeprazole
|
A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
|
|
5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine
|
|
|
Deferoxamine
|
|
|
Metformin
|
A member of the class of guanidines that is the 1,1-dimethyl derivative of biguanide.
|
|
Hydroxydimethylarsine Oxide
|
|
|
Enfuvirtide
|
|
|
Clobazam
|
|
|
8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
|
|
|
1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL 2-ETHYLPHENYLCARBAMATE
|
|
|
Sulfamethizole
|
|
|
XL184
|
|
|
Biperiden
|
|
|
4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol
|
|
|
4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole
|
|
|
(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE
|
|
|
TC-5619
|
|
|
Mifepristone
|
|
|
EPT1647
|
|
|
TZP-101
|
|
|
2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine
|
|
|
Acarbose
|
A tetrasaccharide derivative consisting of a dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl C7 cyclitol moiety [called valienol (or valienamine)] linked via nitrogen to isomaltotriose.
|
|
Pegfilgrastim
|
|
|
Levobupivacaine
|
|
|
Pancuronium
|
A steroid ester in which a 5alpha-androstane skeleton is C-3alpha- and C-17beta-disubstituted with acetoxy groups and 2beta- and 16beta-disubstituted with 1-methylpiperidinium-1-yl groups. It is a non-depolarizing curare-mimetic muscle relaxant.
|
|
4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE
|
|
|
4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine
|
|
|
4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME
|
|
|
4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide
|
|
|
CNF1010
|
|
|
4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine
|
|
|
751689
|
|
|
S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea
|
|
|
AT2220
|
|
|
5-(2-hydroxyethyl)nonane-1,9-diol
|
|
|
(4-fluorophenyl)(pyridin-4-yl)methanone
|
|
|
SR 58611
|
|
|
Reboxetine
|
|
|
3-amino-5-phenylpentane
|
|
|
1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE
|
|
|
N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide
|
|
|
[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA
|
|
|
Tetrabenazine
|
|
|
[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium
|
|
|
Latrunculin A
|
A bicyclic macrolide natural product consisting of a 16-membered bicyclic lactone attached to the rare 2-thiazolidinone moiety. It is obtained from the Red Sea sponge Latrunculia magnifica and from the Fiji Islands sponge Cacospongia mycofijiensis. Latrunculin A inhibits actin polymerisation, microfilament organsation and microfilament-mediated processes.
|
|
4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE
|
|
|
IGN311
|
|
|
AL5424
|
|
|
Isosorbide Mononitrate
|
A glucitol derivative that has formula C6H9NO6.
|
|
Pyridoxine-5'-Phosphate
|
|
|
Phenoxodiol
|
|
|
(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide
|
|
|
Insulin, isophane
|
|
|
Protoporphyrin Ix Containing Zn
|
|
|
N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE
|
A N-acylpyrrolidine that has formula C22H26FN3O2.
|
|
L-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID
|
|
|
(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE
|
|
|
2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid
|
|
|
1,4-Butanediol
|
|
|
N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide
|
|
|
{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID
|
|
|
4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid
|
|
|
Furoyl-Leucine
|
A L-leucine derivative that has formula C11H15NO4.
|
|
1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene
|
|
|
6-Oxo-8,9,10,11-Tetrahydro-7h-Cyclohepta[C][1]Benzopyran-3-O-Sulfamate
|
|
|
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine
|
|
|
Dihydroxyaluminium
|
|
|
2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE
|
|
|
5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine
|
|
|
Cyclizine
|
|
|
2H-1-BENZOPYRAN-2-ONE
|
|
|
Levocabastine
|
|
|
3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE
|
A maleimide that has formula C27H26N4O2.
|
|
Jaspisamide A
|
|
|
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate
|
|
|
7,8-dimethylalloxazine
|
|
|
Phosphonotyrosine
|
|
|
4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide
|
|
|
Isopropamide
|
|
|
6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine
|
A quinoline that has formula C25H31N5O.
|
|
Simvastatin
|
A fatty acid ester comprising a dihydroxyheptanoic acid unit condensed into a lactone; a partially reduced naphthalene structure; and a 2,2-dimethylbutyric acyl substituent at C17. It is used as a cholesterol-lowering and anti-cardiovascular disease drug.
|
|
13-Acetylphorbol
|
|
|
N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide
|
|
|
2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE
|
A thiadiazole that has formula C13H10F5N5O2S2.
|
|
Aspartame
|
|
|
8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
|
|
|
N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine
|
|
|
Fexofenadine
|
A piperidine-based anti-histamine compound.
|
|
Darifenacin
|
|
|
AL6528
|
|
|
(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID
|
|
|
N-(5-Amino-5-Carboxypentyl)Glutamic Acid
|
|
|
PSN9301
|
|
|
L-Alpha-Glycerophospho-D-Myo-Inositol-4,5-Bis-Phosphate
|
|
|
6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE
|
|
|
Ethacrynic acid
|
|
|
(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID
|
|
|
(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine
|
|
|
4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE
|
|
|
N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide
|
|
|
Pentabromophenol
|
|
|
Eniluracil
|
|
|
Cysteine-S-Acetamide
|
|
|
Testolactone
|
|
|
Duroquinone
|
A member of the class of benzoquinones that is 1,4-benzoquinone in which all four hydrogens are substituted by methyl groups.
|
|
Arimoclomol
|
|
|
Levomethadyl Acetate
|
|
|
Ticagrelor
|
|
|
7n-Methyl-8-Hydroguanosine-5'-Diphosphate
|
|
|
2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione
|
|
|
D-leucyl-N-(3-chlorobenzyl)-L-prolinamide
|
|
|
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine
|
|
|
[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid
|
|
|
Pralidoxime
|
A pyridinium ion that is 1-methylpyridinium substituted by a (hydroxyimino)methyl group at position 2.
|
|
5'-Deoxy-5'-(Methylthio)-Tubercidin
|
|
|
N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE
|
|
|
Aminophylline
|
|
|
Ridogrel
|
|
|
Meta-Tyrosine
|
|
|
Temazepam
|
|
|
Diazoxide
|
A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
|
|
Aripiprazole
|
A quinolone that has formula C23H27Cl2N3O2.
|
|
[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester
|
|
|
GMX1777
|
|
|
Pirenzepine
|
|
|
(1R)-2-METHYL-1-(PHENYLMETHYL)PROPYL[(1S)-1-FORMYLPENTYL]CARBAMATE
|
|
|
Aminohippurate
|
|
|
Fludiazepam
|
A 1,4-benzodiazepinone that has formula C16H12ClFN2O.
|
|
2-Deoxy-Glucitol-6-Phosphate
|
|
|
Camptothecin
|
A pyranoindolizinoquinoline that has formula C20H16N2O4.
|
|
2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione
|
An organic heterotetracyclic compound resulting from the formal dimerisation of gallic acid by oxidative aromatic coupling with intramolecular lactonisation of both carboxylic acid groups of the resulting biaryl. It is found in many fruits and vegetables, including raspberries, strawberries, cranberries, and pomegranates.
|
|
4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
|
|
|
2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL
|
|
|
Mecasermin
|
|
|
PARA-(BENZOYL)-PHENYLALANINE
|
|
|
S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine
|
|
|
(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE
|
|
|
Aetiocholanolone
|
|
|
Nicardipine
|
|
|
Carphenazine
|
A propanone that has formula C24H31N3O2S.
|
|
Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester
|
|
|
Promethazine
|
A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety.
|
|
Drostanolone
|
|
|
Spaglumic Acid
|
|
|
(1S)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID
|
|
|
Dorzolamide
|
5,6-Dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide in which hydrogens at the 4 and 6 positions are substituted by ethylamino and methyl groups, respectively (4S, trans-configuration). A carbonic anhydrase inhibitor, it is used as the hydrochloride in ophthalmic solutions to lower increased intraocular pressure in the treatment of open-angle glaucoma and ocular hypertension.
|
|
Ketotifen
|
|
|
Pentanal
|
A fatty aldehyde composed from five carbons in a straight chain
|
|
Nitroprusside
|
An iron coordination entity that has formula C5FeN6O.
|
|
2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE
|
|
|
Picrotoxin
|
|
|
Benzylamine
|
A primary amine compound having benzyl as the N-substituent. It has been isolated from Moringa oleifera (horseradish tree).
|
|
N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide
|
|
|
Anagrelide
|
A 1,5-dihydroimidazo[2,1-]quinazoline having an oxo substituent at the 2-position and chloro substituents at the 6- and 7-positions.
|
|
(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE
|
A hydroxamic acid that has formula C25H27N3O4.
|
|
1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE
|
|
|
2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE
|
|
|
Docosa-4,7,10,13,16,19-Hexaenoic Acid
|
|
|
Cefadroxil
|
A cephalosporin bearing methyl and (2R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton.
|
|
Fx-1006A
|
|
|
(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE
|
An N-acylpyrrolidine that is the pyrrolidine amide of (2S,3S)-2-amino-3-{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}butanoic acid.
|
|
Denosumab
|
|
|
2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE
|
|
|
V1003
|
|
|
Doxylamine
|
A tertiary amine that has formula C17H22N2O.
|
|
2,6-dicarboxynaphthalene
|
|
|
6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE
|
|
|
Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide
|
|
|
N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE
|
|
|
6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine
|
A pyrazolopyrimidine that is pyrazolo[1,5-a]pyrimidine which is substituted at positions 3 and 6 by pyridin-4-yl and p-[2-(piperidin-1-yl)ethoxy]phenyl groups, respectively. It is a potent, selective, reversible, and ATP-competitive inhibitor of AMPK (AMP-activated protein kinase, EC 2.7.11.31) and a selective inhibitor of bone morphogenetic protein (BMP) signaling.
|
|
Valaciclovir
|
|
|
Bifonazole
|
|
|
5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One
|
|
|
Dextroamphetamine
|
|
|
Cilansetron
|
|
|
(1R)-MENTHYL HEXYL PHOSPHONATE GROUP
|
|
|
(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID
|
|
|
Sulodexide
|
|
|
5-N-Allyl-Arginine
|
|
|
2,5-Diaziridin-1-Yl-3-(Hydroxymethyl)-6-Methylcyclohexa-2,5-Diene-1,4-Dione
|
|
|
Tocilizumab
|
|
|
Norepinephrine
|
|
|
Alvimopan
|
|
|
ANA971
|
|
|
2-Methoxy-3-Isopropylpyrazine
|
|
|
(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime
|
|
|
4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID
|
|
|
1,2-Diacyl-Sn-Glycero-3-Phosphoinositol
|
|
|
Ethchlorvynol
|
|
|
3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE
|
|
|
Miconazole
|
A racemate composed of equimolar amounts of (R)- and (S)-miconazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes.
|
|
Cyclohexanol
|
An alcohol that consists of cyclohexane bearing a single hydroxy substituent. The parent of the class of cyclohexanols.
|
|
5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE
|
|
|
Antiproliferative Agent A771726
|
|
|
N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE
|
A subsituted L-phenylalanyl-L-phenylalaninamide dipeptide. It is a potent inhibitor of protein tyrosine phosphatase.
|
|
GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE
|
|
|
4-(Hydroxymercury)Benzoic Acid
|
|
|
SLV 306
|
|
|
OPC-14523
|
|
|
Methohexital
|
A barbiturate, the structure of which is that of barbituric acid substituted at N-1 by a methyl group and at C-5 by allyl and 1-methylpent-2-ynyl groups.
|
|
2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide
|
|
|
Bretylium
|
|
|
Prenylamine
|
|
|
4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE
|
|
|
5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione
|
|
|
[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE
|
A pyrazole that has formula C21H21FN4O2.
|
|
Heptulose-2-Phosphate
|
|
|
Olanzapine
|
A benzodiazepine that has formula C17H20N4S.
|
|
Levosimendan
|
|
|
Amisulpride
|
|
|
PH-284
|
|
|
Minoxidil
|
A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
|
|
Terlipressin
|
|
|
1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE
|
|
|
2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE
|
|
|
Pitavastatin
|
|
|
N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE
|
|
|
Cyclophosphamide
|
A phosphorodiamide that is 1,3,2-oxazaphosphinan-2-amine 2-oxide substituted by two 2-chloroethyl groups at the amino nitrogen atom.
|
|
Enzalutamide
|
|
|
Bosentan
|
|
|
6-O-Cyclohexylmethyl Guanine
|
|
|
Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester
|
|
|
Ergocalciferol
|
|
|
(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL
|
A pyrrolopyrimidine that has formula C21H20N4O2.
|
|
C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide
|
|
|
Uridine 5'-Triphosphate
|
|
|
Nandrolone phenpropionate
|
A 3-phenylpropionate ester that has formula C27H34O3.
|
|
METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE
|
|
|
Hexobarbital
|
|
|
(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID
|
|
|
2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE
|
|
|
2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide
|
|
|
Bismuth Subsalicylate
|
A bismuth salt of salicylic acid.
|
|
N~3~-BENZYLPYRIDINE-2,3-DIAMINE
|
|
|
(3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl-
|
|
|
Fenoldopam
|
A benzazepine that has formula C16H16ClNO3.
|
|
Sulfathiazole
|
A 1,3-thiazole compound having a 4-aminobenzenesulfonamido group at the 2-position.
|
|
1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine
|
|
|
Leucine Phosphonic Acid
|
|
|
S-PALMITOYL-L-CYSTEINE
|
A palmitoyl-L-cysteine in which the palmitoyl group is attached to the sulfur via a thioester linkage.
|
|
Biliverdine Ix Alpha
|
|
|
Ramelteon
|
|
|
Tenocyclidine
|
A tertiary amino compound that consists of cyclohexane having piperidin-1-yl and thiophen-2-yl groups attached at position 1. A dissociative anaesthetic drug with halluccinogenic and stimulant effects. Its effects are similar to those of phencyclidine (PCP, an analogue with the thienyl group replaced by phenyl), but it is rather more potent.
|
|
2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide
|
|
|
5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID
|
|
|
PS433540
|
|
|
(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate
|
|
|
XMT-1001
|
|
|
Bromo-Willardiine
|
|
|
Troleandomycin
|
|
|
Osanetant
|
|
|
5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID
|
|
|
D-Methionine
|
An optically active form of methionine having D-configuration.
|
|
N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE
|
|
|
Desmopressin
|
A synthetic analogue of vasopressin in which 3-mercaptopropionic acid replaces the cysteine residue at position 1 and D-arginine replaces the residue at position 8. An antidiuretic, it increases urine concentration and decreases urine production, and is used (usually as the trihydrate of the acetic acid salt) to prevent and control excessive thirst, urination, and dehydration caused by injury, surgery, and certain medical conditions. It is also used in the diagnosis and treatment of cranial diabetes insipidus and in tests of renal function.
|
|
Tyrosinal
|
|
|
Methylphenidate
|
A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
|
|
2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide
|
|
|
Methyl Methylsulfinylmethyl Sulfide
|
|
|
Ambenonium
|
|
|
2-Cyclopropylmethylenepropanal
|
|
|
Ellagic Acid
|
An organic heterotetracyclic compound resulting from the formal dimerisation of gallic acid by oxidative aromatic coupling with intramolecular lactonisation of both carboxylic acid groups of the resulting biaryl. It is found in many fruits and vegetables, including raspberries, strawberries, cranberries, and pomegranates.
|
|
CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE
|
|
|
MB07811
|
|
|
N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE
|
|
|
6-Hydroxy-1,6-Dihydro Purine Nucleoside
|
|
|
[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,
|
|
|
S-METHYL-GLUTATHIONE
|
|
|
CHR-2797
|
|
|
4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE
|
|
|
motexafin gadolinium
|
A metallotexaphyrin that has formula C52H72GdN5O14.
|
|
CTI-01
|
|
|
3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE
|
|
|
Bimatoprost
|
|
|
(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE
|
A benzoxazine that has formula C24H25F2N5O3.
|
|
Misoprostol
|
A diastereoisomeric mixture composed of approximately equal amounts of a double racemate of four of the sixteen possible diastereoisomers of methyl (13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate that is racemic prostaglandin E1 which is lacking the hydroxy group at position 15, but which has an additional hydroxy group at position 16. It is a synthetic prostaglandin E1 analogue, used in the treatment of gastric and duodenal ulcers. A weak abortifacient, it is also used for cervical ripening prior to surgical termination of pregnancy. The (11R,16S)-diastereoisomer is the pharmacologically active form.
|
|
Tiludronate
|
|
|
Methadone
|
A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
|
|
(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE
|
An aminopiperidine that has formula C22H21F3N4O2S.
|
|
Magnesium salicylate
|
|
|
(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE
|
|
|
(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
|
|
|
2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1S)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE
|
|
|
(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE
|
|
|
KD7040
|
|
|
cyclic 3',5'-thymidine monophosphate
|
|
|
Apraclonidine
|
An imidazoline compound having a 4-amino-2,6-dichloroanilino group at the 2-position.
|
|
N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine
|
|
|
Inosine
|
A purine nucleoside in which hypoxanthine is attached to ribofuranose via a beta-N(9)-glycosidic bond.
|
|
1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid
|
|
|
Elsamitrucin
|
|
|
Guanosine-5'-Monophosphate
|
|
|
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide
|
|
|
Bethanidine
|
|
|
Flurbiprofen Methyl Ester
|
|
|
Quinine
|
A cinchona alkaloid that is cinchonidine in which the hydrogen at the 6-position of the quinoline ring is substituted by methoxy.
|
|
(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE
|
A pyrrolecarboxamide that has formula C23H25F2N3O.
|
|
6-Phosphogluconic Acid
|
|
|
Atorvastatin
|
A dihydroxy monocarboxylic acid that is a member of the drug class known as statins, used primarily for lowering blood cholesterol and for preventing cardiovascular diseases.
|
|
Phenylphosphate
|
An aryl phosphate resulting from the mono-esterification of phosphoric acid with phenol.
|
|
2,4-Dihydroxy-Trans Cinnamic Acid
|
|
|
Benzoyl-Arginine-Alanine-Methyl Ketone
|
|
|
Amido Phenyl Pyruvic Acid
|
|
|
6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one
|
|
|
(S)-ATPA
|
A non-proteinogenic L-alpha-amino acid that is L-alanine in which one of the methyl hydrogens is replaced by a 5-tert-butyl-3-hydroxy-isooxazol-4-yl group.
|
|
Norleucine
|
|
|
3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE
|
|
|
Metocurine
|
|
|
Levofloxacin
|
An optically active form of ofloxacin having (S)-configuration; an inhibitor of bacterial topoisomerase IV and DNA gyrase
|
|
(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide
|
|
|
6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine
|
|
|
2-Methoxyestradiol
|
|
|
5-Iodouracil
|
An organoiodine compound consisting of uracil having an iodo substituent at the 5-position.
|
|
SD118
|
|
|
Triflupromazine
|
|
|
Levothyroxine
|
|
|
Atropine
|
A racemate composed of equimolar concentrations of (S)- and (R)-atropine . It is obtained from deadly nightshade (Atropa belladonna) and other plants of the family Solanaceae.
|
|
N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide
|
|
|
2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE
|
|
|
Sodium bicarbonate
|
|
|
Baclofen
|
A monocarboxylic acid that is butanoic acid substituted by an amino group at position 4 and a 4-chlorophenyl group at position 3. It acts as a central nervous system depressant, GABA agonist and muscle relaxant.
|
|
D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide
|
|
|
Bis(5-Amidino-Benzimidazolyl)Methane
|
|
|
{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide
|
The (Z)-stereoisomer of thiacloprid.
|
|
3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol
|
|
|
Creatine
|
|
|
1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One
|
A heteroarylpiperidine that has formula C26H22Cl2F2N2O.
|
|
Diphenhydramine
|
An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug.
|
|
Methoxsalen
|
|
|
3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID
|
|
|
Iodipamide
|
|
|
Plerixafor
|
|
|
Alrestatin
|
|
|
2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM
|
|
|
Nojirimycine Tetrazole
|
|
|
N-[(4-methoxyphenyl)sulfonyl]-D-alanine
|
|
|
EPIBATIDINE
|
An alkaloid that has formula C11H13ClN2.
|
|
Dansylamide
|
|
|
5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide
|
|
|
Trifluridine
|
|
|
(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE
|
A monohydroxytetrahydrofuran that has formula C17H25N3O3S.
|
|
(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide
|
|
|
M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene
|
|
|
5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE
|
|
|
Gadobenate Dimeglumine
|
|
|
L-Tyrosine
|
An optically active form of tyrosine having L-configuration.
|
|
3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
|
|
|
OMS-103HP
|
|
|
Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine
|
|
|
BL-1020
|
|
|
Avanafil
|
|
|
Benzamidine
|
A carboxamidine that is benzene carrying an amidino group.
|
|
1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE
|
An amidopiperidine that has formula C25H29ClN4O2.
|
|
Nedocromil
|
|
|
(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid
|
|
|
4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL
|
A member of the class of pyrazoles that is 1H-pyrazole carrying 1,4-benzodioxane-6-yl and 5-ethyl-2,4-dihydroxyphenyl substituents at positions 4 and 5 respectively.
|
|
Clofibrate
|
A carboxylic ester that is the ethyl ester of clofibric acid.
|
|
5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE
|
A pyrrolidin-2-one that has formula C17H21ClN6O5S2.
|
|
(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid
|
|
|
MN-305
|
|
|
6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine
|
|
|
SLV 308
|
|
|
DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE
|
|
|
3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER
|
|
|
Oxybutynin
|
An acetylenic compound that has formula C22H31NO3.
|
|
Darbepoetin alfa
|
|
|
2-Benzyl-3-Iodopropanoic Acid
|
|
|
2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID
|
|
|
2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid
|
|
|
Gemtuzumab ozogamicin
|
|
|
HESPERIDIN
|
A disaccharide derivative that consists of hesperetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.
|
|
XL281
|
|
|
Sevoflurane
|
An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
|
|
Phentermine
|
A primary amine that has formula C10H15N.
|
|
Myxothiazol
|
A 2,4'-bi-1,3-thiazole substituted at the 4-position with a (1E,3S,4R,5E)-7-amino-3,5-dimethoxy-4-methyl-7-oxohepta-1,5-dien-1-yl] group and at the 2'-position with a (2S,3E,5E)-7-methylocta-3,5-dien-2-yl group. It is an inhibitor of coenzyme Q - cytochrome c reductase.
|
|
3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE
|
|
|
Oxalic Acid
|
An alpha,omega-dicarboxylic acid that is ethane substituted by carboxyl groups at positions 1 and 2.
|
|
7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE
|
A pyrrolopyrimidine that has formula C20H19N5O3.
|
|
4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM
|
|
|
XL820
|
|
|
2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID
|
|
|
CZEN 002
|
|
|
Diethylcarbamazine
|
|
|
Diclofenamide
|
A sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraocular pressure. It is used for the treatment of glaucoma.
|
|
N-Methylnaloxonium
|
|
|
Cefacetrile
|
|
|
4-(4-Chlorophenyl)Imidazole
|
|
|
1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea
|
|
|
parecoxib
|
|
|
5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE
|
|
|
(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE
|
|
|
1,3,2-Dioxaborolan-2-Ol
|
|
|
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime
|
|
|
FAMOXADONE
|
A racemate composed of equimolar amounts of (R)- and (S)-famoxadone. A fungicide, it is highly against spore germination and mycelial growth of sensitive fungi, and is used in agriculture for the control of various fungal diseases.
|
|
6-MORPHOLIN-4-YL-9H-PURINE
|
|
|
Dodecane-Trimethylamine
|
|
|
3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL
|
|
|
1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE
|
|
|
6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid
|
|
|
Labetalol
|
A secondary amino compound formally derived from ammonia by replacing two of the hydrogens by 2-(3-carbamoyl-4-hydroxyphenyl)-2-hydroxyethyl and 4-phenylbutan-2-yl groups. It is an adrenergic antagonist used to treat high blood pressure.
|
|
Amrinone
|
|
|
Bopindolol
|
|
|
2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid
|
|
|
Rescinnamine
|
|
|
6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE
|
A pyridazine that has formula C13H9ClN2O4S.
|
|
1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide
|
|
|
Ifosfamide
|
The simplest member of the class of ifosfamides that is 1,3,2-oxazaphosphinan-2-amine 2-oxide substituted by 2-chloroethyl groups on both the nitrogen atoms respectively. It is a nitrogen mustard alkylating agent used in the treatment of advanced breast cancer.
|
|
Urea
|
A carbonyl group with two C-bound amine groups.
|
|
4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide
|
|
|
4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE
|
A thiazolidinone that has formula C15H10F3N3O4S2.
|
|
4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide
|
|
|
N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
|
|
|
SCH-530348
|
|
|
2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID
|
An aryloxypyrimidine that has formula C18H11Cl2N3O4.
|
|
Bromodiphenhydramine
|
|
|
2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine
|
|
|
Staurosporine
|
An indolocarbazole alkaloid that has formula C28H26N4O3.
|
|
2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
|
|
|
Riluzole
|
|
|
P54
|
|
|
CR665
|
|
|
N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE
|
|
|
Acetic acid
|
A simple monocarboxylic acid containing two carbons.
|
|
MYO-029
|
|
|
2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One
|
|
|
Bestatin
|
A peptide that has formula C16H24N2O4.
|
|
5-Alpha-Androstane-3-Beta,17beta-Diol
|
An androstane-3,17-diol that is 5alpha-androstane substituted by beta-hydroxy groups at positions 3 and 17. It is a metabolite of dihydrotestosterone.
|
|
Deoxyuridine-5'-Diphosphate
|
|
|
N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside
|
|
|
1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE
|
|
|
(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one
|
|
|
5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE
|
An aminopyridine that has formula C23H24N6O.
|
|
Drotrecogin alfa
|
|
|
L-Glutamine
|
An optically active form of glutamine having L-configuration.
|
|
1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct
|
An azepane that has formula C40H44N12O15P2S.
|
|
OGX-427
|
|
|
4-[5-Pyridin-4-Yl-1h-[1,2,4]Triazol-3-Yl]-Pyridine-2-Carbonitrile
|
|
|
Raloxifene
|
A benzothiophene that has formula C28H27NO4S.
|
|
(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid
|
|
|
2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One
|
|
|
N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE
|
|
|
Thioproperazine
|
|
|
Metoprolol
|
A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
|
|
Coa-S-Acetyl 5-Bromotryptamine
|
|
|
{[4-AMINO-2-(3-CHLOROANILINO)-1,3-THIAZOL-5-YL](4-FLUOROPHENYL)METHANONE
|
|
|
Anisindione
|
|
|
Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine
|
|
|
N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide
|
|
|
Hexatantalum Dodecabromide
|
|
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
|
|
|
Pentostatin
|
|
|
Meclofenamic acid
|
An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.
|
|
N-Alpha-Acetyl-3,5-Diiodotyrosylglycine
|
|
|
1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide
|
|
|
Pyridoxamine-5'-Phosphate
|
|
|
Ketobemidone
|
A piperidine that has formula C15H21NO2.
|
|
Naftifine
|
|
|
2,3-Difluorobenzyl Alcohol
|
A member of the class of benzyl alcohols that is benzyl alcohol substituted by fluoro groups at positions 2 and 3 respectively.
|
|
4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE
|
|
|
Dronabinol
|
|
|
Pagoclone
|
|
|
3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid
|
|
|
Nalidixic Acid
|
A monocarboxylic acid comprising 1,8-naphthyridin-4-one substituted by carboxylic acid, ethyl and methyl groups at positions 3, 1, and 7, respectively.
|
|
9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE
|
|
|
(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester
|
|
|
Cocaine
|
A tropane alkaloid obtained from leaves of the South American shrub Erythroxylon coca.
|
|
Pentazocine
|
A benzazocine that has formula C19H27NO.
|
|
3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA
|
An ethanolamine that has formula C23H26ClN5O3.
|
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE
|
|
|
Miglustat
|
|
|
Trospium
|
|
|
3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium
|
|
|
AL7099A
|
|
|
Fluvoxamine
|
A 5-methoxyvalerophenone O-(2-aminoethyl)oxime that has formula C15H21F3N2O2.
|
|
{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid
|
|
|
(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE
|
|
|
N-Carbamoyl-Alanine
|
|
|
Quinestrol
|
|
|
Heparin Disaccharide I-S
|
|
|
Vinorelbine
|
A vinca alkaloid with a norvinblastine skeleton.
|
|
AL5927
|
|
|
[(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate
|
|
|
Meloxicam
|
|
|
5-phenyl-1H-indazol-3-amine
|
|
|
Fondaparinux sodium
|
An organic sodium salt, being the decasodium salt of fondaparinux.
|
|
5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE
|
|
|
Cyclohexyl-pentyl-maltoside
|
|
|
(S)-Wiskostatin
|
A 1-(3,6-dibromocarbazol-9-yl)-3-(dimethylamino)propan-2-ol that is the (S)-enantiomer of wiskostatin.
|
|
3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID
|
|
|
Alteplase
|
|
|
5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide
|
|
|
Calcidiol
|
A hydroxycalciol that is calciol in which the hydrogen at position 25 has been replaced by a hydroxy group. A prehormone resulting from the oxidation of calciol in the liver, it is further hydroxylated in the kidney to give calcitriol, the active form of vitamin D3.
|
|
2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE
|
|
|
5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine
|
|
|
1,3,5-BENZENETRICARBOXYLIC ACID
|
|
|
S-Oxy Cysteine
|
|
|
Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline
|
|
|
5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID
|
|
|
Crotonaldehyde
|
An enal consisting of propene having a formyl group at the 1-position.
|
|
N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
|
|
|
Kabiramide C
|
An organic molecular entity that has formula C48H71N5O14.
|
|
5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid
|
|
|
Zaleplon
|
A pyrazolo[1,5-a]pyrimidine having a nitrile group at position 3 and a 3-(N-ethylacetamido)phenyl substituent at the 7-position.
|
|
(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID
|
|
|
Deserpidine
|
|
|
ICA-105665
|
|
|
Hydroxychloroquine
|
|
|
Saprisartan
|
|
|
2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide
|
|
|
TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE
|
|
|
Altropane
|
|
|
Lurasidone
|
|
|
1,2,4-Triazole-Carboxamidine
|
|
|
Estazolam
|
A triazolo[4,3-a][1,4]benzodiazepine having a phenyl group at position 6 and a chloro substituent at position 8. A short-acting benzodiazepine with general properties similar to diazepam, it is given by mouth as a hypnotic in the short-term management of insomnia.
|
|
6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID
|
|
|
2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE
|
|
|
Pyridoxal
|
|
|
1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE
|
|
|
3,4-Dihydro-5-Methyl-Isoquinolinone
|
An isoquinoline that has formula C10H11NO.
|
|
L-Cysteine
|
An optically active form of cysteine having L-configuration.
|
|
(6E)-7-{6-[(1E)-OCT-1-ENYL]-2,3-DIAZABICYCLO[2.2.1]HEPT-2-EN-5-YL}HEPT-6-ENOIC ACID
|
|
|
3,4-Dihydroxycinnamic Acid
|
|
|
Indirubin-5-Sulphonate
|
|
|
Fleroxacin
|
|
|
6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one
|
|
|
S,S-(2-Hydroxyethyl)Thiocysteine
|
|
|
Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol
|
|
|
Reglixane
|
|
|
N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE
|
|
|
4-(2-aminoethyl)-2-cyclohexylphenol
|
|
|
Fumarate
|
|
|
V24343
|
|
|
2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
|
|
|
4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME
|
|
|
Chlorpropamide
|
An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.
|
|
Tanaproget
|
|
|
1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine
|
|
|
4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole
|
|
|
5,6-Cyclic-Tetrahydropteridine
|
|
|
Rimonabant
|
|
|
4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE
|
|
|
CAD106
|
|
|
N-Cyclopentyl-N-Cyclobutylformamide
|
|
|
3-ISOBUTYL-1-METHYLXANTHINE
|
An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
|
|
lidocaine patch
|
|
|
Lubiprostone
|
|
|
N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid
|
|
|
(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide
|
|
|
Salmon Calcitonin
|
|
|
Sp7343-Sp7964
|
|
|
1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE
|
|
|
3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL
|
|
|
2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE
|
|
|
Pethidine
|
|
|
CC-8490
|
|
|
gallium maltolate
|
|
|
N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid
|
|
|
Carboxymycobactin T
|
|
|
Benzene Hexacarboxylic Acid
|
|
|
N-Formylmethionine
|
|
|
Hyaluronan
|
|
|
N-Cholylglycine
|
|
|
Glucose-6-Phosphate
|
|
|
2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE
|
|
|
Fotemustine
|
|
|
5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine
|
|
|
Homoserine Lactone
|
A butan-4-olide having an amino substituent at the 2-position.
|
|
1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE
|
|
|
XOMA 052
|
|
|
NXN-188
|
|
|
Guanfacine
|
|
|
Quinapril
|
An isoquinoline that has formula C25H30N2O5.
|
|
2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL
|
|
|
Adenylosuccinic Acid
|
|
|
2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE
|
|
|
ISOPENTENYL PYROPHOSPHATE
|
|
|
5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE
|
|
|
Bis-Benzamidine
|
|
|
Teniposide
|
|
|
N-Ethyl Retinamide
|
|
|
ado-trastuzumab emtansine
|
|
|
4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE
|
A thiazolidinone that has formula C14H11N3O4S2.
|
|
diethyl [(1R)-1,5-diaminopentyl]boronate
|
|
|
SRT501
|
|
|
Pyruvic acid
|
A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.
|
|
Fospropofol
|
|
|
4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID
|
|
|
(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE
|
|
|
APD668
|
|
|
Dihomo-gamma-linolenic acid
|
|
|
8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide
|
A carboxamidine that has formula C15H13N5.
|
|
Gentamicin
|
|
|
2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE
|
|
|
2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE
|
|
|
2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE
|
|
|
Phenylbutazone
|
A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
|
|
(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime
|
|
|
O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID
|
|
|
S-propylamine-L-cysteine
|
|
|
Alimemazine
|
|
|
5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine
|
|
|
Olopatadine
|
|
|
Interferon alfacon-1
|
|
|
H TYPE I TRISACCHARIDE
|
|
|
Fluspirilene
|
|
|
Tadalafil
|
|
|
(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol
|
|
|
N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid
|
|
|
Chitotriose
|
An amino trisaccharide comprising of three 2-amino-2-deoxy-beta-D-glucopyranose units.
|
|
Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor
|
|
|
Mianserin
|
|
|
Probenecid
|
|
|
S-Ethylisothiourea
|
|
|
4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
|
|
|
Ethotoin
|
|
|
(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE
|
|
|
Edrophonium
|
|
|
2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
|
|
|
(CHLOROACETYL)CARBAMIC ACID (3R,4S,5S,5R)-5-METHOXY-4-[(2R,3R)-2-METHYL-3-(3-METHYL-2-BUTENYL)OXIRANYL]-1-OXASPIRO[2.5]OCT-6-YL ESTER
|
|
|
(1R)-2-{[AMINO(IMINO)METHYL]AMINO}-1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE
|
|
|
NBI-56418
|
|
|
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine
|
|
|
Flurazepam
|
|
|
Teriparatide
|
|
|
Allylestrenol
|
|
|
R1295
|
|
|
Oxytetracycline
|
A tetracycline used for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae.
|
|
RU78191
|
|
|
Rolicyclidine
|
Pyrrolidine in which the hydrogen attached to the nitrogen is substituted by a 1-phenylcyclohex-1-yl group.
|
|
TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE
|
|
|
Elaidoylamide
|
|
|
Econazole
|
A racemate composed of equimolar amounts of (R)- and (S)-econazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections.
|
|
4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE
|
|
|
D-tartaric acid
|
The D-enantiomer of tartaric acid.
|
|
N-(Phosphonoacetyl)-L-Ornithine
|
|
|
S-Hydroxymethyl Glutathione
|
Conjugate base of S-(hydroxymethyl)glutathione.
|
|
Levonordefrin
|
|
|
2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate
|
|
|
Hydrocortamate
|
A glycinyl ester that has formula C27H41NO6.
|
|
Trovafloxacin
|
|
|
Primidone
|
A pyrimidone that is dihydropyrimidine-4,6(1H,5H)-dione substituted by an ethyl and a phenyl group at position 5. It is used as an anticonvulsant for treatment of various types of seizures.
|
|
Methyldopa
|
|
|
Amprenavir
|
|
|
1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide
|
|
|
Lorazepam
|
|
|
Beta-D-Glucose
|
D-Glucopyranose with beta configuration at the anomeric centre.
|
|
Prazepam
|
|
|
3-Phosphoglycerol
|
|
|
3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione
|
|
|
N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE
|
|
|
1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane
|
|
|
1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)
|
|
|
CRA_11092
|
|
|
2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID
|
|
|
2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL
|
|
|
Beta-Cyclohexyl-Alanine
|
|
|
(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE
|
|
|
3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE
|
A morpholine that has formula C26H25FN4O2.
|
|
N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine
|
|
|
Methyclothiazide
|
|
|
Lacosamide
|
|
|
Guvacine
|
A citraconoyl group that has formula C6H9NO2.
|
|
Geran-8-Yl Geran
|
|
|
Idarubicin
|
An anthracycline antibiotic that has formula C26H27NO9.
|
|
TM30338
|
|
|
Purvalanol A
|
A purvalanol that has formula C19H25ClN6O.
|
|
2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID
|
|
|
Willardiine
|
|
|
Indirubin-3'-Monoxime
|
|
|
Streptomycin
|
A amino cyclitol glycoside that consists of streptidine having a disaccharyl moiety attached at the 4-position. The parent of the streptomycin class
|
|
Certolizumab pegol
|
|
|
(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE
|
|
|
VP025
|
|
|
Leptin
|
|
|
(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE
|
|
|
Bis(5-Amidino-Benzimidazolyl)Methanone Zinc
|
|
|
(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE
|
|
|
Sucrose Octasulfate
|
An oligosaccharide sulfate that has formula C12H22O35S8.
|
|
BENZOYL-TYROSINE-ALANINE-METHYL KETONE
|
|
|
N-Propargyl-1(S)-Aminoindan
|
|
|
Tizanidine
|
2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.
|
|
(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE
|
|
|
4-Hydroxy-Aconitate Ion
|
|
|
(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one
|
|
|
Guanosine-5'-Triphosphate
|
|
|
Sucralfate
|
|
|
Phenacetin
|
|
|
Doxazosin
|
A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
|
|
5-benzyl-1,3-thiazol-2-amine
|
|
|
(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE
|
|
|
Guanabenz
|
|
|
Cefotiam
|
|
|
All-Trans Axerophthene
|
|
|
Prazosin
|
A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
|
|
Degraded Cephaloridine
|
|
|
4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE
|
|
|
2-Phosphoglycolic Acid
|
The O-phospho derivative of glycolic acid.
|
|
6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE
|
A pyrrolidin-2-one that has formula C21H24ClN3O5S.
|
|
Glutathione Sulfonic Acid
|
|
|
GC-24
|
|
|
N-Ethyl-5'-Carboxamido Adenosine
|
|
|
Sirolimus
|
|
|
4-(Hydroxymethyl)Benzamidine
|
|
|
Verdoheme
|
|
|
MIV-701
|
|
|
Collagenase
|
|
|
Mequitazine
|
|
|
S-Adenosyl-L-Homocysteine
|
The S-adenosyl derivative of L-homocysteine.
|
|
1-(2-{[(6-AMINO-2-METHYLPYRIDIN-3-YL)METHYL]AMINO}ETHYL)-6-CHLORO-3-[(2,2-DIFLUORO-2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL
|
An aminopyridine that has formula C20H30ClF2N7O.
|
|
Hexadecanal
|
A 2,3-saturated fatty aldehyde that has formula C16H32O.
|
|
Oregovomab
|
|
|
FKB-001
|
An organofluorine compound that has formula C35H42F2N2O6.
|
|
Dextrothyroxine
|
|
|
L-[(N-Hydroxyamino)Carbonyl]Phenylalanine
|
|
|
Trans-2-Phenylcyclopropylamine
|
|
|
Radicicol
|
An antifungal macrolactone antibiotic, obtained from Diheterospora chlamydosporia and Chaetomium chiversii that inhibits protein tyrosine kinase and heat shock protein 90 (Hsp90).
|
|
Bitolterol
|
|
|
CRA_10433
|
|
|
Benazepril
|
A benzazepine that has formula C24H28N2O5.
|
|
Dapoxetine
|
|
|
1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID
|
|
|
SSR-126517E
|
|
|
Oxaliplatin
|
A platinum coordination entity that has formula C6H14N2.C2O4.Pt.
|
|
Vidarabine
|
|
|
UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE
|
|
|
[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine
|
|
|
Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome
|
|
|
Double Oxidized Cysteine
|
|
|
{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID
|
|
|
Capecitabine
|
|
|
Daidzin
|
|
|
Dihydroergotamine
|
Ergotamine in which a single bond replaces the double bond between positions 9 and 10. A semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine, it is used (as the methanesulfonic or tartaric acid salts) for the treatment of migraine and orthostatic hypotension.
|
|
Enoxaparin
|
|
|
2-(3-CHLORO-6-{[2,2-DIFLUORO-2-(1-OXIDOPYRIDIN-2-YL)ETHYL]AMINO}-1-OXIDOPYRIDIN-2-YL)-N-[1-(3-CHLOROPHENYL)ETHYL]ACETAMIDE
|
|
|
N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE
|
|
|
Lindane
|
|
|
(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine
|
|
|
ANX-510
|
|
|
(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENYL)GUANIDINE
|
|
|
EC145
|
|
|
AVI-4557
|
|
|
Filgrastim
|
|
|
2-(1H-pyrazol-3-yl)-1H-benzimidazole
|
|
|
GTS-21
|
|
|
1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one
|
|
|
Chlorprothixene
|
|
|
CF-101
|
|
|
Chloroprocaine
|
Procaine in which one of the hydrogens ortho- to the carboxylic acid group is substituted by chlorine. It is used as its monohydrochloride salt as a local anaesthetic, particularly for oral surgery. It has the advantage over lidocaine of constricting blood vessels, so reducing bleeding.
|
|
4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One
|
|
|
N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide
|
|
|
Thiothixene
|
|
|
4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL
|
|
|
4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1-&gt;4)-Alpha-D-Threo-Hexopyranosyl-(1-&gt;6)-Alpha-L-Threo-Hexopyranose
|
|
|
Cytarabine
|
A pyrimidine nucleoside in which cytosine is attached to D-arabinofuranose via a beta-N(1)-glycosidic bond.
|
|
Gadoxetate
|
|
|
4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole
|
|
|
Abiraterone
|
|
|
Quisqualate
|
|
|
BNP 1350
|
|
|
O-Benzylsulfonyl-Serine
|
|
|
Bleomycin
|
A glycopeptide antibiotic produced by the bacterium Streptomyces verticillus. The term, 'bleomycin' refers to a family of structurally related compounds. When used as an anti-cancer agent, the chemotherapeutical forms are primarily bleomycin A2 and B2.
|
|
Methyltrienolone
|
|
|
5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one
|
|
|
Modafinil
|
|
|
Cimetidine
|
A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
|
|
Huperaine A
|
|
|
Trilostane
|
|
|
Adenosine-5'-Diphosphate-2',3'-Vanadate
|
|
|
Vismodegib
|
|
|
(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL
|
An indazole that has formula C24H25N7O.
|
|
3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME
|
|
|
Dantrolene
|
The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin.
|
|
3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One
|
|
|
Ethyl biscoumacetate
|
|
|
Coagulation factor VIIa
|
|
|
PD150606
|
|
|
[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine
|
|
|
Trametinib
|
A pyridopyrimidine that is used (as its dimethyl sulfoxide addition compound) for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and who have not received prior BRAF inhibitor treatment.
|
|
Arbaclofen Placarbil
|
|
|
4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile
|
|
|
CCX282
|
|
|
2,4,6-Tribromophenol
|
A bromophenol that is phenol substituted by bromo groups at positions 2, 4 and 6. It is commonly used as a fungicide and in the preparation of flame retardants.
|
|
Kaempherol
|
|
|
SF1126
|
|
|
Cyclacillin
|
|
|
Aminopterin
|
|
|
Piroxicam
|
A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide with the exocyclic nitrogen of 2-aminopyridine.
|
|
GTI 2040
|
|
|
4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE
|
|
|
Cladribine
|
2'-Deoxyadenosine in which the hydrogen at position 2 on the purine ring has been substituted by chlorine. It inhibits the synthesis and repair of DNA, particularly in lymphocytes and monocytes, and is used as an antimetabolite antineoplastic drug for the treatment of lymphoid malignancies including hairy-cell leukaemia and chronic lymphocytic leukaemia.
|
|
Alpha-D-Glucose 1,6-Bisphosphate
|
A D-glucose 1,6-bisphosphate in which both phosphate groups are monophosphates.
|
|
Isoetarine
|
|
|
6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE
|
|
|
Prednisone
|
A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
|
|
{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate
|
|
|
Tenoxicam
|
|
|
D-Phenylalanine
|
The D-enantiomer of phenylalanine.
|
|
Gatifloxacin
|
|
|
Pipecuronium
|
|
|
A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor
|
|
|
Cyanocobalamin
|
|
|
3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine
|
|
|
Buspirone
|
An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the nitrogen atom.
|
|
(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol
|
A morpholine that has formula C15H23NO3.
|
|
2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE
|
A Photinus luciferin that has formula C10H6N2O2S2.
|
|
CBZ-LEU-LEU-TYR-CH2F
|
|
|
4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile
|
|
|
INS 316
|
|
|
Di-Linoleoyl-3-Sn-Phosphatidylcholine
|
|
|
Rivanicline
|
|
|
(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol
|
|
|
Argininosuccinate
|
|
|
Beclomethasone
|
A 17alpha-hydroxy steroid that is prednisolone in which the hydrogens at the 9alpha and 16beta positions are substituted by a chlorine and a methyl group, respectively.
|
|
Biphenylalanine
|
|
|
(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE
|
|
|
Thiamylal
|
A member of the class of barbiturates that is 2-thioxodihydropyrimidine-4,6(1H,5H)-dione substituted by a pentan-2-yl and prop-2-en-1-yl group at position 5.
|
|
Cefuroxime
|
A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
|
|
Gallamine Triethiodide
|
|
|
Pyruvoyl Group
|
|
|
Compound 9
|
|
|
GW 597599
|
|
|
Cinnarizine
|
|
|
Zk-806450
|
|
|
2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol
|
|
|
9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid
|
|
|
Oxcarbazepine
|
A dibenzoazepine derivative, having a carbamoyl group at the ring nitrogen, substituted with an oxo group at C-4 of the azepeine ring which is also hydrogenated at C-4 and C-5. It is a anticholinergic anticonvulsant and mood stabilizing drug, used primarily in the treatment of epilepsy.
|
|
Nitrendipine
|
|
|
2-Methyl-2-Propanol
|
|
|
Sri-9439
|
|
|
Glycinamid
|
|
|
Telaprevir
|
|
|
Lopinavir
|
|
|
4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID
|
|
|
PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)
|
|
|
1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide
|
|
|
MT-Immucillin-H
|
|
|
Isradipine
|
|
|
5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE
|
|
|
Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine
|
|
|
6-Deoxy-Alpha-D-Glucose
|
|
|
Travoprost
|
|
|
Sodium lauryl sulfate
|
|
|
N-(carboxycarbonyl)-D-phenylalanine
|
|
|
LY374571
|
|
|
4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL
|
|
|
ONO-6818
|
|
|
Benzylpenicillin
|
A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group.
|
|
Brequinar Analog
|
|
|
681323
|
|
|
Stearic acid
|
A C18 straight-chain saturated fatty acid component of many animal and vegetable lipids. As well as in the diet, it is used in hardening soaps, softening plastics and in making cosmetics, candles and plastics.
|
|
2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID
|
|
|
Hexachlorophene
|
|
|
4-Androstenedione
|
|
|
(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide
|
|
|
Ketoconazole
|
A N-carbonylpiperazine that has formula C26H28Cl2N4O4.
|
|
1,8-Di-Hydroxy-4-Nitro-Anthraquinone
|
|
|
Lorcaserin
|
|
|
2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID
|
|
|
1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE
|
|
|
(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE
|
|
|
Pravastatin
|
A carboxylic ester resulting from the formal condensation of (S)-2-methylbutyric acid with the hydroxy group adjacent to the ring junction of (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid. Derived from microbial transformation of mevastatin, pravastatin is a reversible inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA). The sodium salt is used for lowering cholesterol and preventing cardiovascular disease. It is one of the lower potency statins, but has the advantage of fewer side effects compared with lovastatin and simvastatin.
|
|
5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine
|
|
|
3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID
|
|
|
Halofantrine
|
|
|
Deferiprone
|
|
|
D-Eritadenine
|
|
|
N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE
|
|
|
Levobunolol
|
A cyclic ketone that is 3,4-dihydronaphthalen-1-one substituted at position 5 by a 3-(tert-butylamino)-2-hydroxypropoxy group (the S-enantiomer). A non-selective beta-adrenergic antagonist used (as its hydrochloride salt) for treatment of glaucoma.
|
|
5-Amino-1h-Pyrimidine-2,4-Dione
|
|
|
(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione
|
|
|
Alglucosidase alfa
|
|
|
2-O-(3'-AMIDINOPHENYL)-5-O-(4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL
|
|
|
Cefoperazone
|
|
|
Androstanedione
|
|
|
Amitriptyline
|
An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
|
|
2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one
|
|
|
3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID
|
|
|
(11E)-OCTADEC-11-ENOIC ACID
|
The trans- isomer of vaccenic acid.
|
|
3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
|
|
|
N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide
|
|
|
3'-Azido-3'-Deoxythymidine-5'-Monophosphate
|
|
|
Triazolopyridine
|
|
|
2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide
|
|
|
L-Tyrosinamide
|
An amino acid amide that is L-tyrosine in which the carboxy OH group is replaced by NH2.
|
|
4-Amino Hexanoic Acid
|
|
|
(R)—N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester
|
|
|
Gabaculine
|
An organonitrogen compound that has formula C7H9NO2.
|
|
N-(Chlorophenyl)-N'-Hydroxyguanidine
|
|
|
Hexane
|
An unbranched alkane containing six carbon atoms.
|
|
3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid
|
|
|
N-Sulfo-Flavin Mononucleotide
|
|
|
5-Chloryl-2,4,6-Quinazolinetriamine
|
|
|
7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide
|
|
|
Heptyl 1-Thiohexopyranoside
|
|
|
Lumiracoxib
|
An amino acid that is phenylacetic acid which is substituted at position 2 by the nitrogen of 2-chloro-6-fluoroaniline and at position 5 by a methyl group. A highly selective cyclooxygenase 2 inhibitor, it was briefly used for the treatment of osteoarthritis, but was withdrawn due to concersns of hepatotoxicity.
|
|
Cu-Cyclam
|
|
|
Clorazepate
|
|
|
(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE
|
|
|
6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide
|
|
|
Vitamin C
|
|
|
Fencamfamine
|
|
|
3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE
|
|
|
Vitamin E
|
A chromanol that is chroman-6-ol which is substituted at position 2 by a methyl group and (also at position 2) either a saturated or a triply-unsaturated hydrocarbon chain consisting of three isoprenoid units.
|
|
3,6-Dihydroxy-Xanthene-9-Propionic Acid
|
|
|
(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE
|
|
|
Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone
|
|
|
Coa-S-Acetyl Tryptamine
|
|
|
Glycerylphosphorylcholine
|
|
|
Arsenic trioxide
|
|
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine
|
|
|
(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine
|
|
|
6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline
|
|
|
Basiliximab
|
|
|
Interferon Alfa-2a, Recombinant
|
|
|
1-benzylimidazole
|
|
|
5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE
|
|
|
N-Omega-Propyl-L-Arginine
|
|
|
Diclofenac
|
A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
|
|
Tetrabromo-2-Benzotriazole
|
|
|
O-Trifluoromethylphenyl Anthranilic Acid
|
|
|
3-Fluorotyrosine
|
A fluoroamino acid that has formula C9H10FNO3.
|
|
FR221647
|
|
|
Interferon beta-1b
|
|
|
Monastrol
|
A member of the class of thioureas that is 3,4-dihydropyrimidine-2(1)-thione substituted by a 3-hydroxyphenyl group at position 4, a methyl group at position 6 and a ethoxycarbonyl group at position 5.
|
|
Nialamide
|
|
|
Sibutramine
|
|
|
Itopride
|
|
|
Darusentan
|
|
|
Histamine Phosphate
|
A phosphate salt that is the diphosphate salt of histamine.
|
|
Zomepirac
|
|
|
Calyculin A
|
A monoterpenoid that has formula C50H81N4O15P.
|
|
4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
|
|
|
Antrafenine
|
|
|
Midazolam
|
|
|
INCB7839
|
|
|
3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid
|
|
|
16,17-Androstene-3-Ol
|
|
|
Stannsoporfin
|
|
|
2-(Thiomethylene)-4-Methylpentanoic Acid
|
|
|
Procaterol
|
|
|
1,3-Propandiol
|
|
|
dehydroepiandrosterone sulfate
|
A steroid sulfate that is the 3-sulfate of dehydroepiandrosterone.
|
|
N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide
|
A member of the class of isoquinolines that is isoquinoline-8-sulfonamide which is substituted by chlorine at position 5 and in which the sulfonamide nitrogen is substituted by a 2-aminoethyl group. It is an inhibitor of casein kinase I.
|
|
D-Cysteine
|
An optically active form of cysteine having D-configuration.
|
|
Bumetanide
|
A member of the class of benzoic acids that is 4-phenoxybenzoic acid in which the hydrogens ortho to the phenoxy group are substituted by butylamino and sulfamoyl groups. Bumetanide is a diuretic, and is used for treatment of oedema associated with congestive heart failure, hepatic and renal disease.
|
|
Etravirine
|
|
|
N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine
|
|
|
Anastrozole
|
A 1,2,4-triazole compound having a 3,5-bis(2-cyano-2-propyl)benzyl group at the 1-position.
|
|
(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one
|
|
|
Fenoterol
|
|
|
Hydralazine
|
The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
|
|
Chlorothiazide
|
4H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position is substituted by chlorine and that at position 7 is substituted by a sulfonamide group. A diuretic, it is used for treatment of oedema and hypertension.
|
|
Pramipexole
|
A member of the class of benzothiazoles that is 4,5,6,7-tetrahydro-1,3-benzothiazole in which the hydrogens at the 2 and 6-pro-S-positions are substituted by amino and propylamino groups, respectively.
|
|
1-Guanidinium-7-Aminoheptane
|
|
|
1-(3-O-Phosphono-Beta-L-Arabinofuranosyl)Pyrimidine-2,4(1h,3h)-Dione
|
|
|
Beta(2-Thienyl)Alanine
|
|
|
Defibrotide
|
|
|
S-Acetyl-Cysteine
|
|
|
SCIO-469
|
|
|
Adalimumab
|
|
|
2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE
|
|
|
Cefaclor
|
A cephalosporin bearing chloro and (R)-2-amino-2-phenylacetamido groups at positions 3 and 7, respectively, of the cephem skeleton.
|
|
GIBBERELLIN A3
|
A C19-gibberellin that is a pentacyclic diterpenoid responsible for promoting growth and elongation of cells in plants.
|
|
XL844
|
|
|
(2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide
|
A sulfone that is an oral non-steroidal antiandrogen used in the treatment of prostate cancer and hirsutism.
|
|
Rasagiline
|
|
|
atamestane-plus-toremifene
|
|
|
S-Hexylglutathione
|
A glutathione derivative that has formula C16H29N3O6S.
|
|
N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide
|
An adenosine that has formula C19H19N7O8.
|
|
Corticotropin
|
|
|
Felypressin
|
|
|
6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE
|
|
|
6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE
|
A 1-benzothiophene that has formula C19H22ClN3O5S2.
|
|
(2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE
|
|
|
VX-148
|
|
|
2-Phospho-D-Glyceric Acid
|
A 2-Phosphoglyceric acid in which the glyceric acid moiety has D (R) configuration.
|
|
APD125
|
|
|
2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol
|
|
|
RU82209
|
|
|
N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-
|
|
|
Chlorzoxazone
|
A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
|
|
Alclometasone
|
A prednisolone compound having an alpha-chloro substituent at the 7-position and an alpha-methyl substituent at the 16-position.
|
|
Cilastatin
|
|
|
SR11254
|
|
|
3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE
|
|
|
Fluoxymesterone
|
An anabolic androgenic steroid that has formula C20H29FO3.
|
|
Methyprylon
|
|
|
Pentobarbital
|
A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
|
|
EM-1745
|
|
|
Cinchocaine
|
A monocarboxylic acid amide that is the 2-(diethylamino)ethyl amide of 2-butoxyquinoline-4-carboxylic acid. One of the most potent and toxic of the long-acting local anesthetics, its parenteral use was restricted to spinal anesthesia. It is now generally only used (usually as the hydrochloride) in creams and ointments and in suppositories for temporary relief of pain and itching associated with skin and anorectal conditions.
|
|
FavId
|
|
|
Inositol-(1,3,4,5,6)-Pentakisphosphate
|
|
|
(3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID
|
|
|
(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one
|
|
|
LI-301
|
|
|
2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide
|
|
|
Ibuprofen
|
A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group.
|
|
Naphazoline
|
|
|
17-Dmag
|
|
|
Phenprocoumon
|
|
|
Intravenous Immunoglobulin
|
|
|
Lomustine
|
|
|
Sermorelin
|
|
|
D-Myo-Inositol-Hexasulphate
|
|
|
(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-(2,2,2-TRIFLUOROETHYL)-1,4-DIAZEPAN-2-ONE
|
A N-carbonyldiazepane that has formula C17H19F6N3O2.
|
|
1-[2-(3-Biphenyl)-4-Methylvaleryl)]Amino-3-(2-Pyridylsulfonyl)Amino-2-Propanone
|
|
|
Triazolam
|
A triazolobenzodiazepine that has formula C17H12Cl2N4.
|
|
Metiamide
|
An imidazole that has formula C9H16N4S2.
|
|
3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid
|
|
|
Pegademase bovine
|
|
|
P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate
|
|
|
2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE
|
|
|
3'-Phosphate-Adenosine-5'-Phosphate Sulfate
|
|
|
Mebendazole
|
A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
|
|
1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol
|
|
|
9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE
|
|
|
Antithymocyte globulin
|
|
|
3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol
|
|
|
Methacrylyl-Coenzyme A
|
|
|
1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
|
|
|
[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid
|
|
|
Capromab
|
|
|
TLK-199
|
|
|
(9s,10s)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene
|
|
|
9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
|
|
|
Nitroxoline
|
|
|
Thiethylperazine
|
|
|
Furazolidone
|
|
|
Brentuximab vedotin
|
|
|
Torasemide
|
An N-sulfonylurea obtained by formal condensation of [(3-methylphenyl)amino]pyridine-3-sulfonic acid with the free amino group of N-isopropylurea.
|
|
DAS-431 IV
|
|
|
3-Butylthiolane 1-Oxide
|
|
|
Carboplatin
|
A platinum coordination entity with cis square-planar geometry in which platinum(II) is coordinated to two ammonia ligands and a bidentate cyclobutane-1,1-dicarboxylate ligand.
|
|
LX1031
|
|
|
Aplidine
|
|
|
Zolmitriptan
|
|
|
Coa-S-Trimethylene-Acetyl-Tryptamine
|
|
|
(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID
|
|
|
Pantothenoylaminoethenethiol
|
|
|
RPI-78M
|
|
|
Carba-Nicotinamide-Adenine-Dinucleotide
|
|
|
ING-1
|
|
|
5-Hydroxymethylene-6-Hydrofolic Acid
|
|
|
CLX-0921
|
|
|
N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide
|
|
|
1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE
|
|
|
OPC-28326
|
|
|
Abarelix
|
A polypeptide compound composed of ten natural and non-natural amino acid resiudes in a linear sequence.
|
|
(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene
|
|
|
XL999
|
|
|
Norvaline
|
An alpha-amino acid that is valeric acid which is substituted at position 2 by an amino group.
|
|
2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE
|
|
|
MB07803
|
|
|
Acetylsalicylic acid
|
Benzoic acid carrying an acetoxy group at the 2-position. A non-steroidal anti-inflammatory drug with moA cyclooxygenase inhibitor activity.
|
|
Efavirenz
|
|
|
Phosphonoacetohydroxamic Acid
|
The hydroxamate of phosphonoacetic acid.
|
|
(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid
|
|
|
Cefdinir
|
A cephalosporin compound having 7beta-2-(2-amino-thiazol-4-yl)-2-[(Z)-hydroxyimino]-acetylamino- and 3-vinyl side groups.
|
|
4-Methylumbelliferyl Chitobiose
|
|
|
6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE
|
|
|
6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one
|
|
|
CDP323
|
|
|
CRA_17312
|
|
|
S-(Dimethylarsenic)Cysteine
|
|
|
Alfuzosin
|
A tetrahydrofuranol that has formula C19H27N5O4.
|
|
Bacitracin
|
A mixture of at least nine closely related homodetic cyclic peptides produced by Bacillus subtilis and B. licheniformis, which is particularly active against Gram-positive bacteria.
|
|
3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID
|
|
|
(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid
|
|
|
Benzenesulfonyl
|
A sulfonyl group with a phenyl substituent.
|
|
2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid
|
|
|
Cyclobenzaprine
|
5-Methylidene-5H-dibenzo[a,d]cycloheptene in which one of the hydrogens of the methylidene group is substituted by a 2-(dimethylamino)ethyl group. A centrally acting skeletal muscle relaxant, it is used as its hydrochloride salt in the symptomatic treatment of painful muscle spasm.
|
|
HspE7
|
|
|
1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid
|
|
|
8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide
|
|
|
XL518
|
|
|
SR12813
|
An organic phosphonate that is the tetraethyl ester of [2-(3,5-di-tert-butyl-4-hydroxyphenyl)ethene-1,1-diyl]bis(phosphonic acid).
|
|
N-METHYL O-NITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE
|
|
|
SPP1148
|
|
|
Azidocillin
|
|
|
1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL
|
|
|
Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid
|
|
|
Trazodone
|
An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
|
|
Ciprofloxacin
|
A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
|
|
Thiocoumarin
|
|
|
Axitinib
|
|
|
Cyclothiazide
|
|
|
N5-Iminoethyl-L-Ornithine
|
|
|
(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide
|
|
|
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane
|
|
|
Lintitript
|
|
|
Gavestinel
|
|
|
CRA_16847
|
|
|
OBE101
|
|
|
Fluorometholone
|
A member of the class of glucocorticoids that is Delta(1)-progesterone substituted at positions 11beta and 17 by hydroxy groups, at position 6alpha by a methyl group and at position 9 by a fluoro group. Used for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.
|
|
RU81843
|
|
|
Desonide
|
Triamcinolone acetonide with hydrogen instead of the fluorine substituent at position 9. A corticosteroid anti-inflammatory, it is used topically as a cream, ointment or lotion for the treatment of various skin disorders.
|
|
TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE
|
|
|
1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide
|
|
|
Uridine-Diphosphate-N-Acetylglucosamine
|
|
|
Levetiracetam
|
|
|
Naphthyridine Inhibitor
|
|
|
Phenytoin
|
A imidazolidine-2,4-dione that consists of hydantoin bearing two phenyl substituents at position 5.
|
|
METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE
|
|
|
1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine
|
|
|
Budesonide
|
A glucocorticoid steroid having a highly oxygenated pregna-1,4-diene structure. It is used mainly in the treatment of asthma and non-infectious rhinitis and for treatment and prevention of nasal polyposis.
|
|
Trencam-3,2-Hopo
|
|
|
S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
|
|
|
4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE
|
|
|
Tetracycline
|
A broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria.
|
|
Danazol
|
A 17beta-hydroxy steroid that has formula C22H27NO2.
|
|
4,4'-DIPYRIDYL DISULFIDE
|
|
|
Clarithromycin
|
The 6-O-methyl ether of erythromycin A, clarithromycin is a macrolide antibiotic used in the treatment of respiratory-tract, skin and soft-tissue infections. It is also used to eradicate Helicobacter pylori in the treatment of peptic ulcer disease. It prevents bacteria from growing by interfering with their protein synthesis.
|
|
Pentolinium
|
|
|
Desoxycorticosterone Pivalate
|
|
|
Mefloquine
|
A racemate composed of (+)-(11R,2'S)- and (-)-(11S,2'R)-enantiomers of mefloquine. An antimalarial agent which acts as a blood schizonticide; its mechanism of action is unknown.
|
|
Trimethadione
|
|
|
3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid
|
|
|
Bupivacaine
|
A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
|
|
5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE
|
|
|
5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione
|
|
|
Silodosin
|
|
|
Ceruletide
|
A decapeptide comprising 5-oxoprolyl, glutamyl, aspartyl, O-sulfotyrosyl, threonyl, glycyl, tryptopyl, methionyl, aspartyl and phenylalaninamide residues in sequence. Found in the skins of certain Australian amphibians, it is an analogue of the gastrointestinal peptide hormone cholecystokinin and stimulates gastric, biliary, and pancreatic secretion. It is used in cases of paralysis of the intestine (paralytic ileus) and as a diagnostic aid in pancreatic malfunction.
|
|
S-(2-Oxo)Pentadecylcoa
|
|
|
2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL
|
|
|
PASBN
|
|
|
R667
|
|
|
Aminophosphonic Acid-Guanylate Ester
|
|
|
4-(2-amino-1,3-thiazol-4-yl)phenol
|
|
|
Magnesium
|
|
|
UBIQUINONE-1
|
A compound composed of the standard 2,3-dimethoxy-5-methylbenzoquinone nucleus common to ubiquinones; and a side chain of a single isoprenoid unit.
|
|
Iodo-Phenylalanine
|
|
|
1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)
|
|
|
2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid
|
|
|
Lepirudin
|
|
|
N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide
|
|
|
D-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID
|
|
|
3-Hydroxy-3-Methyl-Glutaric Acid
|
A dicarboxylic acid that is glutaric acid in which one of the two hydrogens at position 3 is substituted by a hydroxy group, while the other is substituted by a methyl group. It has been found to accumulate in urine of patients suffering from HMG-CoA lyase (3-hydroxy-3-methylglutaryl-CoA lyase, EC 4.1.3.4) deficiency. It occurs as a plant metabolite in Crotalaria dura.
|
|
Neostigmine
|
A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
|
|
Resveratrol
|
|
|
Ribose-1-Phosphate
|
|
|
Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]
|
|
|
BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE
|
|
|
19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one
|
|
|
2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride
|
|
|
3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE
|
An aminoalkylpyridine that has formula C26H25FN4O2.
|
|
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE
|
|
|
ACP-103
|
|
|
4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE
|
|
|
ACP-104
|
|
|
PHX1149
|
|
|
Hydromorphone
|
A morphinane alkaloid that has formula C17H19NO3.
|
|
5-Formyl-5,6,7,8-Tetrahydrofolate
|
|
|
Triprolidine
|
|
|
substance P
|
|
|
2,5-DI-(TERT-BUTYL)-1,4,BENZOHYDROQUINONE
|
|
|
MMDA
|
|
|
1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid
|
|
|
2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE)
|
|
|
Chlorcyclizine
|
|
|
Phenindione
|
|
|
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One
|
|
|
Glutathionylspermidine Disulfide
|
|
|
1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA
|
|
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide
|
|
|
{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID
|
A 1,2,4-oxadiazole that has formula C21H21N5O5S.
|
|
Dexbrompheniramine
|
The (pharmacologically active) (S)-(+)-enantiomer of brompheniramine. A histamine H1 receptor antagonist, it is used (commonly as its maleate salt) for the symptomatic relief of allergic conditions, including rhinitis and conjunctivitis.
|
|
Botulinum Toxin Type B
|
|
|
Phenylalanylmethane
|
|
|
3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID
|
|
|
(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
|
|
|
Pamidronate
|
|
|
BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE
|
|
|
4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL
|
|
|
(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol
|
|
|
6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID
|
|
|
Palifermin
|
|
|
Raltegravir
|
|
|
4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE
|
A thiazolidinone that has formula C15H13N3O4S2.
|
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine
|
|
|
Alpha-D-Glucose-1-Phosphate-6-Vanadate
|
|
|
Etheno-Nadp
|
|
|
D-phenylalanyl-N-benzyl-L-prolinamide
|
|
|
2-Phenylheme
|
|
|
GLUTATHIONE SULFINATE
|
|
|
Biricodar dicitrate
|
|
|
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide
|
|
|
Romiplostim
|
|
|
2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
|
|
|
Buformin
|
A biguanide that has formula C6H15N5.
|
|
Papaverine
|
A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
|
|
Orciprenaline
|
A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
|
|
Paricalcitol
|
|
|
2',3'-Dideoxythymidine-5'-Monophosphate
|
|
|
N-oxo-2-(phenylsulfonylamino)ethanamide
|
|
|
Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone
|
|
|
RU84687
|
|
|
2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid
|
|
|
Acetohydroxamic Acid
|
|
|
MACITENTAN
|
A member of the class of sulfamides in which the two amino groups of sulfonamide are substituted by 5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl and propyl groups. An orphan drug used for the treatment of pulmonary arterial hypertension.
|
|
ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE
|
|
|
Urokinase
|
|
|
4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE
|
|
|
2-Phenylethylamine
|
A phenylethylamine having the phenyl substituent at the 2-position.
|
|
(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine
|
|
|
Methantheline
|
|
|
Thymidine-5'-Phosphate
|
|
|
Lefradafiban
|
A member of the class of pyrrolidin-2-ones that is pyrrolidin-2-one in which the 3-pro-S-hydrogen is substituted by a 2-methoxy-2-oxoethyl group, while the 5-pro-S-hydrogen is substituted by a ({4'-[N-(methoxycarbonyl)carbamimidoyl]biphenyl-4-yl}oxy)methyl group. It is an orally active prodrug of fradafiban, a figrinogen receptor antagonist.
|
|
Isatin
|
The 2,3-diketo derivative of indole.
|
|
Progabide
|
|
|
(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide
|
|
|
(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone
|
|
|
3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID
|
|
|
N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine
|
An aminopyrimidine that is N-cyclohexyl-N-methylpyrimidin-2-amine in which the pyrimidine ring is substituted at position 4 by an imidazo[1,2-a]pyridin-3-yl group. It is an inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK-4; EC 2.7.11.1).
|
|
Amineptine
|
A carbocyclic fatty acid that is 5-aminoheptanoic acid in which one of the hydrogens attached to the nitrogen is replaced by a 10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl group. A tricyclic antidepressant, it was never approved in the US and was withdrawn from the French market in 1999 due to concerns over abuse, dependence and severe acne.
|
|
Choriogonadotropin alfa
|
|
|
CP-122721
|
|
|
2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid
|
|
|
4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE
|
A pyrimidine that has formula C18H20N6OS.
|
|
[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE
|
|
|
IC261
|
|
|
N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
|
|
|
6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE
|
|
|
CX157
|
|
|
1-N-Acetyl-Beta-D-Glucosamine
|
|
|
4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol
|
|
|
(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid
|
|
|
Dihydrolipoic Acid
|
A thio-fatty acid that is reduced form of lipoic acid. A potent antioxidant shown to directly destroy superoxide, hydroperoxy and hydroxyl radicals; also has neuroprotective and anti-tumour effects.
|
|
5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE
|
|
|
AP1081
|
|
|
Cinolazepam
|
A 1,4-benzodiazepinone compound having a 2-cyanoethyl substituent at the 1-position, a hydroxy substituent at the 3-position, a 2-fluorophenyl group at the 5-position and a chloro substituent at the 7-position, it has general properties similar to those of diazepam and has been used for the short-term management of sleep disorders.
|
|
Beta-L-Methyl-Fucose
|
|
|
Pomalidomide
|
An aromatic amine that is thalidomide substituted at position 4 on the isoindole ring system by an amino group. Used for the treatment of multiple myeloma in patients who failed to respond to previous therapies.
|
|
Cyclic Guanosine Monophosphate
|
|
|
Lisdexamfetamine
|
|
|
9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE
|
|
|
Propofol
|
A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
|
|
(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE
|
|
|
PAS219
|
|
|
Amcinonide
|
A corticosteroid that has formula C28H35FO7.
|
|
Interferon Alfa-2b, Recombinant
|
|
|
Asimadoline
|
|
|
Imexon
|
|
|
Reserpine
|
An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria.
|
|
LLL-3348
|
|
|
Caspofungin
|
|
|
(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide
|
|
|
nocodazole
|
A member of the class of benzimidazoles that is benzimidalole which is substituted at position 2 by a (methoxycarbonyl)amino group and at position 5 by a 2-thienoyl group. It is an antineoplastic agent that exerts its effect by depolymerising microtubules.
|
|
Chlorphenamine
|
A tertiary amino compound that is propylamine which is substituted at position 3 by a pyridin-2-yl group and a p-chlorophenyl group and in which the hydrogens attached to the nitrogen are replaced by methyl groups. A histamine H1 antagonist, it is used to relieve the symptoms of hay fever, rhinitis, urticaria, and asthma.
|
|
Amantadine
|
A member of the class of adamantanes that is used as an antiviral and antiparkinson drug.
|
|
D-Limonene 1,2-Epoxide
|
|
|
6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid
|
|
|
Dolasetron
|
|
|
Ethanolamine
|
|
|
Carbetocin
|
Oxytocin in which the hydrogen on the phenolic hydroxy group is substituted by methyl, the amino group on the cysteine residue is substituted by hydrogen, and the sulfur of the cysteine residue is replaced by a methylene group. A synthetic carba-analogue of oxytocin, it is used to control bleeding after giving birth. Like oxytocin, it causes contraction of the uterus.
|
|
(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid
|
|
|
L-Histidine
|
The L-enantiomer of the amino acid histidine.
|
|
(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
|
|
|
2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
|
|
|
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE
|
|
|
2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine
|
|
|
N-Cyclohexyltaurine
|
|
|
4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE
|
|
|
N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline
|
|
|
5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole
|
|
|
Flibanserin
|
|
|
N-(5,5,8,8-Tetramethyl-5,8-Dihydro-Naphthalen-2-Yl)-Terephthalamic Acid
|
|
|
Carglumic Acid
|
|
|
Ioflupane I 123
|
An azabicycloalkane that is ecgonine methyl ester in which the N-methyl group is replaced by 3-fluoropropyl and the 3beta-hydroxy group is replaced by 4-((123)I)iodophenyl. Used for the imaging of dopamine transporters in the brain of adult patients with potential Parkinsonian Syndromes.
|
|
5-Hydroxymethyl-Chonduritol
|
|
|
Hymenialdisine
|
|
|
ALKS 27
|
|
|
1,3-Dihydroxyacetonephosphate
|
|
|
[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala
|
|
|
Morphine
|
A morphinane alkaloid that is a highly potent opiate analgesic psychoactive drug. Morphine acts directly on the central nervous system (CNS) to relieve pain but has a high potential for addiction, with tolerance and both physical and psychological dependence developing rapidly. Morphine is the most abundant opiate found in Papaver somniferum (the opium poppy).
|
|
2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid
|
A N-acylpyrrolidine that has formula C26H33F3N4O7.
|
|
{4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid
|
|
|
4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid
|
|
|
3,6,9,12,15-Pentaoxaheptadecane
|
A polyether that has formula C12H26O5.
|
|
6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine
|
|
|
Bicifadine
|
|
|
Cerulenin
|
An epoxydodecadienamide isolated from several species, including Acremonium, Acrocylindrum and Helicoceras. It inhibits the biosynthesis of several lipids by interfering with enzyme function.
|
|
Betaxolol
|
A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydoxy is substituted by a 4-[2-(cyclopropylmethoxy)ethyl]phenyl group and one of the hydrogens attached to the amino group is substituted by isopropyl. It is a selective beta1-receptor blocker and is used in the treatment of glaucoma as well as hypertension, arrhythmias, and coronary heart disease. It is also used to reduce non-fatal cardiac events in patients with heart failure.
|
|
(S)-Rolipram
|
|
|
N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE
|
|
|
4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide
|
|
|
Methylphenobarbital
|
|
|
N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide
|
|
|
S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE
|
|
|
Escitalopram
|
|
|
Regorafenib
|
|
|
4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide
|
|
|
8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM
|
|
|
2-Hydroxyethyl Disulfide
|
|
|
(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol
|
|
|
6-Hydroxyuridine-5'-Phosphate
|
|
|
(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol
|
|
|
Vinblastine
|
|
|
S-Mercaptocysteine
|
|
|
Phosphoaminophosphonic Acid-Adenylate Ester
|
|
|
DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID
|
|
|
METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE
|
A N-acylpyrrolidine that has formula C20H29N5O4.
|
|
Peginterferon alfa-2a
|
|
|
Peginterferon alfa-2b
|
|
|
PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE
|
|
|
7,8-Dihydro-L-Biopterin
|
|
|
O3-Sulfonylgalactose
|
|
|
(4e)-4-Aminohex-4-Enoic Acid
|
|
|
9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
|
|
|
4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE
|
|
|
(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid
|
The 13(S)-enantiomer of HODE.
|
|
GERANYLGERANYL DIPHOSPHATE
|
A polyprenol diphosphate having geranylgeranyl as the polyprenyl component.
|
|
Novo Nordisk a/S Compound
|
|
|
(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE
|
A N-acylpyrrolidine that has formula C14H23N3O.
|
|
Menotropins
|
|
|
6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine
|
|
|
4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID
|
A 1,2,4-oxadiazole that has formula C12H11N3O5.
|
|
Carboxin
|
An anilide obtained by formal condensation of the amino group of aniline with the carboxy group of 2-methyl-5,6-dihydro-1,4-oxathiine-3-carboxylic acid. A fungicide for control of bunts and smuts normally that is normally used as a seed treatment.
|
|
Thimerosal
|
An alkylmercury compound (approximately 49% mercury by weight) used as an antiseptic and antifungal agent.
|
|
Lysophosphotidylserine
|
|
|
Orotic Acid
|
|
|
Hydroxyurea
|
A member of the class of ureas that is urea in which one of the hydrogens is replaced by a hydroxy group. An antineoplastic used in the treatment of chronic myeloid leukaemia as well as for sickle-cell disease.
|
|
Guanosine-5'-Diphosphate
|
|
|
Alpha-L-Fucose
|
A L-fucopyranose having alpha-configuration at the anomeric centre.
|
|
Tatp
|
|
|
{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid
|
|
|
5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one
|
|
|
Indacaterol
|
|
|
Methionine Sulfoxide
|
|
|
2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID
|
|
|
2-[(2-methoxy-5-methylphenoxy)methyl]pyridine
|
|
|
2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE
|
|
|
Stavudine
|
A nucleoside analogue obtained by formal dehydration across positions 2 and 3 of thymidine. An inhibitor of HIV-1 reverse transcriptase
|
|
K201
|
|
|
2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide
|
|
|
4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
|
|
|
3,5 DIBROMOTYROSINE
|
A monocarboxylic acid that has formula C9H9Br2NO3.
|
|
N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE
|
|
|
Lapatinib
|
|
|
3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione
|
|
|
N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID
|
|
|
N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate
|
|
|
Inhibitor Idd 384
|
|
|
Glisoxepide
|
|
|
Nafcillin
|
A penicillin that has formula C21H22N2O5S.
|
|
PHENYLALANYLMETHYLCHLORIDE
|
|
|
Lpc-Ether
|
|
|
(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine
|
|
|
7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE
|
|
|
Donepezil
|
Donepezil is a centrally acting reversible acetyl cholinesterase inhibitor. Its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
|
|
1,4-Dithiothreitol
|
The threo-diastereomer of 1,4-dimercaptobutane-2,3-diol.
|
|
Flunisolide
|
A cyclic ketal that has formula C24H31FO6.
|
|
Irbesartan
|
|
|
3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol
|
|
|
4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
|
|
|
2-Aminobenzoic Acid
|
An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system.
|
|
Alpha,Beta-Methyleneadenosine-5'-Triphosphate
|
|
|
CHF 4227
|
|
|
(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine
|
|
|
Dicloxacillin
|
A penicillin that has formula C19H17Cl2N3O5S.
|
|
(2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile
|
|
|
Sri-9662
|
|
|
L-Isoleucine
|
The L-enantiomer of isoleucine.
|
|
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole
|
|
|
Fluoro-Willardiine
|
|
|
Bupropion
|
A propanone that is propan-1-one substituted by a tert-butylamino group at position 2 and a 3-chlorophenyl group at position 1.
|
|
Dinoprostone
|
|
|
Butenafine
|
|
|
N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE
|
An amidopiperidine that has formula C25H31N3O2.
|
|
Timolol
|
1,2,5-Thiadiazole substituted at the 3 position by a 3-(tert-butylamino)-2-hydroxypropoxy group and at the 4 position by a morpholin-4-yl group. The (S)-(-) enantiomer, also known as timolol, is a beta-adrenergic antagonist and is used in the mangement of glaucoma, hypertension, angina pectoris and myocardial infarction, and for the prevention of migraine.
|
|
6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE
|
A carbazole that has formula C22H25N5O.
|
|
8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One
|
|
|
3-Aminosuccinimide
|
|
|
2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid
|
|
|
Dapiprazole
|
|
|
1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide
|
|
|
Montelukast
|
An aliphatic sulfide that has formula C35H36ClNO3S.
|
|
SULTHIAME
|
|
|
4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide
|
|
|
Nevirapine
|
|
|
LY2181308
|
|
|
Lysergic Acid Diethylamide
|
An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
|
|
3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one
|
|
|
N-Methyl-N-Propargyl-1(R)-Aminoindan
|
|
|
Acenocoumarol
|
|
|
5-Bromonicotinamide
|
|
|
N-Butyl Isocyanide
|
|
|
SIMEPREVIR
|
|
|
Compound 19
|
|
|
Compound 18
|
|
|
Carisoprodol
|
A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.
|
|
SGS742
|
|
|
SR-123781A
|
|
|
4-[(5-methoxy-2-methylphenoxy)methyl]pyridine
|
|
|
1-Deoxynojirimycin
|
|
|
Alizapride
|
|
|
Imipramine
|
A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
|
|
Acetazolamide
|
A thiadiazole that has formula C4H6N4O3S2.
|
|
Rbt205 Inhibitor
|
|
|
{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone
|
|
|
Huperzine-A
|
A sesquiterpene alkaloid isolated from a club moss Huperzia serrata that has been shown to exhibit neuroprotective activity.
|
|
B-2-Octylglucoside
|
|
|
Octreotide
|
A homodetic cyclic peptide that has formula C49H66N10O10S2.
|
|
3-hydroxyglutaric acid
|
|
|
3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER
|
|
|
N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide
|
|
|
Rotigotine
|
|
|
Lisuride
|
|
|
D-Myo-Inositol-1,4,5-Triphosphate
|
|
|
Ritodrine
|
|
|
Formycin
|
|
|
Dinor-N(Omega)-Hydroxy-L-Arginine
|
|
|
IMC-11F8
|
|
|
4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID
|
|
|
Aciclovir
|
|
|
Pentosan Polysulfate
|
|
|
Ritonavir
|
A L-valine derivative in which the alpha-nitrogen of L-valinamide is substituted with a methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl group and the amide nitrogen by a (2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl group. An antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS, it is often used as a fixed-dose combination with another protease inhibitor, lopinavir.
|
|
1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE
|
|
|
Orphenadrine
|
A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
|
|
Selenocysteine
|
An alpha-amino acid that consists of alanine where one of the methyl hydrogens is substituted with a seleno group.
|
|
1-ACETYL-2-CARBOXYPIPERIDINE
|
|
|
[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE
|
|
|
3-Hydroxy-Myristic Acid
|
|
|
L-Lysine
|
An L-alpha-amino acid; the L-isomer of lysine.
|
|
Promazine
|
|
|
Forasartan
|
|
|
Cosyntropin
|
A synthetic peptide that is identical to the 24-amino acid segment at the N-terminal of adrenocorticotropic hormone (corticotropin). A segment similar in all species, it contains the biological activity that stimulates production of corticosteroids in the adrenal cortex. It is used diagnostically to investigate adrenocortical insufficiency.
|
|
AL4623
|
|
|
Etheno-Nad
|
|
|
Docetaxel
|
|
|
3-Thiaoctanoyl-Coenzyme A
|
|
|
(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile
|
|
|
5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide
|
|
|
Medroxyprogesterone Acetate
|
A steroid ester that has formula C24H34O4.
|
|
(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium
|
|
|
Idursulfase
|
|
|
4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione
|
|
|
2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE
|
|
|
Cyproheptadine
|
The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.
|
|
N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide
|
|
|
Flunitrazepam
|
|
|
(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL
|
|
|
Carprofen
|
Propanoic acid in which one of the methylene hydrogens is substituted by a 6-chloro-9H-carbazol-2-yl group. A non-steroidal anti-inflammatory drug, it is no longer used in human medicine but is still used for treatment of arthritis in elderly dogs.
|
|
(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
|
|
|
Pyridoxal Phosphate
|
|
|
9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE
|
|
|
TTP889
|
|
|
Salicylic acid
|
A monohydroxybenzoic acid that is benzoic acid with a hydroxy group at the ortho position. It is obtained from the bark of the white willow and wintergreen leaves.
|
|
Aldesleukin
|
|
|
2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL
|
|
|
Temsirolimus
|
|
|
1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID
|
A boronic acid that has formula C23H27BN4O4.
|
|
2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid
|
|
|
(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID
|
|
|
Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]
|
|
|
XL765
|
A sulfonamide obtained by formal condensation of the sulfonic acid group of 4-[(3-methoxy-4-methylbenzoyl)amino]benzenesulfonic acid with the primary aromatic amino group of N-(3,5-dimethoxyphenyl)quinoxaline-2,3-diamine. A dual PI3K/mTOR inhibitor used in cancer treatment.
|
|
TTNPB
|
|
|
2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
|
|
Acamprosate
|
|
|
Tramadol
|
|
|
Valsartan
|
|
|
Eculizumab
|
|
|
Zinc Trihydroxide
|
|
|
NM100060
|
|
|
Tauroursodeoxycholic acid
|
A bile acid taurine conjugate that has formula C26H45NO6S.
|
|
Lomefloxacin
|
|
|
D-[(N-Hydroxyamino)Carbonyl]Phenylalanine
|
|
|
3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium
|
|
|
N-Cyclohexyl-N'-Decylurea
|
|
|
N,O6-Disulfo-Glucosamine
|
|
|
2-OXOHEPTYLPHOSPHONIC ACID
|
|
|
Udenafil
|
|
|
Procainamide
|
4-Aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
|
|
N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide
|
A pyrimidylpyridine that has formula C22H18N6O.
|
|
(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE
|
An oxazolidine that has formula C16H12F2N2O3.
|
|
N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine
|
|
|
6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide
|
|
|
Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide
|
|
|
Dicoumarol
|
A hydroxycoumarin that is methane in which two hydrogens have each been substituted by a 4-hydroxycoumarin-3-yl group.
|
|
Asenapine
|
|
|
Alprenolol
|
|
|
1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
|
|
|
3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID
|
|
|
Cefradine
|
|
|
BENZOTHIAZOLE
|
An organic heterobicyclic compound that is a fusion product between benzene and thiazole. The parent of the class of benzothiazoles.
|
|
Desoximetasone
|
Dexamethasone in which the hydroxy group at the 17alpha position is substituted by hydrogen. A synthetic corticosteroid with glucocorticoid activity, it is used as an anti-inflammatory and anti-pruritic in the treatment of various skin disorders, including skin allergies and psoriasis.
|
|
Eszopiclone
|
|
|
N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID
|
|
|
Prednisolone
|
A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
|
|
octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside
|
|
|
CDB-2914
|
|
|
4-Iodobenzo[B]Thiophene-2-Carboxamidine
|
|
|
Rifabutin
|
|
|
1h-Benoximidazole-2-Carboxylic Acid
|
|
|
3-Phenylpyruvic Acid
|
|
|
2'-Deoxyuridine 3'-Monophosphate
|
|
|
Interferon alfa-n1
|
|
|
(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE
|
|
|
Epoprostenol
|
|
|
Captodiame
|
|
|
UBIQUINONE-2
|
A compound composed of the 2,3-dimethoxy-5-methylbenzoquinone nucleus common to ubiquinones; and a side chain of two isoprenoid units.
|
|
N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE
|
|
|
CD564
|
|
|
4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline
|
|
|
Elacridar
|
|
|
Azimilide
|
An imidazolidine-2,4-dione that has formula C23H28ClN5O3.
|
|
Interferon gamma-1b
|
|
|
Propafenone
|
An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
|
|
AV411
|
|
|
CT-011
|
|
|
N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE
|
A carbocyclic compound that has formula C20H22F4N4O4S.
|
|
5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE
|
A 1,2-thiazole that has formula C9H7NO4S.
|
|
2,3-Dihydroxy-Benzoic Acid
|
A dihydroxybenzoic acid that is benzoic acid substituted by hydroxy groups at positions 2 and 3. It occurs naturally in Phyllanthus acidus and in the aquatic fern Salvinia molesta.
|
|
9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
|
|
|
(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate
|
|
|
transdermal testosterone gel
|
|
|
Guanosine
|
A purine nucleoside in which guanine is attached to ribofuranose via a beta-N(9)-glycosidic bond.
|
|
1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL
|
|
|
Topotecan
|
A pyranoindolizinoquinoline used as an antineoplastic agent. It is a derivative of camptothecin and works by binding to the topoisomerase I-DNA complex and preventing religation of these 328 single strand breaks.
|
|
Minaprine
|
|
|
Fica
|
|
|
Fluoxetine
|
A aromatic ether consisting of 4-trifluoromethylphenol substituted on oxygen by a 3-(methylamino)-1-phenylpropyl group.
|
|
4-(1-methyl-1-phenylethyl)phenol
|
|
|
(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid
|
|
|
Thioproline
|
A sulfur-containing amino acid that is proline in which the methylene group at position 4 is replaced by a sulfur atom.
|
|
5-beta-DIHYDROTESTOSTERONE
|
A 3-hydroxy steroid that has formula C19H30O2.
|
|
3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER
|
|
|
Nicotine
|
An N-alkylpyrrolidine that consists of N-methylpyrrolidine bearing a pyridin-3-yl substituent at position 2. It has been isolated from Nicotiana tabacum.
|
|
Ethynodiol
|
|
|
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE
|
|
|
Mepenzolate
|
|
|
Niflumic Acid
|
|
|
Bendroflumethiazide
|
A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
|
|
Diphenidol
|
|
|
Decylamine-N,N-Dimethyl-N-Oxide
|
A N-oxide of N,N-dimethyldecan-1-amine.
|
|
Clocortolone
|
|
|
O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL
|
|
|
2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole
|
|
|
Nilvadipine
|
|
|
N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE
|
|
|
5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE
|
|
|
Cyclandelate
|
|
|
Acetylcarnitine
|
|
|
N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE
|
|
|
(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime
|
|
|
2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE
|
|
|
5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE
|
A 1-benzothiophene that has formula C19H22ClN3O5S2.
|
|
2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine
|
|
|
(5BETA)-PREGNANE-3,20-DIONE
|
A C21-steroid that is 5beta-pregnane with oxo groups at positions 3 and 20.
|
|
3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE
|
|
|
Anakinra
|
|
|
Tolmetin
|
|
|
S-Adenosylmethionine
|
|
|
Lucanthone
|
A thioxanthen-9-one compound having a methyl substituent at the 1-position and a 2-[(diethylamino)ethyl]amino substituent at the 4-position. Formerly used for the treatment of schistosomiasis. It is a prodrug, being metabolised to hycanthone.
|
|
(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime
|
|
|
2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE
|
|
|
Ado-P-Ch2-P-Ps-Ado
|
|
|
(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE
|
|
|
DPI59
|
|
|
Conjugated Estrogens
|
|
|
AVE-1625
|
|
|
1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine
|
|
|
Tazarotene
|
|
|
Ocriplasmin
|
|
|
Phentolamine
|
|
|
[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone
|
|
|
1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE
|
A sulfonamide that has formula C20H20N2O5S.
|
|
3,3',5,5'-Tetraiodothyroacetic Acid
|
|
|
N-Acetylmethionine
|
|
|
Methylphosphinic Acid
|
|
|
5-aminonaphthalene-1-sulfonic acid
|
|
|
Magnesium Sulfate
|
A magnesium salt having sulfate as the counterion.
|
|
3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole
|
|
|
GSK-923295
|
|
|
Oxymetazoline
|
|
|
5-Alpha-Androstane-3-Beta,17-Alpha-Diol
|
An androstane-3,17-diol that has formula C19H32O2.
|
|
Nizatidine
|
|
|
Malonic acid
|
An alpha,omega-dicarboxylic acid in which the two carboxy groups are separated by a single methylene group.
|
|
Disulfiram
|
An organic disulfide that is 1,1'-[disulfanediylbis(carbonothioylimino)]diethane substituted by ethyl groups at the N atom. An EC 1.2.1.3 [aldehyde dehydrogenase (NAD+)] inhibitor, it is used as an alcohol deterrent.
|
|
1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide
|
|
|
(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID
|
|
|
2s,4r-4-Methylglutamate
|
|
|
2,3,-Dihydroxybenzoylserine
|
|
|
2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE
|
An extended flavonoid resulting from the formal fusion of a benzene ring with the h side of flavone. A synthetic compound, it is an inhibitor of aromatase (EC 1.14.14.14).
|
|
Abatacept
|
|
|
Aflibercept
|
|
|
Olmesartan
|
A biphenylyltetrazole that has formula C24H26N6O3.
|
|
Bexarotene
|
|
|
(R)-tacrine(10)-hupyridone
|
|
|
HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM
|
|
|
3-Methylphenylalanine
|
|
|
Nefazodone
|
A triazole that has formula C25H32ClN5O2.
|
|
5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID
|
|
|
Palivizumab
|
|
|
RU85493
|
|
|
2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM
|
|
|
Salmeterol
|
|
|
N-Methylleucine
|
|
|
Iron Dextran
|
|
|
ATL1101
|
|
|
ATL1102
|
|
|
2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone
|
|
|
Purvalanol
|
|
|
3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE
|
|
|
10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine
|
|
|
4-Hydroxybutan-1-Aminium
|
|
|
LY-517717
|
|
|
trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium
|
|
|
N-(3-AMINOPROPYL)-2-NITROBENZENAMINE
|
|
|
Rilpivirine
|
|
|
Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide
|
A morpholine that has formula C21H30N4O4.
|
|
Norethindrone
|
|
|
(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid
|
|
|
Pentoxifylline
|
|
|
Carfilzomib
|
|
|
CP-945598
|
|
|
Tetramethylammonium Ion
|
|
|
Dienestrol
|
|
|
3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione
|
|
|
3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID
|
|
|
Fosphenytoin
|
|
|
CYC116
|
|
|
Ibandronate
|
|
|
3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE
|
|
|
5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE
|
|
|
E7389
|
|
|
GW 468816
|
|
|
2-Chlorophenol
|
A monochlorophenol that has formula C6H5ClO.
|
|
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide
|
|
|
Glucose-Uridine-C1,5'-Diphosphate
|
|
|
Natalizumab
|
|
|
N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine
|
|
|
RI 624
|
|
|
4-(1,3-BENZOXAZOL-2-YL)-2,6-DIMETHYLPHENOL
|
|
|
2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose
|
|
|
2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate
|
|
|
Flavoxate
|
A carboxylic ester resulting from the formal condensation of 3-methylflavone-8-carboxylic acid with 2-(1-piperidinyl)ethanol.
|
|
Oxprenolol
|
|
|
Dimethyl fumarate
|
An enoate ester resulting from the formal condensation of both carboxy groups of fumaric acid with methanol. Used for treatment of adults with relapsing forms of multiple sclerosis.
|
|
Cordycepin Triphosphate
|
A purine ribonucleoside 5'-triphosphate that has formula C10H16N5O12P3.
|
|
3-Hydroxybutyryl-Coenzyme A
|
|
|
3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione
|
|
|
Pilocarpine
|
|
|
OSI-930
|
|
|
Pioglitazone
|
A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
|
|
Alefacept
|
|
|
CRA_9678
|
|
|
Bifeprunox
|
|
|
Nomifensine
|
|
|
Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester
|
|
|
D-Myo-Inositol-1,4-Bisphosphate
|
|
|
5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE
|
|
|
2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium
|
|
|
N-Aminoethylmorpholine
|
|
|
Virginiamycin factor S1
|
|
|
[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile
|
|
|
Famotidine
|
A guanidine that has formula C8H15N7O2S3.
|
|
L-Cystine
|
The L-enantiomer of the sulfur-containing amino acid cystine.
|
|
Sphingosine
|
A sphing-4-enine in which the double bond is trans.
|
|
Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide
|
|
|
Nitisinone
|
|
|
5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE
|
A pyrimidylpyridine that has formula C18H17ClN4.
|
|
GFT505
|
|
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
|
|
Fontolizumab
|
|
|
Spermine
|
A polyazaalkane that is tetradecane in which the carbons at positions 1, 5, 10 and 14 are replaced by nitrogens. Spermine has broad actions on cellular metabolism.
|
|
6-(2,5-Dimethoxy-Benzyl)-5-Methyl-Pyrido[2,3-D]Pyrimidine-2,4-Diamine
|
|
|
Potassium Chloride
|
A metal chloride salt with a K(+) counterion.
|
|
3-Amino-4-Oxybenzyl-2-Butanone
|
|
|
LErafAON
|
|
|
(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE
|
|
|
Ibritumomab
|
|
|
1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine
|
|
|
Gramicidin D
|
|
|
(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one
|
|
|
Ondansetron
|
|
|
3-Phenyl-1,2-Propandiol
|
|
|
recombinant human GM-CSF
|
|
|
Clofazimine
|
|
|
RPR131247
|
|
|
N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide
|
|
|
Theophylline
|
A dimethylxanthine having the two methyl groups located at positions 1 and 3. It is structurally similar to caffeine and is found in green and black tea.
|
|
TG100801
|
|
|
Ginseng
|
|
|
N'-Pyridoxyl-Lysine-5'-Monophosphate
|
|
|
3'-Oxo-Adenosine
|
|
|
Afimoxifene
|
A tertiary amino compound that is tamoxifen in which the phenyl group which is in a Z- relationship to the ethyl substituent is hydroxylated at the para- position. It is the active metabolite of tamoxifen.
|
|
THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE
|
|
|
4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID
|
A thiazolidinone that has formula C15H10N2O4S.
|
|
Gaboxadol
|
|
|
Tropicamide
|
|
|
Hexane-1,6-Diol
|
A diol that is hexane substituted by hydroxy groups at positions 1 and 6.
|
|
Bambuterol
|
|
|
Matairesinol
|
A lignan that is gamma-butyrolactone in which the 3 and 4 positions are substituted by 4-hydroxy-3-methoxybenzyl groups (the 3R,4R-diastereomer).
|
|
AL7182
|
|
|
5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE
|
Flavone hydroxylated at positions 3', 4', 5, 5' and 7.
|
|
SC-74020
|
|
|
6-(CYCLOHEXYLAMINO)-9-[2-(4-METHYLPIPERAZIN-1-YL)-ETHYL]-9H-PURINE-2-CARBONITRILE
|
A 6-aminopurine that has formula C19H28N8.
|
|
Glucosamine
|
|
|
Bis(5-Amidino-Benzimidazolyl)Methane Zinc
|
|
|
4,4'-PROPANE-2,2-DIYLDIPHENOL
|
|
|
L-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID
|
|
|
[4-(4-Hydroxy-3-Iodo-Phenoxy)-3,5-Diiodo-Phenyl]-Acetic Acid
|
|
|
4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL
|
|
|
(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE
|
|
|
2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole
|
|
|
R048-8071
|
|
|
Genz-112638
|
|
|
Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid
|
|
|
Dihydrotestosterone
|
|
|
S-Ethyl-N-Phenyl-Isothiourea
|
|
|
L-Alpha-Glycerophosphorylethanolamine
|
|
|
2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE
|
|
|
METOPRINE, METHODICHLOROPHEN
|
|
|
M-Cresol
|
A cresol with the methyl substituent at position 3. It is a minor urinary metabolite of toluene.
|
|
2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid
|
|
|
[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE
|
|
|
5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid
|
|
|
Isoprenaline
|
A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
|
|
2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL
|
|
|
[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER
|
|
|
NCX 4016
|
|
|
Perindopril
|
An alpha-amino acid ester that is the ethyl ester of N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvaline
|
|
Adenosine-5-Diphosphoribose
|
|
|
Zinc Substituted Heme C
|
|
|
4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE
|
|
|
Guanidinoethylmercaptosuccinic acid
|
|
|
FM-VP4
|
|
|
Sulfaphenazole
|
A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.
|
|
Balanol
|
|
|
Indinavir
|
|
|
Buprenorphine
|
A morphinane alkaloid that is 7,8-dihydromorphine 6-O-methyl ether in which positions 6 and 14 are joined by a -CH2CH2- bridge, one of the hydrogens of the N-methyl group is substituted by cyclopropyl, and a hydrogen at position 7 is substituted by a 2-hydroxy-3,3-dimethylbutan-2-yl group.
|
|
Pimecrolimus
|
|
|
Benzyl alcohol
|
An aromatic alcohol that consists of benzene bearing a single hydroxymethyl substituent.
|
|
Loratadine
|
|
|
S-Hydroxycysteine
|
|
|
S-(P-Nitrobenzyl)Glutathione
|
|
|
Dexloxiglumide
|
|
|
N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide
|
A pyrrolidinecarbonitrile that has formula C19H26N4O3.
|
|
N-1-Methylheptylformamide
|
|
|
Uridine-Diphosphate-N-Acetylgalactosamine
|
|
|
Adenosine-2'-5'-Diphosphate
|
|
|
2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE
|
A benzamide that has formula C17H15N5O2.
|
|
Methocarbamol
|
|
|
[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE
|
|
|
Ifenprodil
|
|
|
Bromfenac
|
Amfenac in which the the hydrogen at the 4 position of the benzoyl group is substituted by bromine. It is used for the management of ocular pain and treatment of postoperative inflammation in patients who have undergone cataract extraction. It was withdrawn from the US market in 1998, following concerns over off-label abuse and hepatic failure.
|
|
HE3286
|
|
|
Cholesterol
|
|
|
SP2456
|
|
|
1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM
|
|
|
{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)
|
|
|
N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE
|
|
|
8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
|
|
|
1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE
|
|
|
N6-Benzyl Adenosine-5'-Diphosphate
|
|
|
Epoetin alfa
|
|
|
Aluminium
|
A boron group element atom that has formula Al.
|
|
Rocuronium
|
A 5alpha-androstane compound having 3alpha-hydroxy-, 17beta-acetoxy-, 2beta-morpholino- and 16beta-N-allyllyrrolidinium substituents.
|
|
Elafin
|
|
|
Glyoxalate, Glyoxylate
|
|
|
(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID
|
|
|
SOT-107
|
|
|
Thiamine
|
|
|
Porfimer
|
|
|
Benzo[B]Thiophene-2-Carboxamidine
|
|
|
3,4-Dichloroisocoumarin
|
|
|
7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE
|
|
|
Loperamide
|
A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease.
|
|
Ardeparin
|
|
|
Nitrofural
|
|
|
Interferon alfa-n3
|
|
|
4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE
|
|
|
N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide
|
|
|
N-Methyl-N-(Methylbenzyl)Formamide
|
|
|
Pergolide
|
A diamine that is ergoline in which the beta-hydrogen at position 8 is replaced by a (methylthio)methyl group and the hydrogen attached to the piperidine nitrogen (position 6) is replaced by a propyl group. A dopamine D2 receptor agonist which also has D1 and D2 agonist properties, it is used as the mesylate salt in the management of Parkinson's disease, although it was withdrawn from the U.S. and Canadian markets in 2007 due to an increased risk of cardiac valve dysfunction.
|
|
Mefenamic acid
|
An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.
|
|
Inecalcitol
|
|
|
PARA-NITROBENZYL GLUTARYL GLYCINIC ACID
|
|
|
Azelastine
|
A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.
|
|
{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid
|
|
|
7,8-Dihydrobiopterin
|
A dihydropterin that is biopterin dihydrogenated at positions 7 and 8.
|
|
Methacycline
|
|
|
Sufentanil
|
An anilide resulting from the formal condensation of the aryl amino group of 4-(methoxymethyl)-N-phenyl-1-[2-(2-thienyl)ethyl]piperidin-4-amine with propanoic acid.
|
|
XL880
|
|
|
Rosuvastatin
|
|
|
AZD-8330
|
|
|
Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester
|
|
|
2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID
|
|
|
Orlistat
|
|
|
Inhibitor of P38 Kinase
|
|
|
Porphobilinogen
|
A dicarboxylic acid that is pyrole bearing aminomethyl, carboxymethyl and 2-carboxyethyl substituents at positions 2, 3 and 4 respectively.
|
|
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE
|
|
|
3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE
|
|
|
(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine
|
|
|
D-Arginine
|
A D-alpha-amino acid that is the D-isomer of arginine.
|
|
AZD2171
|
|
|
Batimastat
|
|
|
4-Fluorobenzylamine
|
|
|
N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE
|
|
|
Trisalicylate-choline
|
|
|
2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol
|
|
|
Isoflurane
|
An organofluorine compound that has formula C3H2ClF5O.
|
|
WX-G250
|
|
|
2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid
|
|
|
6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM
|
|
|
Diethylphosphono Group
|
|
|
2,6-Difluorobenzenesulfonamide
|
A sulfonamide that has formula C6H5F2NO2S.
|
|
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
|
|
|
CX717
|
|
|
golimumab
|
|
|
Fumagillin
|
A meroterpenoid resulting from the formal condensation of the hydroxy group of fumagillol with the carboxylic acid group of (all-E)-deca-2,4,6,8-tetraenedioic acid. Originally isolated from the fungus Aspergillus fumigatus, it is used for the control of Nosema infection in honey bees.
|
|
Dipyridamole
|
A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
|
|
4-Carboxycinnamic Acid
|
|
|
Levomilnacipran
|
|
|
6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE
|
|
|
Sorafenib
|
|
|
Inositol 1,3-Bisphosphate
|
|
|
Etretinate
|
|
|
(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL
|
A chromanol that is chroman-6-ol which is substituted at positions 2, 3, and 4 by p-(2-pyrrolidin-1-ylethoxy)phenyl, p-hydroxyphenyl, and methyl groups, respectively (the 2R,3R,4S diastereoisomer).
|
|
Di-Stearoyl-3-Sn-Phosphatidylethanolamine
|
|
|
Trimethaphan
|
|
|
4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline
|
|
|
Acarbose Derived Hexasaccharide
|
|
|
Paroxetine
|
A benzodioxole that consists of piperidine bearing 1,3-benzodioxol-5-yloxy)methyl and 4-fluorophenyl substituents at positions 3 and 4 respectively; the (3S,4R)-diastereomer. Highly potent and selective 5-HT uptake inhibitor that binds with high affinity to the serotonin transporter (Ki = 0.05 nM). Ki values are 1.1, 350 and 1100 nM for inhibition of [3H]-5-HT, [3H]-l-NA and [3H]-DA uptake respectively. Displays minimal affinity for alpha1-, alpha2- or beta-adrenoceptors, 5-HT2A, 5-HT1A, D2 or H1 receptors at concentrations below 1000 nM, however displays weak affinity for muscarinic ACh receptors (Ki = 42 nM). Antidepressant and anxiolytic in vivo.
|
|
4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE
|
|
|
5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE
|
A thiadiazolidine that has formula C15H14N2O4S.
|
|
2-Methyl-3-(2-Aminothiazolo)Propanal
|
|
|
5-Fluoro-Beta-L-Gulosyl Fluoride
|
|
|
INCB13739
|
|
|
5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione
|
|
|
(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE
|
|
|
Ramipril
|
A dipeptide that is the prodrug for ramiprilat, the active metabolite obtained by hydrolysis of the ethyl ester group. An angiotensin-converting enzyme (ACE) inhibitor, used to treat high blood pressure and congestive heart failure.
|
|
Coproporphyrin I
|
A coproporphyrin that has formula C36H38N4O8.
|
|
8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine
|
|
|
N-methyl-1-(2-thiophen-2-ylphenyl)methanamine
|
|
|
Glycinamide Ribonucleotide
|
A ribonucleotide that has formula C7H13N2O8P.
|
|
5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide
|
|
|
Adapalene
|
An adamantane that has formula C28H28O3.
|
|
Dichloroacetic Acid
|
An organochlorine compound comprising acetic acid carrying two chloro substituents at the 2-position. It occurs in nature in seaweed, Asparagopsis taxiformis.
|
|
N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide
|
|
|
Cholesterol-Sulfate
|
A steroid sulfate that has formula C27H46O4S.
|
|
N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
|
|
|
INCB3284
|
|
|
TAK-491
|
|
|
Nabilone
|
|
|
Arbutamine
|
|
|
2-Amino-5-Hydroxy-Benzimidazole
|
|
|
Paliperidone
|
|
|
Spirapril
|
|
|
Nebivolol
|
|
|
Z-Pro-Prolinal
|
|
|
Mimosine
|
|
|
N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide
|
|
|
Alpha-D-Glucose-1-Phosphate
|
A D-glucopyranose 1-phosphate in which the anomeric centre has alpha-configuration.
|
|
GSK716155
|
|
|
MK-0974
|
|
|
6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine
|
|
|
(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID
|
|
|
RU90395
|
|
|
4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE
|
A nitrosopyrimidine that has formula C18H22N6O3.
|
|
keyhole limpet hemocyanin
|
|
|
Heptyl-Beta-D-Glucopyranoside
|
|
|
Galsulfase
|
|
|
(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine
|
|
|
Ezetimibe
|
A beta-lactam that is azetidin-2-one which is substituted at 1, 3, and 4 by p-fluorophenyl, 3-(p-fluorophenyl)-3-hydroxypropyl, and 4-hydroxyphenyl groups, respectively (the 3R,3'S,4S enantiomer).
|
|
Amodiaquine
|
|
|
AZD2563
|
|
|
IMC-A12
|
|
|
Chloroquine
|
An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
|
|
6-O-Phosphoryl Inosine Monophosphate
|
|
|
Nicotinamide
|
A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
|
|
1-Proponol
|
|
|
Phosphoenolpyruvate
|
A monocarboxylic acid anion resuting from selective deprotonation of the carboxy group of phosphoenolpyruvic acid.
|
|
5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine
|
|
|
Porphyrin Fe(Iii)
|
|
|
3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium
|
|
|
2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE
|
|
|
N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE
|
A 1,3-thiazole that has formula C14H16ClN3O4S2.
|
|
1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide
|
|
|
Tioguanine
|
A 2-aminopurine that is the 6-thiono derivative of 2-amino-1,9-dihydro-6H-purine.
|
|
(Aminooxy)Acetic Acid
|
|
|
4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one
|
|
|
D-Alanine
|
The D-enantiomer of alanine.
|
|
O-Sialic Acid
|
|
|
2'-O-Acetyl Adenosine-5-Diphosphoribose
|
|
|
M0002
|
|
|
Lamotrigine
|
A member of the class of 1,2,4-triazines in which the triazene skeleton is substituted by amino groups at positions 3 and 5, and by a 2,3-dichlorophenyl group at position 6.
|
|
5-Hydroxy-N-Propargyl-1(R)-Aminoindan
|
|
|
2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate
|
|
|
Malate Ion
|
|
|
Mitotane
|
|
|
Brasofensine
|
|
|
HZT-501
|
|
|
Carmustine
|
|
|
Calcium
|
|
|
Cu-Bicyclam
|
|
|
ISO24
|
|
|
Sinapoyl Coenzyme A
|
|
|
Hydrochlorothiazide
|
|
|
(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
|
|
|
Peldesine
|
|
|
Benzylsulfinic Acid
|
|
|
Eletriptan
|
|
|
Benzquinamide
|
|
|
3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline
|
|
|
4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL
|
|
|
1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine
|
|
|
Octylphenoxy polyethoxyethanol
|
|
|
Protoporphyrin Ix Containing Co
|
|
|
SC12267
|
|
|
Fingolimod
|
|
|
Riboflavin
|
D-Ribitol in which the hydroxy group at position 5 is substituted by a 7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl moiety. It is a nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables, but the richest natural source is yeast. The free form occurs only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin-adenine dinucleotide.
|
|
Saquinavir
|
|
|
Dimetacrine
|
|
|
N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide
|
|
|
Flufenamic Acid
|
|
|
1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
|
|
Chlormezanone
|
|
|
4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE
|
A pyrazolylpiperidine that has formula C14H16ClN3.
|
|
Mepivacaine
|
A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.
|
|
Canakinumab
|
|
|
Ethylisothiourea
|
|
|
N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE
|
|
|
1-Hexadecylsulfonyl Fluoride
|
|
|
N-Acetyl-N'-Beta-D-Glucopyranosyl Urea
|
|
|
TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE
|
|
|
BNP-166
|
|
|
INSM-18
|
|
|
(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE
|
|
|
1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
|
|
|
Menadione
|
A naphthoquinone having a methyl substituent at the 2-position.
|
|
LGD-1550
|
|
|
(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile
|
|
|
Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate
|
|
|
3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE
|
|
|
4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL
|
|
|
N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide
|
|
|
Dimethylthiambutene
|
N,N-Dimethylbut-3-en-2-amine in which each of the hydrogens at position 4 is substituted by a 2-thienyl group. An opioid analgesic drug, it is controlled under the UN Single Convention on Narcotic Drugs (1961), but is used in veterinary medicine, particularly in Japan.
|
|
3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE
|
|
|
Reteplase
|
|
|
3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE
|
|
|
Cefixime
|
|
|
4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide
|
|
|
4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE
|
|
|
2-(cyclohexylamino)benzoic acid
|
|
|
Heme C
|
The cyclic tetrapyrrole anion that is ferroheme c protonated to pH 7.3.
|
|
2,5-Anhydroglucitol-1,6-Biphosphate
|
|
|
(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE
|
A ring assembly that has formula C10H10N2O.
|
|
2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM
|
|
|
PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]
|
|
|
5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL
|
|
|
Terazosin
|
A piperazine that has formula C19H25N5O4.
|
|
Amyl Nitrite
|
A nitrite ester having n-pentyl as the alkyl group.
|
|
BIA
|
|
|
Uridine Diphosphate Galactose
|
|
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine
|
|
|
4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
|
|
|
PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE
|
|
|
D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide
|
|
|
4-Piperidino-Piperidine
|
|
|
Eltrombopag
|
|
|
Heptanoic Acid
|
|
|
Goserelin
|
|
|
2'-deoxyuridylic acid
|
|
|
BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE
|
A dioxanecarboxylic acid that has formula C18H26N2O12.
|
|
VX-765
|
|
|
N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE
|
|
|
DHA-paclitaxel
|
|
|
L-2-Amino-4-(Guanidinooxy)Butyric Acid
|
|
|
ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE
|
|
|
Clotiazepam
|
|
|
3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE
|
|
|
Perampanel
|
|
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE
|
|
|
{5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID
|
|
|
1-DODECANOL
|
|
|
1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
|
|
E2012
|
|
|
(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL
|
|
|
Sulfanilamide
|
A sulfonamide in which the sulfamoyl functional group is attached to aniline at the 4-position.
|
|
4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium
|
|
|
Nifedipine
|
A dihydropyridine that has formula C17H18N2O6.
|
|
Phendimetrazine
|
|
|
Letrozole
|
A triazole that has formula C17H11N5.
|
|
Naloxone
|
A morphinane alkaloid that has formula C19H21NO4.
|
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea
|
|
|
CRA_7806
|
|
|
Agomelatine
|
|
|
Vildagliptin
|
|
|
4-amino-N-[4-(benzyloxy)phenyl]butanamide
|
|
|
N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine
|
|
|
Roxatidine acetate
|
|
|
VEC-162
|
|
|
Oxycodone
|
An organic heteropentacyclic compound that has formula C18H21NO4.
|
|
Emtricitabine
|
|
|
Acebutolol
|
An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
|
|
2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
|
|
|
2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE
|
A thiadiazole that has formula C13H15N5O2S2.
|
|
Geldanamycin
|
A 19-membered macrocyle incorporating a benzoquinone ring and a lactam functionality. it is an ansamycin antibiotic and thus shows antimicrobial activity against many gram-positive and some gram-negative bacteria.
|
|
2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide
|
|
|
Teduglutide
|
A 33-membered polypeptide consisting of His, Gly, Asp, Gly, Ser, Phe, Ser, Asp, Glu, Met, Asn, Thr, Ile, Leu, Asp, Asn, Leu, Ala, Ala, Arg, Asp, Phe, Ile, Asn, Trp, Leu, Ile, Gln, Thr, Lys, Ile, Thr and Asp residues joined in sequence. A glucagon-like peptide-2 receptor agonist used for the treatment of short-bowel syndrome.
|
|
N-Acetyl-D-glucosamine
|
The pyranose form of N-acetyl-D-glucosamine.
|
|
2'-Deoxyadenosine 5'-Triphosphate
|
|
|
1-Beta-Ribofuranosyl-1,3-Diazepinone
|
|
|
rhIGFBP-3
|
|
|
'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine
|
|
|
3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL
|
|
|
5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one
|
|
|
2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol
|
|
|
6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE
|
|
|
Azatadine
|
|
|
Infliximab
|
|
|
P-Anisic Acid
|
|
|
Uridine
|
|
|
(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE
|
|
|
4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one
|
|
|
Glyburide
|
An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
|
|
2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone
|
|
|
Eptifibatide
|
|
|
(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
|
|
|
ISIS 113715
|
|
|
N-Benzyl-4-Sulfamoyl-Benzamide
|
|
|
Penicillamine
|
|
|
N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane
|
|
|
Oxiconazole
|
|
|
N-Propyl-Tartramic Acid
|
|
|
1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole
|
|
|
5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine
|
|
|
9-Deazainosine
|
|
|
Etoposide
|
A furonaphthodioxole that has formula C29H32O13.
|
|
N6-METHYL-(R)-ROSCOVITINE, R-2-[6-(BENZYL-METHYL-AMINO)-9-ISOPROPYL-9H-PURIN-2-YLAMINO]-BUTAN-1-OL
|
|
|
Palmitic Acid
|
A straight-chain, sixteen-carbon, saturated long-chain fatty acid.
|
|
(1S,6R)-3-{[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]CARBONYL}-6-(2,4,5-TRIFLUOROPHENYL)CYCLOHEX-3-EN-1-AMINE
|
|
|
Banoxantrone
|
|
|
N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide
|
|
|
(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID
|
|
|
D-Tryptophan
|
The D-enantiomer of tryptophan.
|
|
4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide
|
|
|
MLN-1202
|
|
|
FARNESYL THIOPYROPHOSPHATE
|
|
|
2-Carboxyethylphosphonic Acid
|
|
|
(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE
|
A pyrrolidin-2-one that has formula C18H24ClN3O5S2.
|
|
Ponatinib
|
A benzamide obtained by the formal condensation of the carboxy group of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylbenzoic acid with the anilino group of 4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)aniline.
|
|
Antihemophilic Factor
|
|
|
Ivacaftor
|
|
|
4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID
|
|
|
2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE
|
|
|
7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN
|
|
|
Liothyronine
|
|
|
Prasugrel
|
|
|
Cisapride
|
The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
|
|
Cortisone acetate
|
A corticosteroid hormone that has formula C23H30O6.
|
|
Cilazapril
|
|
|
(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL
|
|
|
ADX10059
|
|
|
L-Leucine
|
The L-enantiomer of leucine.
|
|
P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid
|
|
|
Acetophenazine
|
|
|
Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate
|
|
|
(1R)-1,2,2-TRIMETHYLPROPYL (S)-METHYLPHOSPHINATE
|
|
|
(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE
|
|
|
ketoprofen transdermal patch
|
|
|
GM6001
|
|
|
Metipranolol
|
3-(Propan-2-ylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by a 4-acetoxy-2,3,5-trimethylphenoxy group. A non-cardioselective beta-blocker, it is used to lower intra-ocular pressure in the management of open-angle glaucoma.
|
|
Maleic Acid
|
A butenedioic acid in which the double bond has cis- (Z)-configuration.
|
|
Dobutamine
|
A catecholamine that is 4-(3-aminobutyl)phenol in which one of the hydrogens attached to the nitrogen is substituted by a 2-(3,4-dihydroxyphenyl)ethyl group. A beta1-adrenergic receptor agonist that has cardiac stimulant action without evoking vasoconstriction or tachycardia, it is used as the hydrochloride to increase the contractility of the heart in the management of acute heart failure.
|
|
Natural alpha interferon
|
|
|
SPP 301
|
|
|
Cerivastatin
|
(3R,5S)-3,5-dihydroxyhept-6-enoic acid in which the (7E)-hydrogen is substituted by a 4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl group. Formerly used (as its sodium salt) to lower cholesterol and prevent cardiovascular disease, it was withdrawn from the market worldwide in 2001 following reports of a severe form of muscle toxicity.
|
|
Tositumomab
|
|
|
Afelimomab
|
|
|
Dexfenfluramine
|
|
|
Alogliptin
|
A piperidine that is 3-methyl-2,4-dioxo-3,4-dihydropyrimidine carrying additional 2-cyanobenzyl and 3-aminopiperidin-1-yl groups at positions 1 and 2 respectively (the R-enantiomer). Used in the form of its benzoate salt for treatment of type 2 diabetes.
|
|
Chenodeoxycholic acid
|
A dihydroxy-5beta-cholanic acid that is (5beta)-cholan-24-oic acid substituted by hydroxy groups at positions 3 and 7 respectively.
|
|
2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide
|
|
|
3-(10-METHYL-ANTHRACEN-9-YL)-PROPIONIC ACID
|
|
|
(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM
|
|
|
Thiotepa
|
|
|
N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide
|
|
|
Clomifene
|
|
|
5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE
|
|
|
Fosinopril
|
A phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. It is used for the treatment of hypertension and heart failure. A pro-drug, it is hydrolysed in vivo to the corresponding phosphininc acid, fosinoprilat, which is the active metabolite.
|
|
Flecainide
|
|
|
Insulin Detemir
|
|
|
Enprofylline
|
Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
|
|
Proguanil
|
|
|
TAK-390MR
|
|
|
Cysteamine
|
|
|
9-(4-HYDROXY-2,6-DIMETHYL-PHENYL)-3,7-DIMETHYL-NONA-4,6,8-TRIENOIC ACID
|
|
|
CEP-1347
|
|
|
N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine
|
|
|
Trifluoroacetonyl Coenzyme A
|
|
|
Vindesine
|
|
|
N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE
|
|
|
Diltiazem
|
A 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate in which both stereocentres have S configuration. A calcium-channel blocker and vasodilator, it is used as the hydrochloride in the management of angina pectoris and hypertension.
|
|
Bis-Napthyl Beta-Ketophosphonic Acid
|
|
|
Gefitinib
|
|
|
Roflumilast
|
|
|
Cis-4-Cyano-4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]Cyclohexanecarboxylic Acid
|
|
|
Lactose
|
|
|
Fludrocortisone
|
A mineralocorticoid that has formula C21H29FO5.
|
|
CP-526423
|
|
|
Malonate Ion
|
|
|
Nandrolone decanoate
|
A steroid ester that has formula C28H44O3.
|
|
AE-941
|
|
|
1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID
|
|
|
Alfentanil
|
A member of the class of piperidines that is piperidine having a 2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl group at the 1-position as well as N-phenylpropanamido- and methoxymethyl groups at the 4-position.
|
|
[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid
|
|
|
N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE
|
|
|
Levorphanol
|
|
|
Ethyl Dihydrogen Phosphate
|
A monoalkyl phosphate epitope having ethyl as the alkyl group.
|
|
6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid
|
|
|
4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
|
|
|
ANISOMYCIN
|
An antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system.
|
|
4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose
|
|
|
4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE
|
|
|
Procyclidine
|
|
|
Benzoylformic Acid
|
|
|
(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine
|
|
|
N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE
|
|
|
4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE
|
|
|
Fidarestat(Stereoisomer)
|
|
|
L-Alanine
|
The L-enantiomer of alanine.
|
|
(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one
|
|
|
Epinastine
|
A benzazepine that is 6,11-dihydro-5H-dibenzo[b,e]azepine in which the azepine ring is fused to the e side of 4,5-dihydro-1H-imidazol-2-amine.
|
|
L-Carnitine
|
|
|
(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE
|
|
|
Domoic Acid
|
A L-proline derivative that is L-proline substituted by a carboxymethyl group at position 3 and a 6-carboxyhepta-2,4-dien-2-yl group at position 4. It is an analog of kainic acid and is the neurotoxin associated with the amnesic shellfish poisoning (ASP).
|
|
Ancrod
|
|
|
(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid
|
|
|
Desmoteplase
|
|
|
Vapreotide
|
|
|
Sulfamethazine
|
|
|
Vitamin A
|
A group of fat-soluble retinoids produced via metabolism of provitamin A carotenoids. Vitamin A is involved in immune function, vision, reproduction, and cellular communication.
|
|
Delavirdine
|
|
|
1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide
|
|
|
Valproic Acid
|
A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
|
|
Ethinamate
|
|
|
Streptozocin
|
|
|
[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID
|
A piperidine that has formula C19H22N2O4S.
|
|
Inosinic Acid
|
|
|
Fluticasone Propionate
|
A trifluorinated corticosteroid that consits of 6alpha,9-difluoro-11beta,17alpha-dihydroxy-17beta-{[(fluoromethyl)sulfanyl]carbonyl}-16-methyl-3-oxoandrosta-1,4-diene bearing a propionyl substituent at position 17; has anti-inflammatory, anti-asthmatic and anti-allergic activity.
|
|
XL418
|
|
|
METHOXYUNDECYLPHOSPHINIC ACID
|
|
|
Dofetilide
|
|
|
3-Mercuri-4-Aminobenzenesulfonamide
|
An arylmercury compound that has formula C6H7HgN2O2S.
|
|
N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE
|
|
|
Beta-(2-Naphthyl)-Alanine
|
|
|
4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid
|
|
|
Zoledronate
|
|
|
1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL
|
|
|
AS-3201
|
|
|
1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)
|
|
|
Cromoglicic acid
|
|
|
DDP733
|
|
|
6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID
|
|
|
Trifluoroethanol
|
|
|
S-Benzyl-Glutathione
|
|
|
Cabozantinib
|
|
|
9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
|
|
|
2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400
|
|
|
2'-Deoxycytidine
|
|
|
Aminoglutethimide
|
|
|
Atazanavir
|
|
|
2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE
|
|
|
Talampanel
|
A benzodioxole that has formula C19H19N3O3.
|
|
(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL
|
|
|
gabapentin enacarbil
|
A carbamate ester that is the N-[1-(isobutyryloxy)ethoxy]carbonyl derivative of [1-(aminomethyl)cyclohexyl]acetic acid. The prodrug for gabapentin, used for treatment of neuropathic pain and restless legs syndrome.
|
|
3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile
|
|
|
GALACTOSE GREASE
|
|
|
UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE
|
|
|
4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile
|
|
|
SB220025
|
Am member of the class of imidazoles carrying piperidin-4-yl, 4-fluophenyl and 2-aminopyrimidin-4-yl substituents at posiitons 1, 4 and 5 respectively.
|
|
R450
|
|
|
Cintredekin Besudotox
|
|
|
(R,R)-2,3-Butanediol
|
|
|
1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE
|
|
|
L-Phenylalanine
|
The L-enantiomer of phenylalanine.
|
|
TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL
|
|
|
Ethyl Oxo(Piperidin-1-Yl)Acetate
|
A N-acylpiperidine that has formula C9H15NO3.
|
|
(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE
|
|
|
Fructose
|
A ketohexose that is an isomer of glucose.
|
|
Bromocriptine
|
An indole alkaloid that has formula C32H40BrN5O5.
|
|
N,N-dimethylarginine
|
|
|
N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide
|
A N-acylpyrrolidine that has formula C19H33N3O4S.
|
|
4-(1,3-BENZOXAZOL-2-YL)-2,6-DIBROMOPHENOL
|
|
|
Cytidine
|
A pyrimidine nucleoside in which cytosine is attached to ribofuranose via a beta-N(1)-glycosidic bond.
|
|
6-Carboxymethyluracil
|
|
|
N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE
|
|
|
Chlorambucil
|
|
|
Uracil
|
|
|
Candoxatril
|
The 2,3-dihydro-1H-inden-5-yl ester of the active enantiomer of candoxatrilat. Candoxatril is an orally active prodrug of candoxatrilat, a potent neutral endopeptidase (NEP, neprilysin) inhibitor used in the treatment of chronic heart failure.
|
|
(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one
|
|
|
Lenalidomide
|
|
|
Mitoxantrone
|
A hydroxyanthraquinone that has formula C22H28N4O6.
|
|
Podofilox
|
|
|
Neramexane
|
|
|
SNX-5422
|
|
|
methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate
|
|
|
Thyrotropin Alfa
|
|
|
Phenmetrazine
|
|
|
Phylloquinone
|
A member of the class of phylloquinones that consists of 1,4-naphthoquinone having methyl and phytyl groups at positions 2 and 3 respectively. The parent of the class of phylloquinones.
|
|
N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID
|
|
|
Midodrine
|
An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
|
|
Ovalicin
|
|
|
3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL
|
|
|
Mercuribenzoic Acid
|
|
|
Pasireotide
|
|
|
3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID
|
|
|
(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL
|
A gamma-aminobutyric acid-based hapten where a 4-substituted benzoyl group is attached to nitrogen.
|
|
(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL
|
|
|
3-Sulfinoalanine
|
|
|
2-Deoxy-Glucose-6-Phosphate
|
|
|
Carfentanil
|
|
|
Velaglucerase alfa
|
|
|
N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide
|
|
|
(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium
|
|
|
L-Methionine
|
The L-enantiomer of methionine.
|
|
Suramin
|
|
|
N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE
|
|
|
Nimesulide
|
|
|
4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
|
|
|
5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole
|
|
|
2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One
|
|
|
6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE
|
|
|
3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol
|
A pyrazolopyrimidine that has formula C15H17N5O.
|
|
RTA 744
|
|
|
Levamisole
|
|
|
Ribavirin
|
A 1-ribosyltriazole that is the 1-ribofuranosyl derivative of 1,2,4-triazole-3-carboxamide. An inhibitor of HCV polymerase.
|
|
6-Aminohexyl-Uridine-C1,5'-Diphosphate
|
|
|
CAT-213
|
|
|
ZK-806711
|
|
|
Hypoxanthine
|
A purine nucleobase that consists of purine bearing an oxo substituent at position 6.
|
|
NGX267
|
|
|
Aminomethylcyclohexane
|
|
|
Adenosine-5'-Ditungstate
|
|
|
Recombinant alpha 1-antitrypsin
|
|
|
Anistreplase
|
|
|
Epratuzumab
|
|
|
[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL
|
|
|
Trimethoprim
|
An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
|
|
AMD-070
|
|
|
PTI-901
|
|
|
4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE
|
|
|
Carboprost Tromethamine
|
The tromethamine salt of carboprost. It is used as an abortifacient agent that is effective in both the first and second trimesters of pregnancy.
|
|
Zanapezil
|
|
|
5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE
|
|
|
Cytidine-2'-Monophosphate
|
|
|
Piboserod
|
|
|
(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE
|
An aminopiperidine that has formula C20H19F3N2O3.
|
|
PNU177836
|
|
|
(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione
|
An organoiodine compound that has formula C4H5IN2O2.
|
|
Cefalotin
|
A semisynthetic, first-generation cephalosporin antibiotic with acetoxymethyl and (2-thienylacetyl)nitrilo moieties at positions 3 and 7, respectively, of the core structure. Administered parenterally during surgery and to treat a wide spectrum of blood infections.
|
|
(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC
|
|
|
AZD-9684
|
|
|
Alsterpaullone
|
|
|
Serum albumin iodonated
|
|
|
N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE
|
|
|
Thionicotinamide-Adenine-Dinucleotide
|
|
|
5-iodotubercidin
|
An organoiodine compound that has formula C11H13IN4O4.
|
|
Belimumab
|
|
|
7-Methyl-Guanosine-5'-Triphosphate
|
|
|
N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE
|
|
|
(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL
|
|
|
8-azaguanine
|
A triazolopyrimidine that consists of 3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidine bearing amino and oxo substituents at positions 5 and 7 respectively.
|
|
Grn163l
|
|
|
Amobarbital
|
|
|
(E)-[4-(3,5-difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol
|
|
|
(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE
|
A N-carbonyldiazepane that has formula C16H20F3N3O2.
|
|
5'-Deoxy-5'-Methylthioadenosine
|
|
|
(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE
|
|
|
GSHNA
|
|
|
Ranitidine
|
A member of the class of furans used to treat peptic ulcer disease (PUD) and gastroesophageal reflux disease.
|
|
Diethylstilbestrol
|
|
|
Thalidomide
|
|
|
Dacarbazine
|
A monocarboxylic acid amide that is 1H-imidazole-4-carboxamide which is substituted at position 5 by a 3,3-dimethyltriaz-1-en-1-yl group. It is used for the treatment of metastatic malignant melanoma, and in combination with other drugs for the treatment of Hodgkin's disease and soft-tissue sarcoma.
|
|
Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate
|
|
|
Codeine
|
A morphinane alkaloid found in the opium poppy, Papaver somniferum var. album; has analgesic, anti-tussive and anti-diarrhoeal properties.
|
|
(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone
|
|
|
(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE
|
|
|
4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE
|
|
|
3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID
|
A phthalazine that has formula C19H12F3N3O3S.
|
|
[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile
|
|
|
Prochlorperazine
|
A member of the class of phenothiazines that is 10H-phenothiazine having a chloro substituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.
|
|
Milrinone
|
A member of the class of bipyridines that is 2-pyridone which is substituted at positions 3, 5, and 6 by cyano, pyrid-4-yl, and methyl groups, respectively. It is used (particularly intravenously, as the lactate) for the short-term management of severe heart failure.
|
|
(1-HYDROXYDODECANE-1,1-DIYL)BIS(PHOSPHONIC ACID)
|
|
|
N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE
|
A pyrrolopyridine that has formula C24H24N6O.
|
|
3-(BUTYLSULPHONYL)-PROPANOIC ACID
|
|
|
Polythiazide
|
|
|
4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE
|
A thiomorpholine that has formula C17H23N3O5S2.
|
|
CDX-110
|
|
|
Sulpiride
|
|
|
Cetuximab
|
|
|
(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE
|
|
|
N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide
|
|
|
Isocitric Acid
|
A tricarboxylic acid that is propan-1-ol with a hydrogen at each of the 3 carbon positions substituted with a carboxy group.
|
|
Quinidine
|
A cinchona alkaloid consisting of cinchonine with the hydrogen at the 6-position of the quinoline ring substituted by methoxy.
|
|
2-Bromoacetyl Group
|
|
|
Alpha-D-Mannose-6-Phosphate
|
The alpha-anomer of D-mannose 6-phosphate.
|
|
(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid
|
|
|
Equilin
|
A 17-oxo steroid that has formula C18H20O2.
|
|
N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide
|
|
|
Albendazole
|
|
|
Ergoloid mesylate
|
A mixture of hydrogenated ergot alkaloids consisting of the methanesulfonic acid salts of dihydroergocornine (R = CHMe2), dihydroergocristine (R = CH2Ph), and alpha- and beta-dihydroergocryptine (R = CH2CHMe2 and CH(Me)Et, respectively). It is used for the symptomatic treatment of mild to moderate dementia in the elderly, although its value is not established.
|
|
Isatoic Anhydride
|
|
|
Remoxipride
|
|
|
Meclizine
|
|
|
Purine Riboside
|
|
|
Phenindamine
|
|
|
N-Heptylformamide
|
|
|
5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine
|
|
|
Pralatrexate
|
|
|
6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL
|
|
|
1,4-Diethylene Dioxide
|
|
|
2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid
|
An amidopiperidine that has formula C40H35N2O6P.
|
|
12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one
|
|
|
2(S)-Amino-6-Boronohexanoic Acid
|
|
|
NADH
|
A coenzyme found in all living cells; consists of two nucleotides joined through their 5'-phosphate groups, with one nucleotide containing an adenine base and the other containing nicotinamide.
|
|
Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate
|
|
|
Antipyrine
|
A member of the class of pyrazoles that is 1,2-dihydropyrazol-3-one substituted with methyl groups at C-1 and C-5 and with a phenyl group at N-2.
|
|
Lamivudine
|
|
|
Melphalan
|
A phenylalanine derivative comprising L-phenylalanine having [bis(2-chloroethyl)amino group at the 4-position on the phenyl ring.
|
|
OSI-461
|
|
|
Mant-Adp
|
|
|
Lornoxicam
|
|
|
2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID
|
|
|
7-methyl-guanosine-5'-triphosphate-5'-guanosine
|
|
|
Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide
|
|
|
Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside
|
|
|
Pralnacasan
|
|
|
3-phenyl-5-(1H-pyrazol-3-yl)isoxazole
|
|
|
2-Deoxy-2-Fluoro-Alpha-D-Mannosyl Fluoride
|
|
|
Coproporphyrin Iii
|
A coproporphyrin that has formula C36H38N4O8.
|
|
Mephenytoin
|
|
|
1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE
|
|
|
Heroin
|
|
|
N-(pyridin-3-ylmethyl)aniline
|
|
|
5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-SULFONAMIDE
|
A pyrrolidin-2-one that has formula C19H23ClN4O5S.
|
|
Methoxyflurane
|
|
|
3[N-Morpholino]Propane Sulfonic Acid
|
A Good's buffer substance, pKa = 7.2 at 20 degreeC.
|
|
Metyrosine
|
|
|
2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE
|
|
|
VX-702
|
|
|
4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide
|
|
|
[3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid
|
|
|
N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine
|
|
|
Ipratropium bromide
|
The anhydrous form of the bromide salt of ipratropium. An anticholinergic drug, ipratropium bromide blocks the muscarinic cholinergic receptors in the smooth muscles of the bronchi in the lungs. This opens the bronchi, so providing relief in chronic obstructive pulmonary disease and acute asthma.
|
|
METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE
|
|
|
(R)-Mesopram
|
|
|
LY249543
|
|
|
4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol
|
|
|
Preotact
|
|
|
3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol
|
|
|
Propanoic Acid
|
|
|
Sucrose
|
Sucrose is a disaccharide formed by glucose and fructose units joined by an acetal oxygen bridge from hemiacetal of glucose to the hemiketal of the fructose.
|
|
Protriptyline
|
An organic tricyclic compound that has formula C19H21N.
|
|
XL147
|
A sulfonamide that is the N-4-toluenesulfonyl (N-tosyl) derivative of N-(2,1,3-benzothiadiazol-5-yl)quinoxaline-2,3-diamine. A selective PI3K inhibitor used in cancer treatment.
|
|
Phenazopyridine
|
|
|
N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE
|
A morpholine that has formula C19H26F4N4O4S.
|
|
2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine
|
|
|
Diprenorphine
|
A morphinane alkaloid that has formula C26H35NO4.
|
|
N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide
|
|
|
YSIL6
|
|
|
N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide
|
|
|
OspA lipoprotein
|
|
|
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane
|
|
|
Cycloserine
|
|
|
Vancomycin
|
A complex glycopeptide from Streptomyces orientalis. It inhibits a specific step in the synthesis of the peptidoglycan layer in the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile.
|
|
Doxapram
|
A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
|
|
(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid
|
|
|
DN-101
|
|
|
1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE
|
A 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole that is the (S)-enantiomer of econazole.
|
|
Methotrimeprazine
|
|
|
N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide
|
|
|
GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE
|
|
|
HE2000
|
|
|
(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
|
|
|
2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE
|
|
|
ONO-2506
|
|
|
2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile
|
|
|
1,6-Fructose Diphosphate (Linear Form)
|
|
|
3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol
|
|
|
Molindone
|
|
|
Niacin
|
|
|
1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID
|
|
|
Leucovorin
|
|
|
Aminolevulinic acid
|
|
|
PF-00356231
|
|
|
Bentiromide
|
|
|
(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
|
|
|
Fentanyl
|
The carboxamide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
|
|
Phosphorylisopropane
|
|
|
Benzphetamine
|
Dextroamphetamine in which the the hydrogens attached to the amino group are substituted by a methyl and a benzyl group. A sympathomimetic agent with properties similar to dextroamphetamine, it is used as its hydrochloride salt in the treatment of obesity.
|
|
Phencyclidine
|
A member of the class of piperidines that is piperidine in which the nitrogen is substituted with a 1-phenylcyclohexyl group. Formerly used as an anaesthetic agent, it exhibits both hallucinogenic and neurotoxic effects.
|
|
Esomeprazole
|
A 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole that has S configuration at the sulfur atom. An inhibitor of gastric acid secretion, it is used (generally as its sodium or magnesium salt) for the treatment of gastro-oesophageal reflux disease, dyspepsia, peptic ulcer disease, and Zollinger-Ellison syndrome.
|
|
2-Isobutyl-3-Methoxypyrazine
|
|
|
N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE
|
|
|
Acetaminophen
|
|
|
HOMOPHENYLALANINYLMETHANE
|
|
|
Pregabalin
|
|
|
3-AMINO-AZACYCLOTRIDECAN-2-ONE
|
|
|
Diphenylacetic Acid
|
A monocarboxylic acid that is acetic acid where the methyl hydrogens have been replaced by two phenyl groups respectively.
|
|
3-(4-nitrophenyl)-1H-pyrazole
|
|
|
(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE
|
|
|
Procaine
|
A benzoate ester, formally the result of esterification of 4-aminobenzoic acid with 2-diethylaminoethanol but formed experimentally by reaction of ethyl 4-aminobenzoate with 2-diethylaminoethanol.
|
|
Tapentadol
|
|
|
Bafilomycin A1
|
The most used of the bafilomycins, a family of toxic macrolide antibiotics derived from Streptomyces griseus.
|
|
Citalopram
|
A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
|
|
Panitumumab
|
|
|
Galantamine
|
|
|
Actelion-1
|
|
|
Dactinomycin
|
|
|
1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea
|
|
|
SGS518
|
|
|
Ropivacaine
|
The piperidinecarboxamide obtained by the formal condensation of N-propylpipecolic acid and 2,6-dimethylaniline.
|
|
Sodium stibogluconate
|
|
|
P-Nitrophenol
|
|
|
Hydroxocobalamin
|
A cobalamin that has formula C62H89CoN13O15P.
|
|
Salbutamol
|
|
|
3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE
|
A maleimide that has formula C27H26N4O2.
|
|
4-Phenylbutylamine
|
|
|
(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE
|
|
|
Carbinoxamine
|
An organochlorine compound that is 2-(4-chlorobenzyl)pyridine in which one of the benzylic hydrogens is substituted by 2-(dimethylamino)ethoxy group. It is an ethanolamine-type antihistamine, used as its maleate salt for treating hay fever, as well as mild cases of Parkinson's disease.
|
|
5-(AMINOCARBONYL)-1,1':4',1''-TERPHENYL-3-CARBOXYLICACID
|
|
|
Ethyl carbamate
|
A carbamate ester obtained by the formal condensation of ethanol with carbamic acid. It has been found in alcoholic beverages.
|
|
Dimethyl Propionate Ester Heme
|
|
|
CRA-024781
|
|
|
Epicept NP-1
|
|
|
Hydroxyaminovaline
|
|
|
Benzylcysteine
|
|
|
Debromohymenialdisine
|
|
|
2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline
|
|
|
CCX915
|
|
|
4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE
|
|
|
N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE
|
|
|
3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one
|
|
|
Methadyl Acetate
|
|
|
9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE
|
|
|
N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE
|
|
|
CRA_8696
|
|
|
BIPHENYL-4-YL-ACETALDEHYDE
|
|
|
NRP409
|
|
|
Apomorphine
|
|
|
Methylumbelliferyl Chitotriose
|
|
|
Dcka, 5,7-Dichlorokynurenic Acid
|
|
|
PCK3145
|
|
|
Secretin
|
|
|
Thiorphan
|
A N-acyl-amino acid that has formula C12H15NO3S.
|
|
4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid
|
|
|
4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
|
|
|
2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One
|
An aminopyrrolidine that has formula C9H18N2O.
|
|
3-HYDROXYPROPYL 3-[({7-[AMINO(IMINO)METHYL]-1-NAPHTHYL}AMINO)CARBONYL]BENZENESULFONATE
|
|
|
Fusidic Acid
|
A steroid antibiotic that is isolated from the fermentation broth of Fusidium coccineum.
|
|
Balsalazide
|
A monohydroxybenzoic acid consisting of 5-aminosalicylic acid (mesalazine) linked to 4-aminobenzoyl-beta-alanine via an azo bond.
|
|
Migalastat
|
|
|
Quinidine barbiturate
|
|
|
XL228
|
|
|
Decitabine
|
|
|
Gemcitabine
|
A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer.
|
|
2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE
|
|
|
[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER
|
A thiadiazole that has formula C19H18N4O3S2.
|
|
18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE
|
|
|
Doxycycline
|
Tetracycline in which the 5beta-hydrogen is replaced by a hydroxy group, while the 6alpha-hydroxy group is replaced by hydrogen. A semi-synthetic tetracycline antibiotic, it is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with chronic obstructive pulmonary disease (COPD), and adult periodontitis.
|
|
5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE
|
A member of the class of barbiturates that is barbituric acid in which the hydrogens at position 5 are replaced by 2-ethoxyethyl and 4-(4-fluorophenoxy)phenoxy groups. It is a potent and selective inhibitor of matrix MMP-13 (metalloproteinase-13, collagenase 3).
|
|
Phthalic Acid
|
A benzenedicarboxylic acid cosisting of two carboxy groups at ortho positions.
|
|
Tridihexethyl
|
|
|
Pyroglutamic Acid
|
|
|
Methotrexate
|
A pteridine that has formula C20H22N8O5.
|
|
Abciximab
|
|
|
Ganaxolone
|
|
|
LM-609
|
|
|
Tolterodine
|
A tertiary amine that has formula C22H31NO.
|
|
PICEATANNOL
|
A stilbenol that has formula C14H12O4.
|
|
L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide
|
|
|
Lercanidipine
|
|
|
Antazoline
|
|
|
Tripelennamine
|
|
|
N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE
|
|
|
Oxandrolone
|
An oxa-steroid that has formula C19H30O3.
|
|
(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE
|
|
|
Nelarabine
|
|
|
Gadopentetate dimeglumine
|
|
|
2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid
|
|
|
Meprobamate
|
|
|
4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol
|
|
|
5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide
|
|
|
5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine
|
|
|
FR117016
|
|
|
MAP-0004
|
|
|
Tetrafluoroaluminate Ion
|
|
|
6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE
|
|
|
Becaplermin
|
|
|
Carteolol
|
A quinolone that has formula C16H24N2O3.
|
|
(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol
|
|
|
5'-deoxy-5'-piperidin-1-ylthymidine
|
|
|
Sildenafil
|
|
|
HuMax-EGFr
|
|
|
2'-Deoxyguanosine-5'-Triphosphate
|
|
|
Piperacillin
|
A penicillin that has formula C23H27N5O7S.
|
|
Chlorotrianisene
|
|
|
Flurbiprofen
|
A fluorobiphenyl that has formula C15H13FO2.
|
|
4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE
|
A N-methylpiperazine that has formula C12H19N5O2S2.
|
|
PRLX 93936
|
|
|
{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID
|
|
|
(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone
|
|
|
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide
|
|
|
6-Fluoro-2-(2'-Fluoro-1,1'-Biphenyl-4-Yl)-3-Methylquinoline-4-Carboxylic Acid
|
|
|
5'-O-(N-Ethyl-Sulfamoyl)Adenosine
|
|
|
L-Phospholactate
|
|
|
Feruloyl Coenzyme A
|
|
|
Butorphanol
|
Levorphanol in which a hydrogen at position 14 of the morphinan skeleton is substituted by hydroxy and one of the hydrogens of the N-methyl group is substituted by cyclopropyl. A semi-synthetic opioid agonist-antagonist analgesic, it is used as its (S,S)-tartaric acid salt for relief or moderate to severe pain.
|
|
Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam
|
|
|
Cefazolin
|
A cephalosporin compound having [(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl and (1H-tetrazol-1-ylacetyl)amino side-groups.
|
|
(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium
|
|
|
N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine
|
|
|
Alprostadil
|
|
|
N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine
|
|
|
99mTc-14 F7 Mab
|
|
|
N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE
|
|
|
1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA
|
A pyrazine that has formula C14H12ClN5O3.
|
|
Decamethonium
|
A quaternary ammonium ion that is a depolarising muscle relaxant whose structure comprises a decane-1,10-diamine core in which each amino group carries three methyl substituents.
|
|
[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE
|
|
|
Clozapine
|
A benzodiazepine that is 5H-dibenzo[b,e][1,4]diazepine substituted by a chloro group at position 8 and a 4-methylpiperazin-1-yl group at position 11. It is a second generation antipsychotic used in the treatment of psychiatric disorders like schizophrenia.
|
|
Doxorubicin
|
An anthracycline antibiotic that has formula C27H29NO11.
|
|
Ethoxzolamide
|
1,3-Benzothiazole substituted a sulfonamide and an ethoxy group at positions 2 and 6, respectively. A carbonic anhydrase inhibitor, it has been used in the treatment of glaucoma, and as a diuretic.
|
|
Clobetasol propionate
|
The 17-O-propionate ester of clobetasol. A potent corticosteroid, it is used to treat various skin disorders, including exzema and psoriasis.
|
|
Talbutal
|
|
|
1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea
|
|
|
N-[Amino(Imino)Methyl]Glycine
|
|
|
Duloxetine
|
|
|
1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE
|
|
|
Flurandrenolide
|
|
|
N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea
|
|
|
3,5-Dinitrocatechol
|
|
|
PCL-016
|
|
|
(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE
|
|
|
Ruxolitinib
|
|
|
Gamma(Amino)-Butyric Acid
|
A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
|
|
Rimexolone
|
|
|
10-Propargyl-5,8-Dideazafolic Acid
|
|
|
2-(1,1'-Biphenyl-4-Yl)Propanoic Acid
|
|
|
Cabergoline
|
An N-acylurea that is (8R)-ergoline-8-carboxamide in which the hydrogen attached to the piperidine nitrogen (position 6) is substituted by an allyl group and the hydrogens attached to the carboxamide nitrogen are substituted by a 3-(dimethylamino)propyl group and an N-ethylcarbamoyl group. A dopamine D2 receptor agonist, cabergoline is used in the management of Parkinson's disease and of disorders associated with hyperprolactinaemia.
|
|
PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)
|
|
|
L-Tryptophanamide
|
An amino acid amide that is the carboxamide of L-tryptophan.
|
|
3'-THIO-THYMIDINE-5'-PHOSPHATE
|
|
|
Oxybuprocaine
|
A benzoate ester in which 4-amino-3-butoxybenzoic acid and 2-(diethylamino)ethanol have combined to form the ester bond; an ester-based local anaesthetic (ester caine) used especially in ophthalmology and otolaryngology.
|
|
Estramustine
|
|
|
1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea
|
|
|
Trimipramine
|
A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)-2-methylpropyl group at the nitrogen atom. It is used as an antidepressant.
|
|
Sumatriptan
|
A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family).
|
|
MMI-175
|
|
|
1,2,4-Triazole
|
|
|
1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE
|
|
|
Glipizide
|
|
|
2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID
|
|
|
OPC-6535
|
|
|
(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol
|
|
|
RU85053
|
|
|
Bb-3497
|
|
|
Canagliflozin
|
A C-glycosyl compound that is used (in its hemihydrate form) for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2.
|
|
3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid
|
|
|
Doxepin
|
A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
|
|
3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide
|
|
|
1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine
|
A phenylpyridine that has formula C25H26N4O4S.
|
|
Floxuridine
|
|
|
Lithium
|
An alkali metal atom that has formula Li.
|
|
4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME
|
|
|
Mexiletine
|
An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
|
|
Tetrahydrofolic acid
|
A group of heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with one or more L-glutamic acid units.
|
|
Bufotenine
|
|
|
Acetoacetyl-Coenzyme A
|
|
|
Aminosalicylic Acid
|
|
|
LGD2941
|
|
|
D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide
|
|
|
3,4-Dihydroxy-1-Methylquinolin-2(1h)-One
|
|
|
L-Valine
|
The L-enantiomer of valine.
|
|
Butalbital
|
A member of the class of barbiturates that is barbituric acid in which the hydrogens at position 5 are substituted by an allyl group and an isobutyl group. Frequently combined with other medicines, such as aspirin, paracetamol and codeine, it is used for treatment of pain and headache.
|
|
(Diaminomethyl-Methyl-Amino)-Acetic Acid
|
|
|
Bromazepam
|
|
|
MPC-7869
|
|
|
Denufosol
|
|
|
1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea
|
|
|
3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE
|
|
|
THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)
|
|
|
Oxytocin
|
A cyclic nonapeptide hormone with amino acid sequence CYIQNCPLG that also acts as a neurotransmitter in the brain; the principal uterine-contracting and milk-ejecting hormone of the posterior pituitary. Together with the neuropeptide vasopressin, it is believed to influence social cognition and behaviour.
|
|
Tioconazole
|
|
|
Obinutuzumab
|
|
|
Dolutegravir
|
A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (4R,12aS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid with the amino group of 2,4-difluorobenzylamine. Used (as its sodium salt) for treatment of HIV-1.
|
|
AC-(D)PHE-PRO-BOROHOMOLYS-OH
|
|
|
methyl L-phenylalaninate
|
An alpha-amino acid ester that is the methyl ester of L-phenylalanine.
|
|
1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE
|
|
|
4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde
|
|
|
2-NAPHTHALENESULFONIC ACID
|
|
|
(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE
|
|
|
3'-Azido-3'-Deoxythymidine-5'-Diphosphate
|
|
|
N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE
|
|
|
T-1249
|
|
|
Procarbazine
|
|
|
Lactic Acid
|
|
|
Progesterone
|
A C21-steroid hormone in which a pregnane skeleton carries oxo substituents at positions 3 and 20 and is unsaturated at C(4)-C(5). As a hormone, it is involved in the female menstrual cycle, pregnancy and embryogenesis of humans and other species.
|
|
Methyl aminolevulinate
|
|
|
Micafungin
|
|
|
Phosphomethylphosphonic Acid-Guanylate Ester
|
|
|
4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID
|
|
|
Crc200 (Chiron-Behring)
|
|
|
CNTO 1275
|
|
|
Fluorotryptophane
|
|
|
oportuzumab monatox
|
|
|
PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER
|
|
|
RHIIP
|
|
|
1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
A pyrrolopyridine that has formula C17H17N7.
|
|
N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide
|
|
|
Methyl Mercury Ion
|
|
|
Naphthalen-1-Yl-Acetic Acid
|
A naphthylacetic acid substituted by a carboxymethyl group at position 1.
|
|
Etomidate
|
The ethyl ester of 1-[(1R)-1-phenylethyl]-1H-imidazole-5-carboxylic acid. It is an intravenous general anaesthetic with no analgesic activity.
|
|
Phosphomethylphosphonic Acid Guanosyl Ester
|
|
|
3,5-Difluorobenzenesulfonamide
|
A sulfonamide that has formula C6H5F2NO2S.
|
|
Dihydrogenphosphate Ion
|
|
|
N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID
|
|
|
KRP-104
|
|
|
2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid
|
|
|
OPC-51803
|
|
|
Alfacalcidol
|
|
|
2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID
|
|
|
Rosiglitazone
|
|
|
Tecadenoson
|
|
|
Follitropin beta
|
|
|
4-PIPERIDIN-4-YLBUTANAL
|
A butanal that has formula C9H17NO.
|
|
Crizotinib
|
|